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SUMMARY 
Autophagy is a highly conserved eukaryotic recycling pathway that protects from various 
diseases, including cancer, infections, and neurodegenerative disorders. It involves the 
formation of the double-membraned autophagosome, which sequesters cytoplasmic 
material, such as aggregated proteins, damaged organelles, or pathogens, and delivers it 
to the lysosome for degradation. During this process, a ubiquitin-like conjugation system 
plays a crucial role. In humans, six ubiquitin-like hATG8 proteins are conjugated to 
autophagosomal membranes. The hATG8 family can be divided into the two subfamilies, 
LC3 and GABARAP, which have been suggested to have non-redundant functions in 
autophagosome formation. A central component of the ubiquitin-like conjugation 
system is the E3-like ATG12−ATG5 conjugate, which forms mutually exclusive complexes 
with either ATG16L1 or TECPR1. While ATG16L1 is known to function during hATG8 
conjugation, little is known about the role of TECPR1 in this system. TECPR1 has been 
implicated in the fusion of autophagosomes with lysosomes as well as in selective types 
of autophagy. However, the molecular details of these processes remain unknown. 
Here, it was found that knockout of TECPR1 in HeLa cells leads to a selective accumula-
tion of the two hATG8 proteins, LC3C and GABARAPL2, in puncta-like structures. 
Moreover, TECPR1 selectively recruits LC3C-positive autophagosomes to lysosomes by 
interacting with lipidated LC3C through an N-terminal LC3-interacting region. In vitro, 
TECPR1 selectively promotes the conjugation of LC3C to artificial membranes, confirm-
ing that TECPR1 selectively recognizes LC3C. Strikingly, TECPR1 and LC3C colocalize at 
ubiquitinated protein aggregates and depletion of TECPR1 impairs the removal of 
protein aggregates in presence of the proteasome inhibitor MG132. Furthermore, it was 
found that TECPR1 possesses a PH domain that specifically binds to PtdIns(4)P and 
targets TECPR1 to PtdIns(4)P-rich lysosomal membranes. Replacing this PH domain by a 
PtdIns(3)P-binding domain mistargets TECPR1 to endosomes, which appear as mul-
tivesicular bodies in electron micrographs. Importantly, LC3C-positive electron-dense 
structures that contain ubiquitin and the late autophagosomal marker STX17 are 
selectively recruited to these endosomal structures. Collectively, the data presented in 
this thesis suggest that TECPR1 recruits LC3C-positive autophagosomes to lysosomes, 
thereby facilitating the selective degradation of protein aggregates through autophagy.  
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1 INTRODUCTION 
Cells need to constantly adapt to different environmental conditions and respond to 
endogenous as well as exogenous stress. Thus, regulated biogenesis and degradation of 
proteins is essential for the survival and health of cells. In eukaryotic cells, proteins are 
degraded by the two following major pathways: (1) the ubiquitin-proteasome pathway 
that involves the selective degradation of ubiquitinated proteins by the proteasome; (2) 
the lysosomal pathway that does not only lead to degradation of proteins but also of 
lipids or carbohydrates by lysosomal enzymes. Lysosomes are central recycling com-
partments that can receive extracellular or intracellular material. While extracellular 
material is transported to lysosomes through the endocytic pathway, intracellular 
material is delivered to the lysosomal lumen through autophagy. 
Autophagy was first discovered in the 1960s by Christian De Duve who also invented 
the term autophagy (from ancient Greek, meaning ‘self-eating’; Klionsky, 2008). 
Afterwards, genetic screens in yeast identified the core autophagy-related (ATG) 
proteins involved in this pathway (Tsukada and Ohsumi, 1993; Thumm et al., 1994; 
Harding et al., 1995). Yoshinori Ohsumi’s major contribution to the discovery and 
understanding of the underlying mechanism was awarded with the Nobel Prize of 
Physiology or Medicine in 2016. Autophagy is important for cell survival since it regu-
lates cellular homeostasis and promotes clearance of toxic protein aggregates and 
pathogens. Therefore, dysfunctions in autophagic processes are associated with cancer, 
neurodegenerative diseases, microbial infection, and ageing (Mizushima et al., 2008). 
There are three main types of autophagy: macroautophagy, microautophagy, and 
chaperone-mediated autophagy (CMA).  
Macroautophagy is the best characterized form of autophagy and involves the de 
novo formation of a double-membraned organelle - the autophagosome (Figure 1). The 
biogenesis of the autophagosome starts with an initial cup-shaped membrane, called 
isolation membrane (IM), which captures cytoplasmic material and expands by fusing 
with small vesicles (Moreau et al., 2011). The membrane surrounding the cargo matures 
and closes before the outer membrane finally fuses with the lysosome to form the 
autolysosome. The sequestration of substrates into the autophagosome can be non-
selective or selective. In non-selective macroautophagy, a portion of the cytoplasm is 
enclosed by the autophagosome and recycled to maintain homeostasis and provide 
nutrients. This process can be induced by starvation of cells and other cytotoxic stress. In 
contrast, selective macroautophagy is mediated by autophagy receptors that select 
cargo and tether it to the inner membrane of the autophagosome (Rogov et al., 2014). 
Examples for selective cargo are protein aggregates (aggrephagy), mitochondria 
(mitophagy), peroxisomes (pexophagy), part of the endoplasmic reticulum (ER-phagy), 
ribosomes (ribophagy), lipid droplets (lipophagy), or intracellular pathogens (xenophagy; 
Mancias and Kimmelman, 2016). 
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Figure 1: Autophagosome formation in macroautophagy. The double-membraned 
autophagosome engulfs either non-selective or selective cargo. After maturation, the completed 
autophagosome fuses with lysosomes resulting in the autolysosome, which degrades the inner 
autophagosome membrane as well as its content.  
The second autophagy pathway is microautophagy, which involves the direct uptake of 
cytoplasmic material by lysosomes via membrane invagination. Microautophagy does 
not only include the uptake of non-selective cytosol but also of selective substrates, such 
as peroxisomes (‘micropexophagy’; Farre and Subramani, 2004). 
Chaperone-mediated autophagy degrades proteins bearing a KFERQ-like motif, which 
is recognized by the chaperone Hsc70 (Dice, 1990). The complex of chaperone and 
substrate binds to the receptor LAMP2A, a channel within lysosomal membranes, 
resulting in translocation of the cytosolic protein into the lysosomal lumen 
(Bandyopadhyay et al., 2008). Both microautophagy and CMA are independent of de 
novo membrane formation and only macroautophagy (in the following referred to as 
‘autophagy’) involves the biogenesis of a new compartment - the autophagosome.  
1.1 Regulation and initiation of autophagy 
Under normal growth conditions, there is a constant low level of basal autophagy, 
whereas under stress conditions, like starvation, autophagy is induced to ensure cell 
survival. Both, the level of basal and starvation-induced autophagy, are highly tissue 
specific (Mizushima et al., 2004). The induction of non-selective autophagy by stress 
such as nutrient deprivation is tightly regulated through inhibition of the mammalian 
target of rapamycin complex 1 (mTORC1) or activation of AMP activated protein kinase 
(AMPK), which promotes autophagy under glucose starvation (Kim et al., 2011). Under 
normal growth conditions, mTORC1 is active and inhibits autophagosome formation. 
Thus, initiation of autophagy can be achieved by inactivation of mTORC1 through various 
upstream signals, including amino acid levels, growth factors, or the mTOR specific 
inhibitor rapamycin (Sengupta et al., 2010).  
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Initiation of autophagy in mammalian cells has been suggested to occur at special 
subdomains of the endoplasmic reticulum (ER), which are phosphatidylinositol 3-
phosphate (PtdIns(3)P)-enriched omega-shaped structures, also known as the ome-
gasome (Itakura and Mizushima, 2010; Nishimura et al., 2017; Axe et al., 2008). Fur-
thermore, the de novo formation and growth of the autophagosome involves the 
incorporation of membranes originating from various sources, such as the ER, the ER-
Golgi intermediate compartment (ERGIC), or the plasma membrane (Juhasz and Neufeld, 
2006; Ge et al., 2013; Ravikumar et al., 2010). Moreover, small vesicles containing the 
transmembrane protein ATG9 were suggested to serve as membrane donors in early 
steps of autophagosome formation (Yamamoto et al., 2012; Orsi et al., 2012; Young et 
al., 2006).  
More than 40 autophagy-related proteins have been identified in yeast. The ‘core’ 
machinery, which is conserved from yeast to humans, comprises about 20 proteins 
organized in several complexes. These complexes are sequentially recruited to 
preautophagosomal membranes and cooperate to form mature autophagosomes 
(Figure 2). Autophagosome initiation starts with the formation and activation of the 
ULK1/2 (Atg1 in yeast) kinase complex consisting of ATG13, ATG101, RB1CC1 (FIP200), 
and the kinase ULK1 or ULK2. The complex is activated by dephosphorylation of ATG13 
and ULK1/2, two substrates of the kinase mTORC1 (Jung et al., 2009; Hosokawa et al., 
2009). Subsequently, a class III phosphatidylinositol 3-kinase (PI3K) complex is recruited, 
which contains Beclin-1 (BECN1), phosphatidylinositol 3-kinase catalytic subunit type 3 
(PIK3C3/VPS34), phosphoinositide 3-kinase regulatory subunit 4 (PIK3R4/VPS15), and 
ATG14 (Kihara et al., 2001; Itakura et al., 2008). Phosphorylation of Beclin-1 by ULK1 
activates the PI3K complex (Russell et al., 2013), which generates PtdIns(3)P at the ER. 
Various PtdIns(3)P-binding proteins are then recruited, including the double FYVE 
domain-containing protein 1 (DFCP1; Axe et al., 2008) and members of the WD-repeat 
protein interacting with phosphoinositide (WIPI) family. WIPI1, a mammalian WIPI 
family member, was proposed to interact with ATG2A at early autophagosomal mem-
branes (Pfisterer et al., 2014). Furthermore, WIPI2b was shown to recruit the 
ATG12−ATG5-ATG16L1 complex to the IM, a crucial step for autophagosome biogenesis 
(Dooley et al., 2014). 
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Figure 2: Initiation of autophagy. When mTORC1 is inactive the ULK1/2 kinase complex activates 
the class III PI3K complex, which produces PtdIns(3)P (PI3P) at the ER. Subsequently, WIPI 
proteins bind to PtdIns(3)P and recruit the ATG12−ATG5-ATG16L1 complex to the IM. 
1.2 The role of ubiquitin-like conjugation systems in autophagy 
Autophagosomal membranes need to expand to capture and engulf cytoplasmic 
material. They seal to generate the autophagosome and finally fuse with lysosomes for 
their degradation. In this maturation process, two ubiquitin-like (UBL) conjugation 
systems play an important role (Suzuki et al., 2007). Canonical ubiquitination cascades 
require three types of enzymes: E1, E2, and E3 enzymes. First, ubiquitin is activated by 
an E1 enzyme, which catalyzes the adenylation of the C-terminal glycine of ubiquitin and 
transfers it to an inherent reactive cysteine within its catalytic center. This first step is 
ATP-dependent and results in a thioester linkage between ubiquitin and E1. Second, 
ubiquitin is transferred to a cysteine in an E2 enzyme and forms another thioester 
intermediate with the E2 enzyme. Finally, an E3 enzyme mediates conjugation of the C-
terminal glycine of ubiquitin to a lysine in the target protein, generating an isopeptide 
bond (Pickart, 2001). 
The following two UBL conjugation systems are involved in autophagosome biogene-
sis: (1) the conjugation of ATG12 to ATG5, and (2) the conjugation of ATG8 proteins to 
the lipid phosphatidylethanolamine (PE) (Figure 3). For the conjugation of ATG12 to 
ATG5, ATG12 is first activated by ATG7 (an E1-like enzyme), next transferred to ATG10 
(an E2-like enzyme), and finally covalently linked to ATG5. This UBL conjugation results 
in the ATG12−ATG5 conjugate, which forms complexes with ATG16L1 and TECPR1 
(Mizushima et al., 1998; Kim et al., 2015). Human ATG8 family proteins (hATG8s; Atg8 in 
yeast) are expressed as pro-proteins with C-terminal amino acid extensions, which mask 
a glycine residue. As a consequence, they first have to be processed by the cysteine 
protease ATG4 to expose the C-terminal glycine (Kabeya et al., 2004). Similar to the 
conjugation of ATG12 to ATG5, hATG8s are activated by ATG7, but subsequently 
transferred to ATG3. Finally, hATG8s are linked to PE in autophagosomal membranes, 
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resulting in a stable amide bond between hATG8 proteins and PE (Ichimura et al., 2000). 
Therefore, the conjugation of hATG8s to PE is also referred to as the hATG8 lipidation. 
This final step is catalyzed by the ATG12−ATG5 conjugate, which serves as an E3-like 
enzyme and links the two UBL conjugation systems (Hanada et al., 2007). ATG16L1 
forms a complex with ATG12−ATG5 by binding to ATG5 and has been reported to specify 
the hATG8 lipidation site (Fujita et al., 2008; Mizushima et al., 2003).  
 
 
Figure 3: Ubiquitin-like conjugation systems in autophagy. The two UBL systems are intercon-
nected through the ATG12−ATG5 conjugate that forms a complex with ATG16L1 and catalyzes 
the last step of the hATG8 conjugation to the lipid PE in autophagosomal membranes.  
1.3 The role of ATG8 proteins in autophagy 
The mammalian ATG8 homologs are conjugated to the inner and outer membrane of 
autophagosomes (Kabeya et al., 2000; Kabeya et al., 2004). At the inner membrane, they 
tether selective cargo to the IM by binding autophagy receptors. Their role at the outer 
autophagosomal membrane, however, is poorly understood. In vitro studies have 
proposed that ATG8 proteins are involved in tethering and fusion of membranes, which 
suggests a role for ATG8 proteins in closure of the autophagosome or in autophago-
some-lysosome fusion (Nakatogawa et al., 2007; Weidberg et al., 2011; Landajuela et al., 
2016). Yet, this hypothesis has not been validated in vivo and alternative functions of 
ATG8 proteins on the outer autophagosomal membrane have been proposed. In yeast, it 
has been shown that Atg8 is able to form a scaffold together with Atg12−Atg5-Atg16 on 
membranes, which can be disassembled by the protease Atg4 and is critical for 
autophagosome biogenesis (Kaufmann et al., 2014). Therefore, scaffold formation on 
the outer autophagosomal membrane has been suggested to regulate the size and 
shape of autophagosomes.  
Similar to yeast, mammalian ATG8 proteins are substrates of the protease family 
ATG4, which consists of the four homologs ATG4A, ATG4B, ATG4C, and ATG4D. ATG4 
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family members process PE-conjugated ATG8 proteins with different specificities, while 
ATG4B seems to be the most active ATG4 homolog in human cells (Li et al., 2011; Kabeya 
et al., 2004). The activity of ATG4 is tightly regulated by phosphorylation (Sanchez-
Wandelmer et al., 2017). ATG4B, for example, can be phosphorylated by ULK1, resulting 
in inactivation of the protease. On the other hand, ATG4B can be dephosphorylated by 
the phosphatase PP2A-PP2R3B, which leads to its activation (Pengo et al., 2017). ATG4 is 
not only priming ATG8 proteins by C-terminal processing of the pro-protein but also 
recycling ATG8 family members by cleaving them of the membrane (Kabeya et al., 2004; 
Kirisako et al., 2000). The release of yeast Atg8 from the autophagosomal membrane has 
been proposed to trigger the fusion of autophagosomes with lysosomes (Nair et al., 
2012). 
The importance of mammalian ATG8 proteins in autophagosome biogenesis was 
demonstrated by various studies, which inhibited lipidation of ATG8 proteins by 
knockout of proteins of the UBL conjugation cascade, like ATG7, ATG3, or ATG5 in mice 
(Komatsu et al., 2005; Sou et al., 2008; Kuma et al., 2004). These knockout mice were 
neonatal lethal and showed impaired autophagosome formation, including defective 
elongation and closure of the isolation membrane. Therefore, ATG8 proteins were 
suggested to play a role in stabilizing and shaping autophagosomal membranes.  
Mammalian ATG8 homologs 
Mammalian ATG8 proteins were first described to be involved in other cellular processes 
than in autophagy. For example, LC3A and LC3B were found to be associated with 
microtubules (Kuznetsov and Gelfand, 1987; Mann and Hammarback, 1994), where they 
got their name microtubule-associated proteins 1A/1B light chain 3 (MAP1LC3) from. In 
contrast, gamma-aminobutyric acid receptor-associated protein (GABARAP) was found 
to interact with GABA(A) receptors (Wang et al., 1999) and GABARAPL2 has been 
identified as an essential factor for intra-Golgi protein transport (Legesse-Miller et al., 
1998). Besides these functions in various cellular pathways, all ATG8 proteins have been 
found to play an important role in autophagy. 
Mammalian ATG8 proteins can be divided into two subfamilies: the LC3 and the 
GABARAP subfamily. The presence of the subfamilies and the number of homologs vary 
in metazoans. Humans have at least seven different genes coding for hATG8 homologs: 
four members of the LC3 subfamily (MAP1LC3A, MAP1LC3B, MAP1LC3B2, and 
MAP1LC3C; short names LC3A, LC3B, LC3B2, and LC3C) and three members of the 
GABARAP subfamily (GABARAP, GABARAPL1/GEC1, and GABARAPL2/GATE-16/GEF2; 
Shpilka, 2011). A significance of LC3B2 in autophagy or other pathways has not been 
reported. Although most hATG8s are ubiquitously expressed, some hATG8 homologs 
exhibit tissue specific expression levels. LC3C, for example, was reported to be predomi-
nantly expressed in the lung and only at low levels in other tissues (He et al., 2003). 
GABARAPL1 was shown to be highly expressed in the central nervous system, whereas 
GABARAP is more expressed in endocrine glands (Nemos et al., 2003). The variations in 
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expression levels suggest that hATG8 homologs can have distinct functions in different 
cell types and partially compensate for each other. 
To date, many crystal structures of ATG8 family members have been solved and show 
that all ATG8 proteins share a ubiquitin-like fold with two additional N-terminal α-
helices. Those additional α-helices vary among the ATG8 proteins and could explain why 
some proteins specifically interact with only one or several ATG8 homologs. It was 
suggested that, depending on the association with membranes, the variable α-helices in 
ATG8 proteins have two distinct conformations, which might modify the binding 
capacity of ATG8 interaction partners (Coyle et al., 2002; Ichimura et al., 2004; 
Nakatogawa et al., 2007). Despite the differences in their amino acid sequence, there is 
little known about the individual functions of the different mammalian ATG8 homologs 
in autophagosome biogenesis.  
Specific functions of the different mammalian ATG8 homologs 
The first report of different functions of hATG8 homologs in autophagy utilized an 
siRNA-mediated knockdown of either the LC3 or the GABARAP subfamily in HeLa cells. 
This approach confirmed that both subfamilies are important for autophagosome 
biogenesis and further indicated that they act at different time points in autophagosome 
formation (Weidberg et al., 2010). In particular, this study suggested that the LC3 
subfamily is involved in elongation of the isolation membrane, whereas the GABARAP 
subfamily plays a role at a later stage. However, in LNCaP prostate cancer cells, au-
tophagic sequestration of the cytosolic cargo LDH was not impaired when the LC3 
subfamily was depleted, but was strongly decreased when expression of the GABARAP 
subfamily was inhibited (Szalai et al., 2015). Similar results were obtained for 
CRISPR/Cas9-mediated knockouts of either the three LC3s, the three GABARAPs, or all 
six hATG8 homologs in HeLa cells (Nguyen et al., 2016). Surprisingly, neither the LC3s nor 
the GABARAPs were necessary for the formation and sealing of autophagosomes, 
although the loss of all six hATG8s resulted in a smaller size of autophagosomes. 
However, the GABARAPs were essential for PINK1/Parkin-mediated mitophagy as well as 
for autophagosome-lysosome fusion, whereas the LC3 subfamily seems to play a minor 
role in these processes. These observations were suggested to result from the stronger 
in vivo affinity of the GABARAPs over the LC3s to PLEKHM1, a protein that recruits the 
HOPS complex and drives the autophagosome-lysosome fusion process (McEwan et al., 
2015).  
Most studies that investigated the different functions of mammalian ATG8 homologs 
focused on the differences between the LC3 and the GABARAP subfamily and only few 
analyzed the role of a specific hATG8 protein. The most widely studied member of the 
hATG8 family is LC3B, which is commonly used as an autophagic marker, although there 
is no evidence that it is always associated with autophagosomes (Klionsky et al., 2016). 
Other hATG8 family members seem to have very specific functions in autophagy, 
including LC3C and GABARAP. LC3C has been mainly implicated in selective types of 
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autophagy, like xenophagy, mitophagy, and aggrephagy. For example, LC3C has been 
shown to be essential in the clearance of intracellular Salmonella, being selectively 
recognized by the autophagy receptor NDP52 (von Muhlinen et al., 2012; Verlhac et al., 
2015). Furthermore, LC3C has been reported to be involved in HIV-1 release (Madjo et 
al., 2016), in PINK1/Parkin-independent basal mitophagy (Le Guerroué et al., 2017), and 
in aggrephagy, being recruited to protein aggregates by WDR81 (Liu et al., 2017). In 
addition, LC3C is bound by TECPR2, thereby regulating ER exit sites, which contributes to 
autophagosome formation (Stadel et al., 2015). GABARAP has been demonstrated to be 
transported from the centrosome to autophagosomes during starvation-induced 
autophagy and contributes to autophagosome formation by activation of ULK1 (Joachim 
et al., 2015; Joachim et al., 2017). Moreover, GABARAP has been suggested to be 
essential for autophagosome-lysosome fusion by recruiting the PtdIns(4)P-generating 
kinase PI4KIIα to autophagosomes (Wang et al., 2015). Collectively, these recent studies 
indicate that the mammalian ATG8 homologs have distinct functions in autophagosome 
biogenesis and can partially compensate for each other. 
ATG8-interacting proteins 
Many mammalian ATG8-interacting proteins contain a short hydrophobic LC3-
interacting region (LIR), which in yeast is referred to as Atg8-interacting motif (AIM; Wild 
et al., 2014). The LIR motif is a W-X-X-L sequence that is commonly preceded by acidic 
residues. The tryptophan (W) in the LIR motif can also be replaced by other bulky 
aromatic residues, including tyrosine (Y) or phenylalanine (F). Moreover, the leucine (L) 
can be replaced by isoleucine (I) or valine (V). The two hydrophobic residues bind into 
two corresponding pockets of the LIR docking site in ATG8 proteins (Noda et al., 2008). 
The interaction via a LIR motif can be regulated by phosphorylation. For example, 
phosphorylation of the autophagy receptor optineurin (OPTN) at serine 177, which is 
adjacent to its LIR motif, enhances its interaction with LC3B (Wild et al., 2011). Interac-
tions with ATG8-interacting proteins can also be regulated by phosphorylation of ATG8 
proteins. LC3A and LC3B, for example, are phosphorylated by protein kinase A (PKA), 
which has an inhibitory effect on their activity (Cherra et al., 2010). Moreover, mouse 
LC3B gets phosphorylated by STK3 and STK4 at threonine 50, resulting in a block of 
autophagy and clearance of intracellular bacteria (Wilkinson et al., 2015).  
The LIR motif was first discovered in the autophagy receptor p62/SQSTM1 (sequesto-
some-1, hereafter referred to as p62), which was also the first autophagy receptor 
described (Pankiv et al., 2007; Bjørkøy et al., 2005). Like many autophagy receptors, p62 
can bind to ATG8 proteins and to ubiquitin at the same time, thereby mediating the 
contact between autophagosomal membranes and polyubiquitinated cargo. The cargo 
of p62 can be ubiquitinated protein aggregates, damaged mitochondria, peroxisomes, or 
intracellular bacteria. A number of additional autophagy receptors have been identified 
that recognize different types of polyubiquitin chains, such as NBR1, NDP52, or OPTN, 
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which have all been implicated in aggrephagy, mitophagy, and xenophagy (Rogov et al., 
2014). 
The binding preferences of ATG8-interacting proteins are very diverse. Some proteins 
possess a canonical LIR motif that interacts with all ATG8 homologs, others are specific 
for one subfamily or even for a single ATG8 homolog. A proteomic study revealed that 
insight of autophagosomal membranes the interactome of LC3 and GABARAP subfami-
lies only minimally overlaps, which suggests that they mediate capturing of different 
cargo (Le Guerroué et al., 2017). From comparison of LIR motifs that are specific for one 
subfamily, a GABARAP interaction motif (GIM; [W/F]-[V/I]-X-V) was defined. This GIM 
motif is for example present in the adaptor protein PLEKHM1 that preferably binds to 
GABARAPs over LC3s. On the other hand, there is a number of ATG8-interacting proteins 
that do not contain a canonical LIR motif (Behrends et al., 2010). The autophagy 
receptor NDP52, for example, binds exclusively to LC3C via an L-V-V (also referred to as 
CLIR) motif (von Muhlinen et al., 2012). Furthermore, some ATG8 interaction partners 
have a preference towards the lipidated form of ATG8 proteins, while other proteins 
show stronger interaction with the unlipidated form (Behrends et al., 2010). For 
example, p62 binds to both LC3B and GABARAPL2 in their unlipidated form, but only 
lipidated LC3B is able to recruit p62 to autophagosomes (Shvets et al., 2011). When the 
N-terminus of LC3B is removed or mutated it fails to bind p62, indicating that the 
specific interaction with lipidated LC3B is mediated by its N-terminal domain.  
Taken together, ATG8 proteins play a crucial role in autophagosome biogenesis. 
Many ATG8-interacting proteins have been identified that regulate the activity or 
selectivity of autophagy. However, the precise function of the mammalian ATG8 
homologs and their interaction with specific binding partners remain elusive. 
1.4 The role of the endocytic pathway in autophagy 
The endocytic pathway 
The endocytic pathway consists of several membrane compartments that are specialized 
for the uptake, sorting, recycling, and degradation of molecules originating from the 
plasma membrane. The main components of the endocytic pathway are early endo-
somes (EEs), late endosomes (LEs), and lysosomes. Initially, vesicles that contain 
extracellular material or proteins of the plasma membrane, like transmembrane 
receptors, form at the plasma membrane. These vesicles fuse with Rab5- and EEA1-
positive early endosomes to deliver their membrane and content. During maturation of 
early endosomes to late endosomes, specific proteins and lipids are exchanged or 
converted. For example, the small GTPase Rab5 is replaced by Rab7 and the lipid 
PtdIns(3)P that is predominantly found on early endosomes is converted into other 
phosphoinositides, like PtdIns(3,5)P2 or PtdIns(4)P. The regulation of phosphoinositides 
is important for the maturation and fusion of various endocytic compartments (Jeschke 
et al., 2015).  
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Endocytic cargo is sorted in early endosomes and can be targeted to at least three 
different destinations: (1) the plasma membrane through Rab11-positive recycling 
endosomes (REs), (2) the trans-Golgi network (TGN) mediated by retromer, or (3) 
intraluminal vesicles of multivesicular bodies (MVBs) using the endosomal sorting 
complexes required for transport (ESCRT) machinery. For degradation of their content, 
MVBs and LEs fuse with lysosomes, which results in a decrease of the luminal pH (Elkin 
et al., 2016). The integrity of lysosomes depends on hydrolases that degrade specific 
substrates as well as on integral membrane proteins, such as the vacuolar H+-ATPase, 
LAMP1, and LAMP2. Lysosomal membrane proteins can have diverse functions, includ-
ing acidification of the lysosomal lumen, protein import from the cytoplasm, and 
transport of degradation products to the cytoplasm (Saftig and Klumperman, 2009).  
Endocytic membrane compartments undergo dynamic fusion and fission events. 
Generally, the fusion of two membrane compartments requires tethering factors and 
soluble N-ethylmaleimide-sensitive-factor attachment receptor (SNARE) proteins. In the 
endocytic pathway, at least two tethering complexes are important: (1) the CORVET 
complex that functions in endosome-endosome fusion by binding to Rab5, and (2) the 
HOPS complex that is important for endosome-lysosome fusion and is a Rab7 effector 
(Balderhaar and Ungermann, 2013). SNARE proteins are located on two opposing 
membranes and drive membrane fusion by a zipper-like mechanism. This process 
involves the formation of a four-helix bundle of a Qa-, Qb, Qc, and R-SNARE. After fusion 
has occurred, the stable SNARE complexes must be disassembled by the ATPase NSF and 
α-SNAP (Chen and Scheller, 2001). 
Autophagy and the endocytic pathway 
Autophagy and the endocytic pathway are interconnected at different stages in 
autophagosome biogenesis. Most important, complete autophagosomes fuse either 
directly with lysosomes or first with early or late endosomes, such as MVBs. The fusion 
with endosomes results in amphisomes, which then fuse with lysosomes to form 
autolysosomes. However, the contribution of the endocytic pathway to autophagosome 
biogenesis is diverse and still poorly described.   
Rab11-positive REs, for example, are involved in starvation-induced autophagy by 
delivering ULK1 and ATG9 to forming autophagosomes (Longatti et al., 2012). A factor 
that was suggested to regulate ATG9 trafficking between recycling endosomes and Golgi 
membranes is the TRAPPIII tethering complex (Lamb et al., 2016). The human TRAPPIII 
complex was first identified in a proteomic study as part of the autophagy interaction 
network (Behrends et al., 2010). It consists of the core TRAPP subunits and an autopha-
gy-specific subunit (TRAPPC8 in mammals) and was suggested to positively regulate 
autophagosome formation. 
The formation of the isolation membrane involves ATG16L1-positive autophagosome 
precursors that form at the plasma membrane and undergo homotypic fusion. This 
process depends on the SNARE VAMP7 together with its partner SNAREs (Moreau et al., 
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2011; Ravikumar et al., 2010). Similar to endosome-lysosome fusion, Rab7 is present on 
mature autophagosomes and required for autophagosome maturation and autophago-
some-lysosome fusion (Jager et al., 2004; Ganley et al., 2011). The Rab7 effector and 
tethering complex HOPS plays an essential role in the fusion of autophagosomes with 
lysosomes. Knockdown of components of the HOPS complex leads to an accumulation of 
LC3- and Syntaxin17 (STX17)-positive puncta (Jiang et al., 2014). STX17 is a late autopha-
gosome marker that has been identified as the autophagosomal SNARE, which localizes 
to the outer membrane of completed autophagosomes (Itakura et al., 2012). The 
complex of STX17 and its partner SNAREs SNAP-29 and the lysosomal SNARE VAMP8 is 
stabilized by ATG14 to promote autophagosome-lysosome fusion (Diao et al., 2015). 
Furthermore, autophagosome-lysosome fusion has been shown to require the lipid 
kinase PI4KIIα that generates PtdIns(4)P and is recruited by GABARAP (Wang et al., 
2015). This suggests an important role of both PtdIns(4)P and the GABARAP protein 
family in the fusion of autophagosomes with lysosomes. 
After fusion with LEs or autophagosomes, lysosomes need to be recycled to maintain 
their function. In case of autolysosomes this process is called autophagic lysosome 
reformation (ALR) and is regulated by reactivation of mTORC1, which causes the 
formation of protolysosomal tubules emerging from the autolysosome (Yu et al., 2010). 
ALR depends on clathrin and on the conversion of PtdIns(4) to PtdIns(4,5)P2 by phospha-
tidylinositol-4-phosphate 5-kinases like PIP5K1B (Rong et al., 2012). Although there is 
evidence that autophagy and the endocytic pathway closely cooperate, the mechanism 
of how autophagosomes interact with the endosomal system is still poorly understood.  
1.5 The role of TECPR1 in autophagy 
The fusion of autophagosomes with endosomes or lysosomes must be tightly regulated 
to ensure correct degradation of autophagic cargo. One factor that was suggested to 
promote autophagosome-lysosome fusion is tectonin beta-propeller repeat containing 
protein 1 (TECPR1). In a proteomic analysis, TECPR1 was identified for the first time and 
found to be associated with ATG5, ATG12, and ATG3, all components of the hATG8 
lipidation machinery (Behrends et al., 2010). Moreover, the same study showed that 
TECPR1 is associated with the TRAPPIII complex. However, a direct interaction has only 
been confirmed between TECPR1 and ATG5 and is mediated through an ATG5-
interacting region (AIR; Chen et al., 2012; Ogawa et al., 2011; Kim et al., 2015). ATG16L1 
also binds to ATG5 via its N-terminal AIR motif. Consequently, complex formation of 
ATG16L1 or TECPR1 with ATG12−ATG5 is mutually exclusive (Chen et al., 2012; Kim et 
al., 2015). 
TECPR1 is a multidomain protein of 130 kDa, containing two WD-repeat domains 
composed of four or five β-propeller repeats, two dysferlin motifs, a pleckstrin homolo-
gy (PH) domain, and a disordered region (DR) adjacent to the PH domain (Figure 4). The 
lipid-binding PH domain has been reported to interact with PtdIns(3)P and this interac-
tion was suggested to depend on the binding of ATG12−ATG5 to TECPR1 (Chen et al., 
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2012). TECPR1 was further shown to colocalize with the autophagosomal and lysosomal 
proteins LC3 and LAMP2, respectively, suggesting that it is predominantly present on 
autolysosomes (Chen et al., 2012). Contradictory data exist about the function of 
TECPR1 in canonical autophagy. On the one hand, knockdown of TECPR1 in U2OS cells 
resulted in an increase of the autophagosome markers LC3-II (lipidated LC3) and p62, 
suggesting that TECPR1 depletion leads to an accumulation of autophagosomes (Chen et 
al., 2012). Furthermore, the same study reported that in TECPR1 depleted cells lysoso-
mal degradation of the RFP-GFP-LC3 reporter is reduced, indicating that autophagosome 
maturation and fusion with lysosomes is affected. On the other hand, knockdown of 
TECPR1 in HeLa or HEK293T cells resulted in a slight decrease of LC3-II (Ogawa et al., 
2011). These data suggest that TECPR1 does not play an essential role in canonical 
autophagy. Instead, TECPR1 has been implicated in selective types of autophagy, 
including xenophagy, mitophagy, and aggrephagy. For example, it was demonstrated 
that TECPR1 localizes together with LC3, ATG5, and WIPI-2 to intracellular Shigella and is 
important for their autophagic clearance (Ogawa et al., 2011).  
In conclusion, TECPR1 plays an important role in selective autophagy, likely by acting 
in a late step in autophagosome maturation. However, how TECPR1 is targeted to 
autolysosomal membranes and how it coordinates the fusion of selective autophago-
somes with lysosomes remains to be elucidated.  
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1.6 Aims of this study 
Autophagy is crucial for many cellular processes by maintaining cellular homeostasis and 
recycling damaged organelles. As a consequence, perturbation of the pathway has been 
implemented in the onset of various diseases, like cancer and neurodegeneration. 
Unraveling the underlying mechanism is thus of eminent importance to identify 
potential drug targets to treat these diseases. To date, the molecular mechanism of 
autophagosome formation in yeast is well described; however, the mechanism in higher 
eukaryotes is not well understood. For example, there are at least six different mamma-
lian ATG8 homologs, while yeast has only one Atg8 gene. In addition, there is no TECPR1 
ortholog in yeast despite its important function in animals.  
TECPR1 has been shown to play a role in selective types of autophagy as well as in 
autophagosome-lysosome fusion. Moreover, it interacts with ATG12−ATG5, the E3-like 
ligase of the UBL conjugation cascade, which is known to also form a complex with 
ATG16L1. However, the function of TECPR1 in the human UBL conjugation system has 
not been investigated. Additionally, there is contradictory data about the effect of 
TECPR1 depletion on autophagy, and therefore the precise function of TECPR1 in 
autophagosome biogenesis needs to be clarified.  
Previously, our lab has successfully reconstituted the human UBL system in vitro using 
recombinant proteins and giant unilamellar vesicles (GUVs) as model membranes 
(Dempfle, 2014; Kaufmann, 2015). I have further succeeded in expressing and purifying 
human TECPR1 from insect cells and demonstrated that TECPR1, in addition to ATG16L1, 
is able to promote hATG8 lipidation (Dempfle, 2014). Based on these data, four specific 
aims of this study were defined: First, the catalytic activity of TECPR1 with respect to the 
different hATG8 homologs was to be further characterized, both in vitro and in vivo. 
Therefore, CRISPR/Cas9-mediated knockouts of ATG16L1 and TECPR1 were required. 
Second, the interaction of TECPR1 with components of the UBL conjugation system, such 
as the different hATG8s, should be analyzed. Third, the cellular localization of TECPR1 
and interacting proteins was to be investigated. For this purpose, the proteins should be 
fluorescently tagged and visualized by immunofluorescence or electron microscopy. In 
addition, expressing single domains of TECPR1 or deleting them should provide infor-
mation on their function. Especially the deletion of the lipid-binding PH domain in 
combination with in vitro lipid binding assays should reveal how TECPR1 is targeted to its 
cellular destinations. Finally, the role of TECPR1 and hATG8 proteins in selective and 
non-selective autophagy had to be clarified. Therefore, degradation of selective and 
non-selective autophagic cargo should be analyzed under depletion of the respective 
proteins.  
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2 MATERIALS AND METHODS 
2.1 Reagents 
Used buffers and media are listed in Table 1, Table 8, and Table 10. Antibodies are 
specified in Table 15 and Table 16. 
 
Table 1: Buffers for agarose gels, SDS-PAGE, and western blotting 
Buffer Components 
TAE buffer 40 mM Tris-HCl (Sigma-Aldrich) 
20 mM acetic acid (Sigma-Aldrich) 
1 mM EDTA, pH 8.0 (Carl Roth) 
5x SDS loading buffer 225 mM Tris-HCl, pH 6.8 
50% glycerol (Carl Roth) 
5% (w/v) SDS (Carl Roth) 
0.05% bromphenol blue (Merck) 
250 mM DTT (PanReac AppliChem) 
SDS running buffer 25 mM Tris-HCl 
19.21 mM glycine (Sigma-Aldrich) 
0.1% (w/v) SDS 
MES SDS running buffer 50 mM MES (PanReac AppliChem) 
50 mM Tris-HCl, pH 7.3 
0.1% (w/v) SDS  
1 mM EDTA 
Coomassie staining solution 0.25% (w/v) Coomassie R-250 (PanReac AppliChem) 
30% (v/v) ethanol (Sigma-Aldrich) 
10% (v/v) acetic acid 
Coomassie destaining solution 40% (v/v) ethanol 
10% (v/v) acetic acid  
Shrinking solution 50% (v/v) methanol (Sigma-Aldrich) 
3% (v/v) glycerol 
Blotting (transfer) buffer 25 mM Tris 
192 mM glycine 
0.1% (w/v) SDS 
20% (v/v) methanol 
Tris-buffered saline with Tween 20 
(TBS-T) buffer 
25 mM Tris-HCl, pH 7.6 
150 mM NaCl 
0.05% (v/v) Tween-20 (Fisher Scientific) 
2.2 Cloning  
In general, cDNA was amplified from an open reading frame (ORF) template (Table 2) by 
polymerase chain reaction (PCR) using gene specific primers and Phusion High-Fidelity 
DNA Polymerase (NEB) according to the manufacturer’s instructions. The quality of PCR 
products was controlled by agarose gel electrophoresis using self-casted 1% agarose 
(Biomol) gels containing one drop of Ethidium Bromide solution 0.07% (PanReac 
AppliChem) per gel in TAE buffer (Table 1). PCR products were either purified using the 
QIAquick PCR Purification Kit (Qiagen) or isolated from a 1% agarose gel using the 
QIAquick Gel Extraction Kit (Qiagen). Vectors (Table 3) were either linearized by PCR as 
described above or by restriction enzyme digest. For the latter, 2 µg of vector was mixed 
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with 1 µl of each enzyme (all NEB) in the provided buffer and incubated for at least 
1 hour at 37 °C. The digested vector was then extracted from a 1% agarose gel. If the 
PCR product of the insert contained the corresponding restriction sites (which were 
added to the 5’-end of the primers) the PCR product was also digested with the same 
restriction enzymes as the vector. 100 ng of digested vector was mixed with the digested 
insert in a ratio of 1:2 to 1:7 and incubated with T4 DNA ligase (NEB) in the provided 
1X T4 DNA Ligase Reaction Buffer for 1 hour at room temperature or 16 °C overnight. If 
the PCR product of the insert contained extensions at the 5’-end that were complemen-
tary to the ends of the linearized vector, insert and vector were combined via homolo-
gous recombination. For linearized pCoofy vectors the recombinase RecAf (NEB) was 
used according to Scholz et al., 2013. For the recombination of other linearized vectors 
with inserts the In-Fusion HD Cloning Kit (Clontech Laboratories) was used according to 
the manufacturer’s instructions. 1-5 µl of ligated or recombined plasmids were then 
transformed into 50 µl XL1 Blue or omniMAX competent cells by heat shock at 42 °C for 
45 sec. Transformed cells were plated on LB-Agar plates containing the appropriate 
antibiotics and incubated at 37 °C overnight. Single colonies were picked, grown in 5 ml 
LB with the respective antibiotics, and plasmid DNA was isolated using the QIAprep Spin 
Miniprep Kit (Qiagen). The correct insertion of cDNAs into the vectors was validated by 
sanger sequencing (Eurofins Genomics).  
 
Table 2: Used open reading frames (ORFs) for cloning 
ORF gene name accession  
number 
origin cDNA clone 
name/ID 
TECPR1 TECPR1 NM_015395.2 ImaGenes cDNA library IRATp970H0679D 
LC3A MAP1LC3A NM_032514.3 ImaGenes cDNA library IRATp970E0811D 
LC3B MAP1LC3B NM_022818.4 ImaGenes cDNA library IRAUp969H0456D 
LC3C MAP1LC3C NM_001004343.2 LC3C in pmCherry-C1, 
provided by Prof. Ivan Dikic 
 
GABARAP GABARAP NM_007278.1 ImaGenes cDNA library IRCMp5012H094D 
GABARAPL1 GABARAPL1 NM_031412.2 GABARAPL1 in pmCherry-C1, 
provided by Prof. Ivan Dikic 
 
GABARAPL2 GABARAPL2 NM_007285.6 ImaGenes cDNA library IRAUp969E1044D 
WDR81 WDR81 NM_001163809.1 HeLa mRNA extract 
+ ImaGenes cDNA library 
 
BC114568 
HGS HGS NM_004712.4 ImaGenes cDNA library BC003565 
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Table 3: Used vectors 
Vector name Tag/insert origin 
pEGFP-C1 eGFP (N-terminal) Dr. Zuzana Storchova 
pMRFP-C1 mRFP (N-terminal) cloned from pEGFP-C1 and ptfLC3 
pLPCX - Dr. Julia von Blume 
pSpCas9(BB)-2A-Puro 
(PX459)  
hSpCas9-2A-Puro Feng Zhang (Addgene plasmid # 48139) 
ptfLC3 mRFP-eGFP-LC3b (rat) Tamotsu Yoshimori (Addgene plasmid 
# 21074) 
pCoofy1 His6 (N-terminal) MPIB core facility 
pCoofy4 His6-MBP (N-terminal) MPIB core facility 
pCoofy29 His6-MBP (N-terminal) MPIB core facility 
mCherry-P4M-SidM mCherry-P4M-SidM(546-647) Tamas Balla (Addgene plasmid # 51471) 
pYM-N8 3xHA Prof. Roland Wedlich-Söldner 
pMRFP-C1 
The vector pMRFP-C1 was cloned by replacing the ORF of eGFP by mRFP in the vector 
pEGFP-C1. Therefore, the vector pEGFP-C1 was digested with NheI and BspEI and the 
vector pTfLC3 was digested with NheI and AgeI. pEGFP-C1 backbone and pTfLC3 insert 
(mRFP) were extracted from an agarose gel and ligated with T4 DNA ligase. 
PtdInsP-sensors 
The PtdIns(4)P-sensor mCherry-P4M-SidM (Table 3; Hammond et al., 2014) and the 
PtdIns(3)P-sensor RFP-2xFYVE were used. For cloning of RFP-2xFYVE, two repeats of the 
FYVE domain of HGS (AA 147-222; Table 2) were amplified using the primers listed in 
Table 4 and recombined with a BamHI and XhoI digested pMRFP-C1 vector in one step 
using the In-Fusion HD Cloning Kit. This resulted in a vector with N-terminal mRFP-tag 
and the two FYVE domains separated by the linker QGQGS. 
 
Table 4: Primers used for cloning of RFP-2xFYVE. Gene specific sequences are black, homolog 
sequences to either the linearized vector or the preceding ORF sequence are marked in green, 
and additionally added base pairs are marked in red. 
DNA Construct Name of Primer Sequence (5’ 3’) 
RFP-2xFYVE FYVE-F1-FW                                       
FYVE-F1-REV                                               
FYVE-F2-FW                                            
FYVE-F2-REV                                      
ggactcagatctcgaggagagcgatgccatgtttg 
ggatccttgtccttgtttcctgttcagctgctcg 
caaggacaaggatccgagagcgatgccatgtttg 
tagatccggtggatcctatttcctgttcagctgctcg 
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hATG8s and other ATG proteins 
Cloning of LC3A, LC3B, GABARAP, GABARAPL2, ATG3, ATG7, ATG16L1, and TECPR1 in 
pCoofy vectors was performed by Anna Kaufmann as described in her doctoral thesis 
(Kaufmann, 2015). LC3C and GABARAPL1 were cloned into pCoofy1 and pEGFP-C1 by 
Sumit Kumar. 
Primers used for cloning of hATG8s are listed in Table 5. hATG8s were inserted into 
pEGFP-C1 and pTfLC3 between BglII and KpnI restriction sites, resulting in GFP-hATG8s 
and RFP-GFP-hATG8s, respectively. Therefore, hATG8 cDNAs were amplified and vectors 
and inserts digested with BglII and KpnI, followed by ligation with T4 DNA ligase. LC3C 
was cloned into pTfLC3 by linearizing the vector using PCR, amplifying the cDNA, and 
recombining linearized vector and cDNA with RecAf. 
For cloning of hATG8s with N-terminal HA-tag, LC3A, LC3B, GABARAP, and 
GABARAPL2 were first amplified with primers containing the HA-sequence and ligated 
with HindIII and NotI digested pLPCX vector. LC3C and GABARAPL1 were first cloned into 
pLPCX without HA-tag using PCR linearized vector and insert, followed by recombination 
with the In-Fusion HD Cloning Kit. Since the antibody signal for 1xHA-tagged proteins 
was not strong enough, three repeats of HA instead of one were added to the N-
terminus of hATG8s in pLPCX. Therefore, the 3xHA tag was amplified from pYM-N8 
(Table 3), pLPCX vectors containing hATG8 inserts were linearized, and both were 
recombined using the In-Fusion HD Cloning Kit. In the following, 3xHA-tagged hATG8 
proteins are referred to as HA-hATG8s. 
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Table 5: Primers used for cloning of hATG8s. Gene specific sequences are black, restriction sites 
are marked in blue, homolog sequences to the linearized vector are marked in green, and 
additionally added base pairs are indicated in red. 
DNA 
Construct 
Name of Primer Sequence (5’ 3’) 
GFP-LC3A LC3a_BglII_fw 
LC3a_KpnI_rev_2 
tatagatctatgccctcagaccggcct 
taaggtacctcagaagccgaaggtttcc 
GFP-LC3B LC3b_BglII_fw 
LC3b_KpnI_rev 
tatagatctatgccgtcggagaagacc 
ggcggtaccttacactgacaatttcatcccg 
GFP-
GABARAP 
GABARAP_BglII_fw 
GABARAP_KpnI_rev_2 
ggcagatctatgaagttcgtgtacaaagaagagc 
gacggtacctcacagaccgtagacactttcg 
GFP-
GABARAPL2 
GATE-16_BglII_fw 
GATE-16_KpnI_rev_2 
ggcagatctatgaagtggatgttcaaggagg 
gacggtacctcagaagccaaaagtgttctca 
RFP-GFP-
LC3C 
pTf_lin_fw 
pTf_lin_rev 
LC3C-SLIC-fw 
LC3C-SLIC-rev 
cagacatacagccacttccaactaa 
tctagatctgagtccggacttgtac 
agtccggactcagatctagaatgccgcctccacaga 
tggaagtggctgtatgtctgctagagaggattgcagggtctg 
1xHA-LC3A LC3a_HindIII_HA_fw 
LC3a_NotI_rev 
cagaagcttatgtacccatacgacgtcccagactacgctatgccctcagaccggc 
tatgcggccgctcagaagccgaaggtttcc 
1xHA-LC3B LC3b_HindIII_HA_fw 
LC3b_NotI_rev 
cagaagcttatgtacccatacgacgtcccagactacgctatgccgtcggagaagacc 
caggcggccgcttacactgacaatttcatcccg 
1xHA-
GABARAP 
GABARAP_HindIII_HA_fw 
 
GABARAP_NotI_rev 
cggaagcttatgtacccatacgacgtcccagactacgctatgaagttcgtgtacaaa-
gaagagc 
caagcggccgctcacagaccgtagacactttcg 
1xHA-
GABARAPL2 
GATE-16_HindIII_HA_fw 
 
GATE-16_NotI_rev 
cagaagcttatgtacccatacgacgtcccagactacgctatgaagtg-
gatgttcaaggagg 
caagcggccgctcagaagccaaaagtgttctctc 
pLPCX 
linearization 
LP1_pLPCX_RV 
LP2_pLPCX_FW 
aagcttgagctcgagatctg 
cgttaggccattaaggcc 
LC3C in 
pLPCX 
FW_LC3C_for_pLPCX 
RV_LC3C_for_pLPCX 
ctcgagctcaagcttatgccgcctccacag 
cttaatggcctaacgctagagaggattgcagggtc 
GABARAPL1 
in pLPCX 
FW_GABL1_for_pLPCX 
RV_GABL1_for_pLPCX 
ctcgagctcaagcttatgaagttccagtacaaggagg 
cttaatggcctaacgtcatttcccatagacactctcatc 
3xHA insert FW_HA_for_pLPCX 
RV_HA_link+LC3A 
RV_HA_link+LC3B 
RV_HA_link+LC3C 
RV_HA_link+GAB 
RV_HA_link+GABL1 
RV_HA_link+GATE16 
ctcgagctcaagcttccccggaatgggttacc 
ccggtctgagggcatcgatgaattctctgtcggac 
gtcttctccgacggcatcgatgaattctctgtcggac 
ctgtggaggcggcatcgatgaattctctgtcggac 
gtacacgaacttcatcgatgaattctctgtcggac 
gtactggaacttcatcgatgaattctctgtcggac 
gaacatccacttcatcgatgaattctctgtcggac 
linearization 
of hATG8s in 
pLPCX  
LP1_pLPCX_RV 
LP2_pLPCX_LC3A_FW 
LP2_pLPCX_LC3B_FW 
LP2_pLPCX_LC3C_FW 
LP2_pLPCX_GAB_FW 
LP2_pLPCX_GABL1_FW 
LP2_pLPCX_GATE-16_FW 
aagcttgagctcgagatctg 
atgccctcagaccgg 
atgccgtcggagaagac 
atgccgcctccacag 
atgaagttcgtgtacaaagaagag 
atgaagttccagtacaaggagg 
atgaagtggatgttcaaggag 
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TECPR1 and TECPR1 constructs 
TECPR1 domains and constructs used in this thesis are depicted in Figure 4. 
 
 
Figure 4: TECPR1 domains. TECPR1 contains a pleckstrin homology (PH, AA 611-717) domain, a 
disordered region (DR, AA 378-606), an ATG5-interacting region (AIR, AA 578-605), a potential 
LC3-interacting region (LIR, AA 175-178), nine β-propeller repeats (TECPR, AA 209–240, 254–285, 
301–332, 344–376, 729–756, 953–984, 1044–1075, 1087–1127), and two dysferlin domains 
(Dysf, AA 64-170, 816-922). The TECPR1 constructs TR1 (AA 1-377), TR2 (AA 722-1165), 
TECPR1ΔPH (ΔAA 611-717), and TECPR1ΔPH-2xFYVE are illustrated beneath. 
Cloning of the TECPR1 domains TR1 and TR2 into pCoofy4 is described in my master 
thesis (Dempfle, 2014). Primers used in this thesis for cloning of TECPR1 and TECPR1 
constructs are listed in Table 6. 
TECPR1 full-length and TECPR1 constructs (TR1, AA 1-377; DR, AA 378-606; TR2, AA 
722-1165) were inserted into pEGFP-C1 between XhoI and HindIII or EcoRI restriction 
sites. TECPR1 cDNA was amplified and both vector and inserts were digested with the 
respective restriction enzymes before ligation with T4 DNA ligase. 
TECPR1 was further cloned into pMRFP-C1 between XhoI and HindIII restriction sites. 
Therefore, TECPR1 cDNA was amplified and restriction enzyme digest was performed on 
both insert and vector followed by ligation with T4 DNA ligase.  
The deletion of the PH domain (AA 611-717) in TECPR1 was introduced by amplifica-
tion of GFP-TECPR1 and RFP-TECPR1 using PCR followed by recombination with RecAf. In 
the following the PH deletion constructs are referred to as GFP-TECPR1ΔPH and RFP-
TECPR1ΔPH. 
The TECPR1ΔPH-2xFYVE constructs were cloned by linearizing GFP-TECPR1 and RFP-
TECPR1 and amplifying the FYVE domain from HGS (AA 147-222), followed by recombi-
nation of vector and two repeats of the FYVE domain using the In-Fusion HD Cloning Kit. 
The TECPR1 constructs TECPR1wt, TECPR1ΔPH, and TECPR1ΔPH-2xFYVE were additionally 
inserted into pLPCX without tag. Therefore, the pLPCX vector was linearized by PCR and 
TECPR1 constructs were amplified from GFP-TECPR1, GFP-TECPR1ΔPH, and GFP-
TECPR1ΔPH-2xFYVE, followed by recombination with RecAf. 
GFP-TECPR1ΔAIR (ΔAA 578-605) and GFP-TECPR1ΔPH-2xFYVE-ΔAIR were cloned using the 
QuikChange Lightning Site-directed Mutagenesis Kit (Agilent) according to the manufac-
turer’s instructions with GFP-TECPR1 or GFP-TECPR1ΔPH-2xFYVE as template. 
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TECPR1 peptides (TECPR174-103 and TECPR1158-187) containing potential LIR motifs were 
cloned into pCoofy4 by homologous recombination as described (Scholz et al., 2013). 
TECPR1 LIR mutations W175A/I178A and LLL(87-89)SSS were introduced into GFP-
TECPR1, GFP-TR1, GFP-TECPR1ΔPH-2xFYVE, MBP-TR1 (pCoofy4), TECPR174-103 (pCoofy4), and 
TECPR1158-187 (pCoofy4) using the QuikChange Lightning Site-Directed Mutagenesis Kit 
according to the manufacturer’s instructions. 
 
Table 6: Primers used for cloning of TECPR1 and TECPR1 constructs. Gene specific sequences are 
black, restriction sites are marked in blue, homolog sequences to either the linearized vector or 
the preceding ORF sequence are marked in green, and additionally added or altered base pairs 
are marked in red. 
DNA Construct Name of Primer Sequence (5’ 3’) 
GFP-TECPR1 TECPR_XhoI_fw 
TECPR_HindIII_rev_2 
taactcgaggcatgcccaactcagtgctgtg 
tataagctttcagcagcagacggggc 
GFP-TR1 TR1_XhoI_fw 
TR1_HindIII_rev  
=   TECPR_XhoI_fw 
gacaagctttcacgcgatgatggctttcca 
GFP-DR DR_XhoI_fw 
DR_HindIII_rev 
taactcgagcggcccgagagtgtgaccg 
tataagctttcactgctccacggcctgct 
GFP-TR2 TR2_XhoI_fw_new 
TR2_EcoRI_rev 
tatactcgagaggtgcagggccgcc 
tatagaattctcagcagcagacggggc 
RFP-TECPR1 TECPR-XhoI-fw-2 
TECPR_HindIII_rev_2 
gtaactcgagatgcccaactcagtgctgtg 
tataagctttcagcagcagacggggc 
GFP-TECPR1
ΔPH
/ 
RFP-TECPR1
ΔPH
 
TECPR1dPH-FW 
TECPR1dPH-REV 
ggtgtgggtggagagccggaaggtgcag 
tccggctctccacccacaccgactgctc 
GFP-TECPR1
ΔPH-
2xFYVE 
and 
RFP-TECPR1
ΔPH-
2xFYVE
 
TECPR1dPH-FW_b 
TECPR1dPH-REV_b 
FYVE-F1-FW_b 
FYVE-F1-REV  
FYVE-F2-FW 
FYVE-F2-REV_b 
gagagccggaaggtgcag 
cacccacaccgactgctc 
cagtcggtgtgggtggagagcgatgccatgtttg 
ggatccttgtccttgtttcctgttcagctgctcg 
caaggacaaggatccgagagcgatgccatgtttg 
caccttccggctctctttcctgttcagctgctcg 
TECPR1, 
TECPR1
ΔPH
, and 
TECPR1
ΔPH-2xFYVE 
in pLPCX 
pLPCX-lin-fw 
pLPCX-lin-rev 
TECPR1-pLPCX-SLIC-fw 
TEPR1-pLPCX-SLIC-rev 
cattaaggcctgtcgacaagcg 
gaattcgaagcttgagctcgagatc 
cgagctcaagcttcgaattcatgcccaactcagtgctgtg 
cttgtcgacaggccttaatgtcagcagcagacgggg 
GFP-TECPR1
ΔAIR
 TECPR1dAIR-fw-QCL 
TECPR1dAIR-rev-QCL 
cccacaccgactgggcagcggtctgg 
ccagaccgctgcccagtcggtgtggg 
TECPR1
74-103
 
and 
TECPR1
158-187
 
in pCoofy4 
TECPR1_74-103_fw 
TECPR1_74-103_rev 
TECPR1_158-187_fw 
TECPR1_158-187_rev 
aagttctgttccaggggcccaatcagcgctggaatcccatg 
ccccagaacatcaggttaatggcgtcagtgctggagcccactcac 
aagttctgttccaggggcccgtgcggcgccggaag 
ccccagaacatcaggttaatggcgttacagctccttggggtcatcc 
TECPR1 LIR 
mutants: 
TECPR1
W175A/I178A
 
and 
TECPR1
LLL(87-89)SSS
 
TECPR1-W175A-I178A-fw 
TECPR1-W175A-I178A-rev 
TECPR1-3L(87-89)3S-fw 
TECPR1-3L(87-89)3S-rev 
TECPR1-W175A-fw 
TECPR1-W175A-rev 
TECPR1-I178A-fw 
TECPR1-I178A-rev 
catccttcgagggggccttggccgcgatgtcccgggact 
agtcccgggacatcgcggccaaggccccctcgaaggatg 
ctccacccccagcggtcactcgacgaggacttctcacagaagccgcccat 
atgggcggcttctgtgagaagtcctcgtcgagtgaccgctgggggtggag 
ggggatcttggccgcgatgtcccgggac 
gtcccgggacatcgcggccaagatcccc 
gtcatccttcgagggggccttggcccagatgtcc 
ggacatctgggccaaggccccctcgaaggatgac 
  
Cloning  
26   
WDR81 
WDR81 was cloned with N-terminal 3xHA-tag into pLPCX and into pEGFP-C1 using the 
primers listed in Table 7. Only cDNA of the C-terminal part of WDR81 was available in 
the ImaGenes cDNA library provided by the MPIB core facility (clone BC114568, see 
Table 2). Thus, WDR81 cDNA was obtained by reverse transcription of RNA, which was 
extracted from HeLa cells using TRIzol Reagent (Invitrogen) according to the manufac-
turer’s protocol. Subsequently, the cDNA was synthesized with RevertAid H Minus 
Reverse Transcriptase (Thermo Scientific) using 1 µg of RNA extract as template and 
Random Hexamer Primer (Thermo Scientific). Next, WDR81 cDNA was amplified in 
3 fragments of which each one was about 2 kb using Phusion High-Fidelity DNA Poly-
merase. The PCR products of fragment 1 and 2 were used as template for a second PCR 
with primers containing sequences homolog to either the vector or the preceding 
WDR81 fragment. Fragment 3 was amplified directly from the ImaGenes cDNA library 
clone BC114568.  
To obtain 3xHA-WDR81 (in the following referred to as HA-WDR81), 3xHA-LC3B in 
pLPCX was digested with EcoRI and NotI and fused with the three WDR81 fragments 
containing homolog overlaps using the In-Fusion HD Cloning Kit. The insert of GFP-
WDR81 was then amplified from 3xHA-WDR81 and recombined with pEGFP-C1 that was 
digested with SacI and BamHI before. 
 
Table 7: Primers used for cloning of WDR81. Gene specific sequences are black, homolog 
sequences to the linearized vector are marked in green, and additionally added base pairs are 
marked in red. 
DNA Construct Name of Primer Sequence (5’ 3’) 
WDR81 fragment 1 cDNA_WDR81_1_fw_new 
cDNA_WDR81_1_rev_new 
gcggcctggaggagatg 
gctgaggccactgagaaaga 
WDR81 fragment 2 cDNA_WDR81_2_fw_new 
cDNA_WDR81_2_rev_new 
gacgacttggaacaggccac 
tgatcttctgagtcagcgtcac 
3xHA-WDR81 in pLPCX 3xHA-WDR81_1_fw 
WDR81_1_rev 
WDR81_2_fw 
WDR81_2_rev 
WDR81_3_fw 
3xHA-WDR81_3_rev 
gtccgacagagaattcatcgatggcccagggcagc  
gaggagcccagctggtc 
gaccagctgggctcctc 
cctccttacggctgttcagtc 
gactgaacagccgtaaggagg 
gtttggccgaggcggccctatgccaggaggcggataac 
GFP-WDR81 GFP-WDR81_1_fw 
GFP-WDR81_3_rev 
cggactcagatctcgagctatggcccagggcagc 
ctagatccggtggatcctatgccaggaggcggataac 
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2.3 Recombinant expression and purification of proteins 
Buffers and media used for expression and purification of proteins are listed in Table 8. 
Constructs, strains, and medium used for protein expression are summarized in Table 9. 
 
Table 8: Buffers for protein expression, purification, and lipidation assays 
Buffer Components 
LB (lysogeny broth) medium 0.5% (w/v) yeast extract (Bacto) 
1% (w/v) tryptone (Bacto) 
7.5% (w/v) NaCl (AnalaR Normapur) 
Lysis buffer 100 mM Tris-HCl, pH 8.0 
300 mM NaCl  
20 mM imidazole, pH 8.0 (Merck) 
10% (v/v) glycerol 
5 mM β-mercaptoethanol (Merck) 
1% (v/v) protease inhibitor cocktail (Sigma) 
Washing buffer (Ni-NTA) 50 mM Tris-HCl, pH 8.0 
300 mM NaCl  
5 mM imidazole, pH 8.0 
10% (v/v) glycerol 
5 mM β-mercaptoethanol 
Elution buffer (Ni-NTA) 50 mM Tris-HCl, pH 7.4 
300 mM NaCl (400mM for TECPR1) 
500 mM imidazole 
10% (v/v) glycerol 
SEC running buffer = 2x lipidation buffer 
(SEC, size exclusion chromatography) 
25 mM Tris-HCl, pH 7.4 
275 mM NaCl  
Lipidation buffer (1x) 12.5 mM Tris-HCl, pH 7.4  
137.5 mM NaCl  
Floatation buffer 25 mM HEPES (Biomol), pH 7.0  
100 mM NaCl 
 
Table 9: Constructs, strains, and medium used for protein expression. 
Insert Vector Expression strain Medium 
Cys-LC3A pCoofy1 E. coli, Rosetta LB 
Cys-LC3B pCoofy1 E. coli, Rosetta LB 
Cys-LC3C pCoofy1 E. coli, Rosetta LB 
Cys-GABARAP pCoofy1 E. coli, Rosetta LB 
Cys-GABARAPL1 pCoofy1 E. coli, Rosetta LB 
Cys-GABARAPL2 pCoofy1 E. coli, Rosetta LB 
ATG3 pCoofy1 E. coli, Rosetta LB 
ATG7-ATG10-His10-Cys-ATG12−ATG5 pST39 E. coli, Rosetta LB 
ATG7 pCoofy27 Insect cells SF9 EX-CELL 420 + 5% FCS 
ATG16L1 pCoofy29 Insect cells High Five EX-CELL 420 
ATG16NT (11-43) pCoofy4 E. coli, Rosetta LB 
TECPR1 pCoofy29 Insect cells High Five EX-CELL 420 
TECPR1 TR1 (AA 1-384)  pCoofy4 E. coli, Rosetta LB 
TECPR1 TR2 (AA 722-1165) pCoofy4 E. coli, Rosetta LB 
TECPR1
74-103
  pCoofy4 E. coli, Rosetta LB 
TECPR1
158-187
  pCoofy4 E. coli, Rosetta LB 
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TECPR1 and TECPR1 constructs 
The expression and purification of TECPR1 is described in detail in my master thesis 
(Dempfle, 2014). In brief, TECPR1 was expressed with N-terminal His6-MBP tag in High 
Five insect cells from the vector pCoofy29, while shaking the culture for 72 hours at 
25 °C in EX-CELL 420 medium (Table 10). The cell lysate was incubated with Ni-NTA 
agarose (Qiagen) for 1 hour at 4 °C and His6-MBP-TECPR1 was eluted with elution buffer 
(Table 8) containing 400 mM instead of 300 mM NaCl. The His6-MBP tag was then 
cleaved using PreScission protease (His-tagged, provided by MPIB core facility) in 
presence of 10 mM DTT. Finally, the protein was purified by size-exclusion chromatog-
raphy using a HiLoad 16/60 Superdex 200 column (GE Healthcare).  
TECPR1 domains TR1 (AA 1-384) and TR2 (AA 722-1165) as well as the TR1 LIR mu-
tants W175A and LLL(87-89)SSS were expressed in E. coli Rosetta cells from the vector 
pCoofy4 according to the protocol in my master thesis (Dempfle, 2014). 
TECPR1 peptides containing a potential LIR motif (TECPR174-103 and TECPR1158-187) and 
the corresponding LIR mutants (W175A, I178A, and W175A/I178A) were expressed as N-
terminal His6-MBP fusion constructs from pCoofy4 in E. coli Rosetta cells. Cultures were 
grown in LB-medium containing kanamycin (Sigma-Aldrich, 30 µg/ml) and chloramphen-
icol (SERVA, 34 µg/ml) at 37 °C and 180 rpm. When OD600nm reached 0.6, cultures were 
induced with 0.3 mM IPTG (Carl Roth) and grown for 3 hours before cells were harvested 
by centrifugation at 4500 g for 10 min. Cell pellets were resuspended in lysis buffer 
supplemented with Sm DNAse (1:1000, provided by MPIB core facility) and lyzed by 
sonication (2x 5 min). The suspension was centrifuged at 45000 g for 1 hour and the 
supernatant was incubated with 1 mL Ni-NTA agarose for 1 hour at 4 °C, followed by 
washing with 500 mL washing buffer and elution with 5 mL elution buffer. Eluted 
proteins were directly (without cleavage of the His6-MBP tag) subjected to a HiLoad 
16/60 Superdex 200 column and eluted with SEC running buffer.   
hATG8s and other ATG proteins 
Cys-LC3C and Cys-GABARAPL1 were expressed from pCoofy1 in E. coli Rosetta overnight 
at 18 °C. Purification was performed using buffers without β-mercaptoethanol (Table 8) 
as described in Anna Kaufmann’s doctoral thesis for the other hATG8 proteins 
(Kaufmann, 2015). The expression and purification of all other ATG proteins used in this 
thesis, including ATG3, ATG7, ATG12−ATG5, ATG16L1, and ATG16NT are also described 
in the same thesis. 
Protein methods and storage 
All purified proteins were concentrated using Vivaspin cellulose centrifugation filters 
(Sartorius) according to the size of the protein. They were subsequently flash frozen in 
liquid nitrogen and stored at -80 °C. Protein concentrations were determined using the 
Pierce BCA Protein Assay Kit (Thermo Scientific) according to the manufacturer’s 
instructions. Protein identity and integrity was confirmed by liquid chromatography-
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mass spectrometry (LC-MS), using a Bruker Daltonik ESI-MS microTOF (operated by the 
MPIB core facility).  
Purity and quality of proteins was further monitored by SDS-PAGE using self-casted 
gels as previously described (Dempfle, 2014; Kaufmann, 2015). 6 M urea SDS-PAGE was 
performed as described elsewhere (Nakatogawa and Ohsumi, 2012). 
Proteins and lipids were labeled with Atto dyes (ATTO-TEC), Alexa dyes (Molecular 
Probes), or CF405M (Biotium) as previously described (Kaufmann, 2015; Dempfle, 2014). 
In vitro pull-down experiments were performed as described in my master thesis 
(Dempfle, 2014). 
2.4 Preparation of liposomes 
Lipid mixes 
All lipids were purchased from Avanti Polar Lipids. Normal lipid mixtures contained 
39.9 mol% 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 10 mol% 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine (POPS), 30 mol% 1,2-dioleoyl-sn-glycero-
3-phosphoethanolamine (DOPE), 20 mol% cholesterol, and 0.1 mol% lissamine-
rhodamine-PE. The ‘Otomo’ mix contained 39.9 mol% DOPC, 40 mol% DOPE, 20 mol% 
liver L-α-phosphatidylinositol (PI), and 0.1 mol% lissamine-rhodamine-PE (Otomo et al., 
2013). Lipid mixes for floatation assays with TECPR1 peptides contained 59.9 mol% 
DOPC, 40 mol% DOPE, and 0.1 mol% lissamine-rhodamine-PE.  
Lipid compositions for PtdInsP-binding assays were similar to the normal lipid mix-
tures, but contained additionally 3 mol% 1,2-dioleoyl-sn-glycero-3-phosphoinositol-3’-
phosphate (PtdIns(3)P), 1,2-dioleoyl-sn-glycero-3-phosphoinositol-3',5'-bisphosphate 
(PtdIns(3,5)P2), or 1,2-dioleoyl-sn-glycero-3-phosphoinositol-4’-phosphate (PtdIns(4)P) 
and instead 3 mol% less POPC. Before incorporation into liposomes, PtdInsPs were 
protonated. Therefore, 100 μg of PtdInsP powder was resuspended in 1 mL chloroform, 
dried under nitrogen gas stream and dessicated for 1 hour in vacuum. The powder was 
resuspended in CHCl3:MeOH:1N HCl in a ratio of 2:1:0.01, incubated for 15 min at room 
temperature, dried under nitrogen gas stream and dessicated for 1 hour in vacuum. 
PtdInsPs were then washed with CHCl3:MeOH (3:1) and subsequently with CHCl3. Finally, 
the powder was dissolved in 100 μl chloroform to obtain a concentration of 0.5 mg/ml. 
Small unilamellar vesicles  
To form small unilamellar vesicles (SUVs), lipids were dried under nitrogen flow in a 
small glass vial (Duran) and further in vacuum overnight. Dried lipids were resuspended 
in 1x lipidation buffer (Table 8) to a total lipid concentration of 2 mM by vortexing until 
the mixture was opaque. The solution was subjected to three freeze-thaw cycles, 
followed by sonication (3x 5 min, 30% power) and centrifugation at full speed for 5 min. 
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Large unilamellar vesicles 
For large unilamellar vesicles (LUVs), 1 mg total lipid was dried under nitrogen flow in a 
small glass vial (Duran) and further in vacuum overnight. Dried lipids were resuspended 
in 1 ml 1x lipidation buffer by vortexing. LUVs were then formed by extruding the 
mixture using a Mini-Extruder (Avanti) and a 100 nm pore size membrane (Whatman 
# 800309). 
Giant unilamellar vesicles 
Giant unilamellar vesicles (GUVs) were prepared by electroformation. Therefore, 7 μl of 
the lipid mixture (1 mg/ml in chloroform) was spread on two platinum wires of a 
custom-made teflon chamber and dried under vacuum for at least 30 min. The chamber 
was filled with 600 mM sucrose solution (Sigma-Aldrich) and assembled. Electrofor-
mation was performed by applying alternating electric current (2 V, 10 Hz) for 1.5 hours. 
Subsequently, the frequency was decreased to 2 Hz for 30 min in order to detach the 
vesicles from the electrodes. The solution was mixed in a 1:1 ratio with 600 mM sucrose 
solution. 100 μl of the solution was transferred to one well in a 8-well chamber (Lab-
Tek). The chamber was previously coated with bovine serum albumin (BSA, AMRESCO) 
by incubation with 5 mg/ml BSA in 25 mM Tris, pH 7.4 for 10 min at room temperature. 
For PtdInsP-binding assays, proteins were incubated with GUVs containing 3 mol% 
PtdInsP for 30 min at 37 °C and subsequently analyzed using confocal microscopy. 
2.5 In vitro lipidation reaction 
If not stated differently, concentrations in the samples were: 0.1 mM DTT, 1 mM 
ATP/Mg2+, 1 µM ATG7, 1.5 µM ATG3, 6 µM hATG8, 0.5 µM ATG12−ATG5, and 0.5 µM 
ATG16L1 or TECPR1.  
GUV experiments 
For GUV experiments ATG7, ATG3, and hATG8s were first incubated with ATP/Mg2+ and 
DTT in 2x lipidation buffer (Table 8) for 30 min at 37 °C, followed by the addition of 
ATG12−ATG5 and ATG16L1 or TECPR1, respectively. hATG8s were used in a 2:1 ratio of 
unlabeled to labeled protein. The protein mix (V = 100 µl) was added to 100 µl of GUV 
suspension (see above) in an 8-well imaging chamber and mixed carefully. The reaction 
was then incubated for 1 hour at 37 °C before imaging. To measure intensities of labeled 
proteins on GUVs, 2 µl of fluorescent beads with 1% intensity from the InSpeck Green 
(505/515) Microscope Image Intensity Calibration Kit, 6 µm (Invitrogen) were added to 
each sample. 
Floatation assay 
For floatation assays with SUVs or LUVs, reactions were performed as described above in 
150 µl 1x lipidation buffer and added to 150 µl liposome suspension, followed by 
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incubation for 1 hour at 37 °C. The protein/liposome mix was then mixed 1:1 with 80% 
(w/v) Histodenz (Sigma-Aldrich) in floatation buffer (Table 8) in a centrifugation tube. 
The mix was overlaid with 300 µl of 30% Histodenz in floatation buffer and on top with 
100 µl of floatation buffer to generate a Histodenz step gradient (40%/30%/0%). 
Samples were immediately centrifuged at 165000 g for 1 hour using a S55-S Swinging-
Bucket Rotor. 80 µl of proteoliposomes was collected from the 0/30% Histodenz 
interface (sample ‘L’) and 80 µl from the bottom fraction containing unbound proteins 
(sample ‘P’). Samples were mixed with 20 µl 5x SDS loading buffer (Table 1) and 15 µl of 
each sample was run on a 4-20% Mini-PROTEAN TGX gel (Bio-Rad).  
2.6 Cell culture 
Reagents and buffers used for cell culture are listed in Table 10. 
 
Table 10: Reagents and buffers used for cell culture 
Reagent/Buffer Components 
DMEM (Gibco #31966-021)  
FCS (Sigma-Aldrich #F4135)  
Penicillin-Streptomycin (Gibco #15140-122)  
EBSS (Sigma #E2888)  
DPBS (Gibco #14190-094)  
Trypsin-EDTA (Gibco #2530054)  
Opti-MEM I Reduced Serum Medium  
(Gibco #31985-062) 
 
EX-CELL 420 Serum-Free Medium for Insect Cells  
(Sigma #24420C) 
 
PBS 137 mM NaCl 
2.7 mM KCl (Carl Roth) 
10 mM Na2HPO4 (Merck) 
2 mM KH2PO4 (Carl Roth) 
Permeabilization solution  0.2% (v/v) Triton X-100 (Carl Roth)  
0.5% (w/v) SDS  
4% (w/v) BSA (Fisher Scientific)  
in PBS 
Mammalian lysis buffer 20 mM Tris, pH 7.5 
150 mM NaCl 
1 mM EDTA 
1 mM EGTA (PanReac AppliChem) 
1% (v/v) Triton X-100 
1% (v/v) Protease inhibitor (Sigma #P8340) 
Co-IP buffer  50 mM Tris, pH 7.5 
150 mM NaCl 
1 mM EDTA 
1 mM EGTA 
0.1% (v/v) NP-40  
1% (v/v) Protease inhibitor 
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HeLa and HEK293 cells (both provided by Dr. Julia von Blume) were cultured in DMEM 
supplemented with 10% FCS and 1% Penicillin-Streptomycin in 75 cm2 flasks (Corning 
#353136) at 37°C in a 5% CO2 incubator. Cells were tested for mycoplasma contamina-
tion once a month using the Mycoplasma Detection Kit-QuickTest (Biotool). Cultured 
cells were discarded in case of a contamination or latest after 30 passages. To starve 
cells, they were washed 3 times with DPBS and then incubated in Earle's Balanced Salt 
Solution (EBSS) for 2 hours. In selected experiments, 100 nM Bafilomycin A1 (BafA) was 
added and cells were incubated for 2 hours. When treating cells with lysotracker, 
100 nM LysoTracker Deep Red (Thermo Fisher Scientific) was added 30 min prior to 
imaging. To induce PINK1/Parkin-mediated autophagy, HEK293 cells were treated with 
10 µM CCCP (Sigma # C2759) for 4 hours before cell lysis.   
Transfection of cells 
To transfect cells, they were seeded in TC-treated 6- or 24-well plates (Corning) or in µ-
Slide 8 Well chambers (ibidi #80826) for live cell imaging. Cells were seeded such that 
the confluency was 60-80% on the day of fixation, lysis, or imaging (dilution usually 
1:10). Plasmid transfection in HeLa cells was performed with TransIT-HeLaMONSTER 
Transfection Kit and HEK293 cells were transfected with TransIT-293 Transfection 
Reagent (both Mirus) according to the manufacturer’s instructions. Cells were usually 
analyzed 24 hours after transfection. 
Transfection of siRNAs was performed with HighPerfect Transfection Reagent (Qi-
agen). Therefore, siRNAs were diluted in Opti-Mem medium and mixed with 3 µl or 12 µl 
of transfection reagent per transfection in a 24- or 6-well plate, respectively. After 5-10 
min incubation at room temperature, the mix was added to the cells and incubated for 
in total 72 hours. Used siRNAs had a final concentration of 10 nM each and are listed in 
Table 11. When cells were transfected with both, siRNAs and plasmids, plasmids were 
transfected 48 hours after siRNA transfection as described above.  
 
Table 11: Used siRNAs from Invitrogen. 
siRNA order number sequence (5’-3’) 
siControl  Stealth RNAi CAACUUGAUCCGUCUGACGUGGAAU 
siLC3A s39156  
siLC3B s37748  
siLC3C  Stealth RNAi GCUUGGCAAUCAGACAAGAGGAAGU 
siGABARAP s22361  
siGABARAPL1 s24332  
siGABARAPL2 s223228  
siTECPR1 Stealth RNAi CCAGUUGGAUUGAGAUGGUUGGUGA 
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Generation of KO lines using CRISPR/Cas9 gene editing 
Knockouts (KO) of TECPR1 and ATG16L1 were performed in HeLa cells using the 
CRISPR/Cas9 system according to Ran et al., 2013. Generation of ATG16L1 KO cells was 
performed by Sumit Kumar. 3-5 different guide RNAs (sgRNAs) were tested and are 
listed in Table 12. The sgRNAs were inserted into pSpCas9(BB)-2A-Puro (Table 3). 
Cloning was performed as previously described (Ran et al., 2013) with the exception that 
the ligation was conducted with T4 DNA ligase instead of T7 DNA ligase. In brief, HeLa 
cells were transfected with sgRNAs cloned into pSpCas9(BB)-2A-Puro in 24-well plates 
and transfected cells were selected with 2 µg/ml puromycin for 1-2 days. Clonal cell lines 
were then isolated by diluting them in 96-well plates. The wells containing one single 
colony after 1 week were expanded and screened for genomic mutations. Therefore, the 
DNA was extracted using 50 µl QuickExtract solution (Epicentre) per well of a 24-well 
plate according to the manufacturer’s instructions. Using the extracted DNA as template 
together with gene specific primers, a sequence of 400-600 bp containing the editing 
site was amplified by PCR with the Q5 High-Fidelity DNA polymerase (NEB) according to 
the manufacturer’s instructions. The primers used for the genomic PCR are listed in 
Table 13. The mutations of the KO cell lines are depicted in Table 14. PCR products were 
purified using the QIAquick PCR Purification Kit (Qiagen) and sequenced with one of the 
two primers used for amplification. To detect heterogeneous mutations, the PCR 
product of clone TECPR1 sgRNA4 A3 was additionally cloned into the vector pCoofy1 
according to Scholz et al., 2013 using the primers listed in Table 13. 
 
Table 12: Guide RNAs used for CRISPR/Cas9-mediated gene knockout of TECPR1 and ATG16L1. 
Added BbsI restriction sites are indicated in blue and additionally added G-C pairs are indicated 
in red. 
Name Guide RNA Target Primers (5’ 3’) 
TECPR1 
sgRNA 1 
CTAGACGATTCCAAGAATGC Exon 9 top: CACCGCATTCTTGGAATCGTCTAG 
bottom: AAACCTAGACGATTCCAAGAATGC 
TECPR1 
sgRNA 2 
CGGCTGCTTCTTCGGTGATG Exon 9 top: CACCGCGGCTGCTTCTTCGGTGATG 
bottom: AAACCATCACCGAAGAAGCAGCCGC 
TECPR1 
sgRNA 3 
ATCCGCCGCCGAGAGGAGGC Exon 1 top: CACCGCCTCCTCTCGGCGGCGGAT 
bottom: AAACATCCGCCGCCGAGAGGAGGC 
TECPR1 
sgRNA 4 
CTTCGGGAGAGTGTACACGC Exon 1 top: CACCGCGTGTACACTCTCCCGAAG 
bottom: AAACCTTCGGGAGAGTGTACACGC 
TECPR1 
sgRNA 5 
GCTGGAGTTCAAGCGCGTCA Exon 1 top: CACCGTGACGCGCTTGAACTCCAGC 
bottom: AAACGCTGGAGTTCAAGCGCGTCAC 
ATG16L1 
sgRNA 3 
GCTGCAGAGACAGGCGTTCG Exon 1 top: CACCGCTGCAGAGACAGGCGTTCG 
bottom: AAACCGAACGCCTGTCTCTGCAGC 
ATG16L1 
sgRNA 4 
GCAGCAAGTGACATGTCGTC Exon 1 top: CACCGCAGCAAGTGACATGTCGTC 
bottom: AAACGACGACATGTCACTTGCTGC 
ATG16L1 
sgRNA 5 
CCGCTGGAAGCGCCACATCT Exon 1 top: CACCGAGATGTGGCGCTTCCAGCGG 
bottom: AAACCCGCTGGAAGCGCCACATCTC 
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Table 13: Primers used for genomic PCR and cloning of PCR products into pCoofy1. Sequences 
marked in green are homolog to pCoofy1. 
Primer name Sequence (5’ 3’) sgRNA 
contained in 
PCR product 
TECPR_KO_fw_new 
TECPR_KO_rev_new 
GTGATGGGTCTGCCCTGATT 
GCAGGCATCTTCCACGGTAT 
TECPR1  
sgRNA 1 and 2 
S_TECPR1-KO-FW 
S_TECPR1-KO-REV 
CTGGGCTGGGAGCCTGAAC 
CTGGGGCCTCTATTTCCCTTCT 
TECPR1  
sgRNA 3 - 5 
ATG16-KO-For 
ATG16-KO-Rev 
CCTCTCGAAAATCATTTCCGG 
CTCCAAAGATAAAACGCAGGTTA 
ATG16L1  
sgRNA 3 - 6 
TEC-KO-fw-pC1 
TEC-KO-rev-pC1 
AAGTTCTGTTCCAGGGGCCCCTGGGCTGGGAGCCTGAAC 
CCCCAGAACATCAGGTTAATGGCGCTGGGGCCTCTATTTCCCTTCT 
TECPR1  
sgRNA 3 - 5 
 
Table 14: Mutations in HeLa KO cell lines. Underlined sequences correspond to the guide RNAs, 
deletions are indicated in red, insertions in blue, and stop codons in bold. The resulting changes 
in the amino acid sequences are highlighted in red. 
Clone 
Name 
Genomic sequence (5’ 3’) Amino acid sequence 
 
TECPR1 KO 
sgRNA2 
A11 
…TTCCCCTGCAAGGGAGTGATGGGTCTGCC
CTGATTTGTCCCCAGTGCCGGCTGCTTCTTC
GGTGATGAGGTGAGGGGTAGTGGCGAGTC
TGCCCCCAGCGACACCGATGCCTCCTCGGA
AGTCGAGAGACCAGGGCCTGGCCAGATTCT
CCCTGCAGAACCTCTAG 
MPNSVLWAVDLFGRVYTLSTAGQYWEMCKDSQLEF
KRVSATTQCCWGIACDNQVYVYVCASDVPIRRREEAY
ENQRWNPMGGFCEKLLLSDRWGWSDVSGLQHRPL
DRVALPSPHWEWESDWYVDENFGGEPTEKGGWTY
AIDFPATYTKDKKWNSCVRRRKWIRYRRYKSRDIWAKI
PSKDDPKELPDPFNDLSVGGWEITEEPVGRLSVWAVS
LQGKVWYREDVSHSNPEGSSWSLLDTPGEVVQISCG
PHDLLWATLWEGQALVREGINRSNPKGSSWSIVEPP
GSENGVMHISVGVSVVWAVTKDWKVWFRRGVNSH
NPCGTSWIEMVGEMTMVNVGMNDQVWGIGCEDR
AVYFRQGVTPSELSGKTWKAIIAARECDRSHSGSSSSLS
AGCFFGVVASLPPATPMPPRKSRDQGLARFSLQNL- 
 
TECPR1 KO 
sgRNA4 A3 
Allele 1: 
ATGCCCAACTCAGTGCTGTGGGCGGTGGAC
CTCTTCGGGAGAGTGTACACGCTGTCCACA
GCAGGCCAGTACTGGGAAATGTGCAAGGA
CTCCCAGCTGGAGTTCAAGCGCGTCAGCGC
CACCACGCAGTGCTGCTGGGGCATTGCCTG
TGACAACCAGGTCTACGTGTATGTGTGTGCC
AGCGATGTCCCCATCCGCCGCCGAGAGGAG
GCCTATGAGAATCAG……CGCTGGAATCCCA
TGGGCGGCTTCTGTGAGAAGCTCCTGCTGA 
 
Allele 2: 
ATGCCCAACTCAGTGCTGTGGGCGGTGGAC
CTCTTCACTAAAAGGGCTGTTCCAGCCGTCC
GTGCTGGCGCCTGGGGATCCAGGCCAGTTC
CCGGTACCCGCCCATGCCCAGCCCGGCGGC
CTAGGGCGTTACCTTGA 
 
 
MPNSVLWAVDLLRCPQQASTGKCARTPSWSSSASAP
PRSAAGALPVTTRSTCMCVPAMSPSAAERRPMRISA
GIPWAASVRSSC- 
 
 
 
 
 
 
 
 
MPNSVLWAVDLFTKRAVPAVRAGAWGSRPVPGTRP
CPARRPRALP- 
 
ATG16L1 
KO  
sgRNA3 B3 
ATGTCGTCGGGCCTCCGCGCCGCTGACTTCC
CCCGCTGGAAGCGCCACATCTCGGAGCAAC
TGAGGCGCCGGGACCGGCTGCAGAGACAG
GCGTTCGAGGAGATCATCCTGCAGT…ATAA 
MSSGLRAADFPRWKRHISEQLRRRDRLQRQARGDHP
AV- 
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Generation of stable cell lines 
HeLa cells stably expressing GFP-hATG8s were generated by transfection of cells with 
GFP-hATG8 plasmids. 48-72 hours after transfection, cells were selected with 600 µg/ml 
G418 until all cells in the non-transfected control were dead. Stable cell lines were 
expanded and cultured in presence of 300 µg/ml G418 and analyzed by confocal 
microscopy or western blotting. 
Immunofluorescence 
To perform immunofluorescence (IF), cells were grown on coverslips in 6-well plates. 
They were first washed with PBS (Table 10) and fixed in 4% formaldehyde (Carl Roth) in 
PBS for 10 min at room temperature. After washing the cells 3 times with PBS they were 
permeabilized in permeabilization solution (Table 10) for 5 min. Cells were washed again 
3 times with PBS before treating them with blocking buffer (4% BSA in PBS) for 1 hour at 
room temperature. Following blocking, cells were incubated with primary antibodies in 
4% BSA in PBS (dilutions see Table 15) for 1 hour at room temperature. Cells were 
washed at least 5 times with PBS before incubation with Alexa Fluor-conjugated 
secondary antibodies in 4% BSA in PBS (dilution 1:500, Table 16) for 1 hour at room 
temperature. Cells were washed again at least 5 times with PBS and finally mounted on 
a microscope slide with one droplet of ProLong Gold antifade reagent (Invitrogen). 
For the antibodies anti-PtdIns(4)P, anti-LC3 (M152-3), and anti-Rab11 the ‘Golgi 
staining protocol’ was used according to Hammond et al., 2009. The immunofluores-
cence staining with anti-PtdIns(3)P was performed according to the protocol provided by 
the manufacturer (Echelon).  
For DAPI staining, fixed cells were permeabilized with 0.2% Triton X-100 in PBS for 
5 min followed by washing 3 times with PBS. Cells were then incubated in 2 µg/ml DAPI 
(PanReac AppliChem) in PBS for 3 min at room temperature, washed 3 times with PBS, 
and mounted as described above. 
 
  
Cell culture  
36   
Table 15: Used primary antibodies 
Antibody name Host Supplier Article  
number 
Dilution for 
WB 
Dilution for IF 
anti-GFP (clones 7.1 and 
13.1) 
mouse Roche 11814460001 1:1000 in 3% 
BSA (TBS-T) 
 
HA-probe (F-7) mouse Santa Cruz sc-7392 1:200 in 5% 
milk (TBS-T) 
1:100 
β-actin antibody (C4) mouse Santa Cruz sc-47778 1:200 in 5% 
milk (TBS-T) 
 
beta Actin Monoclonal 
Antibody (15G5A11/E2) 
mouse Invitrogen MA1-140 
 
1:10000  
LAMP-2 Antibody (H4B4) mouse Santa Cruz sc-18822  1:100 
anti-LAMP1 (H4A3) mouse BD Biosciences 555798  1:100 
LC3B antibody rabbit Novus 
Biologicals 
NB100-2220 1:2000 in 5% 
milk + 1% 
BSA (TBS-T) 
 
LC3A/B (D3U4C) 
 
rabbit Cell Signaling 12741 
 
1:1000 in 5% 
milk (TBS-T) 
 
Anti-LC3 (Human) mAb 
 
mouse MBL  M152-3  1:100 (Golgi 
staining protocol) 
GABARAP Polyclonal 
Antibody 
rabbit Invitrogen OSG00009W 1:1000 in 5% 
milk (TBS-T) 
 
GABARAPL2 antibody rabbit GeneTex 
 
GTX102006 
 
1:2000 in 1% 
BSA (TBS-T) 
 
Anti-p62 Ick lig-
and  Clone  3/P62 
mouse BD Biosciences 610833 
 
 1:100 
STX17 antibody rabbit GeneTex GTX130212  1:100 
Anti-mAtg9 rabbit S.A. Tooze 
(Young et al., 
2006) 
-  1:100 
EEA1 (C45B10) rabbit Cell Signaling 3288  1:100 
Rab5 (C8B1) rabbit Cell Signaling 3547  1:100 
Rab7 (D95F2) rabbit Cell Signaling 9367  1:100 
RAB11 Antibody 
(3H18L5) 
rabbit Invitrogen 700184  1:100 (Golgi 
staining protocol) 
Anti-TGN46 antibody rabbit Sigma-Aldrich T7576  1:100 
Anti-Sec31A mouse BD Biosciences 612350  1:500 
Mono- and polyubiquiti-
nylated conjugates 
monoclonal antibody 
(FK2) 
mouse Enzo 
lifesciences 
BML-PW8810  1:100 
Anti-Ubiquitin Antibody, 
Lys48-Specific, clone 
Apu2 
rabbit Merck 05-1307 
 
 1:100 
HSP60 (D6F1) 
 
rabbit Cell Signaling 12165 
 
1:1000 in 5% 
milk (TBS-T) 
1:100 
Anti-PMP70 antibody mouse Sigma-Aldrich SAB4200181  1:100 
EGFR (1005)-G  goat Santa Cruz sc-03-G 1:200 in 5% 
milk (TBS-T) 
 
Anti-PtdIns(4)P IgM mouse Echelon Z-P004  1:100 (Golgi 
staining protocol) 
Anti-PtdIns(3)P IgG mouse Echelon Z-P003  1:200 
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Table 16: Used secondary antibodies 
Antibody name Host Supplier Article 
number 
Dilution for 
WB 
Dilution 
for IF 
Goat anti-Mouse IgG Antibody, 
(H+L) HRP conjugate 
goat Merck AP308P 
 
1:5000 in TBS-T  
RABBIT IgG (H&L) Secondary 
Antibody Peroxidase Conjugated 
goat Rockland 611-1302 1:5000 in TBS-T  
donkey anti-goat IgG-HRP donkey Santa Cruz sc-2020 1:5000 in TBS-T  
Alexa Fluor 488/594/647-
conjugated secondary antibodies 
goat Molecular 
Probes 
  1:500 
Western blot 
Cells grown in wells were washed 3 times with PBS, followed by incubation with 
mammalian lysis buffer (Table 10; 200 µl or 50 µl per well for 6-well or 24-well plate, 
respectively) for 20 min on ice. Subsequently, cells were scraped off the well and 
centrifuged for 15 min at full speed. Samples were normalized using the Pierce BCA 
Protein assay kit (Thermo Scientific) according to the manufacturer’s instructions. 
Normalized samples were mixed with 5x SDS loading buffer and heated for 5 min at 
95 °C. 
For gel electrophoresis, either self-made SDS-PAGE gels, NuPAGE 4-12% Bis-Tris gels 
(Novex), or 4-20% Mini-PROTEAN TGX Precast Gels (Bio-Rad) were used. For subsequent 
western blotting, Sharp Pre-Stained Protein Standard was used as protein marker. SDS-
PAGE and Mini-PROTEAN TGX Precast Gels were run in SDS running buffer and NuPAGE 
4-12% Bis-Tris gels were run in MES SDS running buffer (Table 1). Electrophoresis was 
performed at 40 mA for self-made gels and at 200 V for precast gels. 
Gels were equilibrated in blotting buffer (Table 1) for 10 min and the PVDF mem-
brane (Bio-Rad) was activated for 1 min in methanol. Blotting was performed in a semi 
dry blotting chamber at 15 V for 20-60 min, depending on the protein size. The mem-
brane was blocked in blocking buffer (5% milk in TBS-T or 3% milk, 25 mg/mL BSA in 
TBS-T) for 1 hour at room temperature, followed by incubation with primary antibody 
(dilutions and buffers see Table 15) overnight at 4 °C. The membrane was then washed 
3 times with TBS-T (Table 1) for 5 min each and incubated with secondary antibody 
(1:5000 in TBS-T, Table 16) for 1 hour at room temperature. The membrane was washed 
again 3 times with TBS-T for 5 min each and developed using Western BLoT Hyper HRP 
Substrate (TaKaRa). Chemiluminescence was detected with the luminescent Image 
Analyzer LAS-3000 (Fuji). 
Co-Immunoprecipitation 
To perform co-immunoprecipitation (Co-IP), transfected HeLa cells grown in 6-well 
plates were lyzed with Co-IP buffer (Table 10) for 20 min on ice. Cells were then scraped 
off the well, centrifuged for 15 min at full speed, and normalized using the Pierce BCA 
Protein assay kit. For immunoprecipitation of one sample, 20 µl of anti-HA Affinity 
Matrix (Roche) or 50 µl of GFP-Trap (anti-GFP VHH coupled to agarose beads, provided 
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by MPIB core facility) was used. The beads were first washed twice with 500 µl Co-IP 
buffer before cell lysates were added in 1 ml Co-IP buffer and incubated for 2 hours at 
4 °C while rotating. Subsequently, beads were pelleted, washed 3 times with 1 ml Co-IP 
buffer, and bound protein was eluted with 30 µl 2x SDS loading buffer, followed by 
heating for 5 min at 95 °C. Samples were analyzed on a Western Blot using NuPAGE 
4-12% Bis-Tris gels as described above. 
Formation of aggregates and aggregate clearance assay 
Formation of aggregates was induced by treatment of cells with 5 µg/ml puromycin for 
2 hours or with 10 µM (S)-MG132 (Cayman Chemical, in the following referred to 
MG132) for 8 hours. For the aggregate clearance assay, cells were treated with 5 µg/ml 
puromycin for 4 hours. Cells were then washed 3 times with DPBS (‘0h’ sample) and 
incubated for another 4 hours in full medium without puromycin (‘4h’ sample). Subse-
quently, cells were fixed and stained for ubiquitin (FK2, Table 15).  
EGFR degradation assay 
To perform EGFR degradation assays, cells were treated with 50 ng/ml EGF (Tebu-bio 
# AF-100-15) for 0, 30, 60, and 120 min. Cells were lyzed with mammalian lysis buffer, 
normalized using the Pierce BCA Protein assay kit, and subjected to SDS-PAGE using 
NuPAGE 4-12% Bis-Tris gels. Samples were then immunoblotted using anti-EGFR and 
anti-β-actin antibodies as described above (Table 15). 
2.7 Confocal microscopy and image analysis  
Microscopy experiments were conducted on a TCS SP8 AOBS Confocal Laser Scanning 
Microscope (Leica) with a 63x/1.4NA objective for fixed cells and GUVs and a 63x/1.2NA 
objective for live cell imaging. 405 nm, 488 nm, 514 nm, 561 nm, 594 nm, and 633 nm 
laser lines were used for excitation of fluorophores. Confocal images were acquired 
using Leica LAS AF SP8 Software and analyzed using Fiji (Schindelin et al., 2012). 
Structured Illumination Microscopy (SIM) samples were imaged and processed on a 
Zeiss Elyra PS.1 microscope (63x/1.4NA objective) using the Zeiss ZEN 2 software with 
SR-SIM module. 
For analysis of GFP-hATG8 puncta per cell and aggregate clearance assays, Z-stacks of 
images were acquired and merged into a projection with max intensity. GFP-hATG8 
puncta per cell were counted using the tool ‘Analyze Particles’ and cells containing large 
protein aggregates as well as GUVs were counted manually using the ‘Cell Counter’ 
plugin. Intensities of GUVs were measured by drawing a segmented line on the GUV 
membrane. The mean intensity of each GUV was then corrected with the background 
intensity of the sample and normalized to the intensity of InSpeck Fluorescent beads. 
Colocalization parameters were analyzed using a script provided by Giovanni Cardone 
from the imaging facility of the MPI of Biochemistry and is based on the Fiji plugin 
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Coloc2. Images of western blots were quantified using the software Image Studio Lite 
(LI-COR, Ver. 5.2). Intensities were normalized to the respective β-actin band intensities. 
Statistical analysis 
Data are expressed as mean ± standard deviation (SD) of at least three independent 
experiments or 20 cells, unless otherwise stated. Box plots were generated using the 
OriginPro 9.1G software. Bottom and top of the box represent the first (25%) and third 
(75%) quartiles, respectively. The band insight the box represents the median, whereas 
the white circle represents the mean value. Moreover, the whiskers mark the standard 
deviation (SD). For statistical comparison of two groups of samples, the two-tailed 
unpaired t-test was used. P-values of <0.05 were considered statistically significant and 
are indicated as following: *p<0.05; **p<0.01; ***p<0.001. 
2.8 Electron microscopy of cells 
Cellular electron microscopy experiments were conducted at the European Molecular 
Biology Laboratory (EMBL) in Heidelberg using equipment and material from the 
electron microscopy core facility of the EMBL. 
Immunoelectron microscopy  
Immunoelectron microscopy (immuno-EM) was performed by cryosectioning and 
immunolabeling using the Tokuyasu method (Tokuyasu, 1973). Therefore, HeLa cells 
were seeded in a 10 mm petri dish, transfected with GFP-tagged constructs, starved for 
2 hours in EBSS, and fixed in two steps. First they were incubated in 8% paraformalde-
hyde (PFA) and 0.4% glutaraldehyde (GA) in PHEM Buffer (60 mM Pipes, 25 mM Hepes, 
2 mM MgCl2, 10 mM EGTA, pH 6.9) for 5 min at room temperature, followed by incuba-
tion in 4% PFA/0.2% GA in PHEM Buffer for 30 min at room temperature. The cells were 
embedded in 12% gelatin and sliced into small pieces. Samples were then infused with 
2.3 M sucrose overnight on a rotary stirrer at 4 °C, mounted onto pins, and plunge-
frozen in liquid nitrogen. Ultrathin sections (60 nm) were cut with a diamond knife using 
a Leica EM FC6 cryo-ultramicrotome. Sections were collected on 100 mesh formvar-
coated Cu/Pd grids. They were blocked in 0.8-1.5% BSA + 0.1% fish skin gelatin (FSG) in 
PBS and stained with anti-GFP (1:50, rabbit, Molecular Probes A6455) and protein A 
conjugated to 10 nm gold in blocking buffer. Samples were contrasted and embedded in 
methylcellulose and 0.3% uranyl acetate and viewed on a Philips CM120 BioTWIN 
Electron Microscope. 
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Correlative light and electron microscopy 
Correlative light and electron microscopy (CLEM) was performed according to Kukulski 
et al., 2012. Cells were grown on carbon-coated sapphire discs in 35 mm petri dishes, 
transfected, and some samples were starved for 2 hours in EBSS. For high pressure 
freezing with a HPM-010 High Pressure Freezing Machine (ABRA Fluid), sapphire discs 
were clamped between two carriers and a gold spacer. After disassembling the sandwich 
under liquid nitrogen, samples were embedded in Lowicryl HM20 by freeze substitution 
using a Leica EM AFS2. Therefore, the following program was used: Freeze substitution 
was performed at -90 °C for 9 or 11 hours with 0.1% (w/v) uranyl acetate in glass 
distilled acetone. The temperature was then raised to -45 °C (5 °C/h) and stayed 
at -45 °C for 5 hours. Samples were washed 3 times with acetone and infiltrated with 
increasing concentrations (10%, 25%, 50%, 75%, 2 or 4 hours each) of Lowicryl HM20 in 
acetone while the temperature was further increased to -25 °C. 100% Lowicryl was 
exchanged 3 times in 10 hours steps and UV polymerized at -25 °C for 48 hours, after 
which the temperature was raised to 20 °C (5 °C/h). After polymerization, the samples 
were stored protected from light. 
Sections of 70 nm or 300 nm were cut with a diamond knife on a Leica EM UC7 ul-
tramicrotome and picked up on carbon coated 200 mesh finder copper grids. As 
fluorescent fiducial markers TetraSpeck Microspheres (100 nm, Invitrogen) were diluted 
1:200 in PBS, sonicated, and adhered to the sections. For fluorescent imaging, grids were 
sandwiched between two coverslips each carrying a drop of water and hold together by 
a ring holder, followed by imaging with a widefield Olympus IX81 microscope equipped 
with an Olympus PlanApo 100x/1.40NA oil immersion objective. Images were collected 
with GFP- and Cy3-specific settings to identify fiducial markers. Grids with 70 nm 
sections were removed and post-stained with 2% uranyl acetate and lead citrate. They 
were imaged on a Philips CM120 BioTWIN Electron Microscope. Grids carrying 300 nm 
sections were incubated with 10 nm protein A-coupled gold beads on both sides of the 
grid as tomographic fiducial markers, followed by post-staining with 2% uranyl acetate 
and lead citrate. Tomograms were collected on a TECNAI F30 Transmission Electron 
Microscope (FEI company) as dual-axis tilt series over a -60° to 60° tilt range with 
1° increment and a magnification of 9400x or 15500x. Furthermore, a montage of the 
whole cell was created with lower magnification in order to correlate the EM image with 
the fluorescent image using the ec-CLEM plugin of ICY (Paul-Gilloteaux et al., 2017). 
Montages were aligned and tomograms reconstructed using the IMOD software package 
(Kremer et al., 1996). 
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3 RESULTS 
3.1 Conjugation of hATG8 proteins to membranes 
Conjugation of hATG8 proteins to GUVs by ATG12−ATG5-TECPR1 
The ATG12−ATG5 conjugate serves as an E3-like enzyme in the UBL conjugation of 
hATG8 proteins to the lipid PE. Moreover, ATG16L1 binds with an N-terminal region to 
ATG5 in the ATG12−ATG5 conjugate, thereby promoting LC3 lipidation (Fujita et al., 
2008). For yeast Atg8, it has been shown that Atg12−Atg5 is necessary and at the same 
time sufficient for an efficient conjugation to PE in vitro (Hanada et al., 2007). However, 
our lab demonstrated that ATG12−ATG5 needs to be ac vated by ATG16L1 to efficiently 
catalyze the in vitro lipidation of hATG8 homologs (Kaufmann, 2015). Furthermore, 
TECPR1 forms a complex with ATG12−ATG5 that is mutually exclusive from the 
ATG12−ATG5-ATG16L1 complex (Chen et al., 2012; Kim et al., 2015). It was previously 
shown that the ATG12−ATG5-TECPR1 complex is, in addition to ATG12−ATG5-ATG16L1, 
able to promote lipidation of hATG8 proteins (Dempfle, 2014). Therefore, the aim was to 
further characterize the catalytic activity of TECPR1 in respect to the different hATG8 
homologs.  
Our lab was successful in expressing and purifying the full-length proteins of the 
human UBL conjugation machinery, including ATG7, ATG3, ATG12−ATG5, ATG16L1, 
TECPR1, and the six hATG8 proteins (Figure 38 in the appendix). This was an essential 
requirement to systematically compare the conjugation of the different hATG8 proteins 
to giant unilamellar vesicles (GUVs). In absence of ATG16L1 or TECPR1, there was no 
conjugation of LC3A, LC3B, or GABARAPL2, and only limited conjugation of LC3C, 
GABARAP, and GABARAPL1. Note that although a substantial percentage of GUVs was 
positive for Alexa Fluor 488-labeled LC3C and GABARAP (Figure 5A), the intensity of 
labeled LC3C and GABARAP on the membrane was very low (Figure 5B). However, in the 
presence of ATG16L1, the hATG8 lipidation efficiency was strongly increased with best 
lipidation of the LC3s and GABARAP, followed by GABARAPL1 and GABARAPL2. Remark-
ably, in absence of ATG16L1 but presence of TECPR1 the lipidation of LC3C and 
GABARAP and to a smaller extend GABARAPL1 and GABARAPL2 was promoted (Figure 
5C). Although the lipidation efficiency in presence of TECPR1 was reduced compared to 
ATG16L1, TECPR1 was highly selective for LC3C and the GABARAP family members. 
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Figure 5: Conjugation of hATG8 homologs to GUVs in absence and presence of ATG16L1 or 
TECPR1. (A) Percent of GUVs that are positive for Alexa Fluor 488-labeled hATG8s (n > 150 GUVs 
from 3 independent experiments). (B) Fluorescence intensity of Alexa Fluor 488-labeled hATG8s 
on the GUV membrane (n = 30 GUVs from 3 independent experiments). (C) Conjugation of Alexa 
Fluor 488-labeled hATG8 homologs to GUVs in presence of ATG12−ATG5-TECPR1. Scale bar, 
10 µm.  
In vivo hATG8 conjugation and puncta formation 
The ability of both, ATG16L1 and TECPR1, to promote conjugation of hATG8s to PE on 
GUV membranes gave rise to the question whether both proteins contribute to hATG8 
lipidation in vivo and whether they can compensate for each other. Therefore, 
CRISPR/Cas9-mediated HeLa knockout cell lines were generated that are deficient for 
ATG16L1 (ATG16L1-\-) or TECPR1 (TECPR1-\-, Table 14). To monitor lipidation of the 
different hATG8 homologs, wildtype (wt) and knockout cells were transfected with HA-
tagged hATG8s and analyzed by western blotting. Using SDS-PAGE, the difference in 
retention time between non-lipidated (form I) and lipidated (form II) members of the 
LC3 subfamily was clearly visible, whereas only a faint band corresponding to lipidated 
HA-GABARAPL2 and no band for lipidated GABARAP or GABARAPL1 could be observed 
(Figure 6A). Strikingly, the band corresponding to the lipidated form of hATG8s com-
pletely disappeared in ATG16L1-\- cells, while in TECPR1-\- cells the same level of hATG8 
lipidation was observed as in wt cells. This observation indicates that ATG16L1 is 
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essential for the lipidation of hATG8 proteins, whereas TECPR1 does not promote hATG8 
lipidation in vivo.  
Consistent with the loss of hATG8 lipidation, almost no GFP-hATG8 puncta were 
observed in ATG16L1-\- cells with the most drastic effect on LC3 subfamily members 
(Figure 6B). In contrast, knockout of TECPR1 had no effect on the number of GFP-LC3A, 
GFP-GABARAP, and GFP-GABARAPL1 puncta. However, the number of GFP-LC3B puncta 
was reduced, while GFP-LC3C and GFP-GABARAPL2 puncta significantly accumulated in 
TECPR1-\- cells (Figure 6C). In accordance, complementing the TECPR1 knockout with 
transient expression of a wt TECPR1 construct (RFP-TECPR1) reduced the number of 
GFP-LC3C and GFP-GABARAPL2 puncta to wt levels. In conclusion, the accumulation of 
LC3C and GABARAPL2 puncta in TECPR1-\- cells suggests that TECPR1 is important for the 
turnover of LC3C- and GABARAPL2-positive membrane compartments.  
 
Figure 6: In vivo hATG8 conjugation and puncta formation. (A) HeLa wt, ATG16L1-\-, or TECPR1-\- 
cells transiently expressing HA-tagged hATG8s were starved for 2 hours. Cell lysates were run on 
a 6 M urea SDS-PAGE gel (LC3 subfamily) or on a 4-20% Mini-PROTEAN TGX gel (GABARAP 
subfamily) and subsequently immunoblotted with anti-HA antibody. (B) HeLa wt or ATG16L1-\- 
cells were transfected with GFP-tagged hATG8s and starved for 2 hours before fixation. The 
number of GFP-hATG8 puncta was counted in at least 30 cells per sample. (C) Confocal images of 
HeLa wt or TECPR1-\- cells that were transfected with GFP-tagged hATG8s or cotransfected with 
GFP-hATG8s and RFP-TECPR1 and starved for 2 hours before fixation. The number of GFP-hATG8 
puncta was counted in at least 50 cells per sample. Scale bar, 10 µm. 
Conjugation of hATG8 proteins to membranes  
44   
Turnover of endogenous LC3B in wt and TECPR1-\- cells 
There is contradictory data on the influence of TECPR1 on canonical autophagy, which 
involves LC3B conjugation to autophagosomal membranes. It has been reported that 
levels of lipidated LC3B can be increased or decreased upon TECPR1 depletion, which 
seems to depend on the cell type (Ogawa et al., 2011; Chen et al., 2012). To clarify the 
effect of TECPR1 knockout on the flux of endogenous LC3B in the here used HeLa cells, 
LC3B-II levels were monitored in absence or presence of the lysosome inhibitor Bafilo-
mycin A1 (BafA). Due to reduced lysosomal activity by inhibition of the vacuolar 
H+-ATPase, BafA causes an accumulation of LC3B-II that has been transported into the 
lysosomal lumen. Importantly, LC3B-II levels were slightly but not significantly reduced 
compared to wt cells in both, absence and presence, of BafA (Figure 7). This observation 
is in agreement with the data of Ogawa et al., 2011, suggesting that TECPR1 plays a 
minor role in canonical autophagy. 
 
 
Figure 7: Turnover of endogenous LC3B in wt and TECPR1-\- cells. HeLa wt or TECPR1-\- cells were 
incubated for 2 hours in either full growth medium (DMEM), or DMEM including BafA. Cell 
lysates were run on a 4-20% Mini-PROTEAN TGX gel and immunoblotted using antibodies against 
LC3B and β-actin. LC3B-II levels were normalized to β-actin (n=3 independent experiments).  
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3.2 Subcellular localization of TECPR1 
Previously, it was reported that TECPR1 localizes to early autophagosomal structures to 
target bacteria to autophagosomal membranes (Ogawa et al., 2011), whereas another 
study observed that TECPR1 localizes to autolysosomes (Chen et al., 2012). To clarify the 
subcellular localization of TECPR1, two different electron microscopy (EM) techniques 
were performed using HeLa cells transiently expressing GFP-tagged TECPR1: correlative 
light and electron microscopy (CLEM) and immunogold-labeling of ultrathin cryo-
sections (immuno-EM). CLEM revealed that bright GFP-TECPR1 structures correspond to 
electron-dense compartments containing intraluminal membranes (Figure 8A). These 
TECPR1-positive structures likely represent lysosomes or autolysosomes. Immuno-EM, 
however, showed that a subpopulation of GFP-TECPR1 also localizes to membranes of 
small vesicles with a size of 100 to 200 nm in diameter that form large clusters (Figure 
8B). These data indicate that GFP-TECPR1 is recruited to diverse membrane compart-
ments. 
 
 
Figure 8: Subcellular localization of GFP-TECPR1 revealed by EM. (A) CLEM of HeLa cells 
transiently expressing GFP-TECPR1 and starved for 2 hours. Tomograms of 300 nm sections were 
acquired and one representative slice of the tomogram and the correlated fluorescent image are 
depicted here. (B) Immuno-EM of HeLa cells expressing GFP-TECPR1 and starved for 2 hours 
using anti-GFP antibody (10 nm gold). 
 
To identify the nature of the different membrane compartments to which TECPR1 gets 
recruited, immunofluorescent staining of HeLa cells expressing GFP-TECPR1 was 
performed (Figure 9). Staining for endosomal markers showed that TECPR1 is not 
colocalizing with the early endosomal marker EEA1. However, large TECPR1 structures 
strongly colocalized with the late endosomal marker Rab7 as well as with the lysosomal 
marker LAMP2. This result is consistent with the CLEM data that showed that TECPR1 
localizes to late endosomal or lysosomal compartments. Interestingly, there was partial 
colocalization of GFP-TECPR1 with the recycling endosomal marker Rab11A. Notably, 
small GFP-TECPR1 puncta were negative for the tested endosomal markers.   
The vesicle clusters observed in immuno-EM resemble ATG9 vesicles or vesicles 
belonging to the trans-Golgi network. Therefore, antibody staining for appropriate 
markers was performed and revealed that GFP-TECPR1 significantly colocalizes with 
ATG9, whereas there was only weak colocalization between GFP-TECPR1 and TGN46. 
Subcellular localization of TECPR1  
46   
This suggests that the vesicle clusters observed in immuno-EM correspond to ATG9 
vesicles. 
Since TECPR1 has been implicated in selective autophagy (Ogawa et al., 2011), 
colocalization with the autophagy receptor p62 was analyzed. Most GFP-TECPR1 
structures were p62-positive, indicating that TECPR1 does indeed play a role in selective 
autophagy. Furthermore, it has been shown that TECPR2, a homolog of TECPR1, is 
involved in formation of ER exit sites. To test if TECPR1 could have a similar function, the 
colocalization of TECPR1 with the COPII-coat protein SEC31A was analyzed. However, 
TECPR1 did not colocalize with SEC31A, suggesting that it does not play a role in ER exit 
site formation. Taken together, TECPR1 localizes to late endosomes and 
(auto-)lysosomes as well as to small vesicle clusters that might correspond to ATG9 
vesicles. 
 
 
Figure 9: Subcellular localization of GFP-TECPR1 revealed by immunofluorescence. Confocal 
images of HeLa cells that are transiently expressing GFP-TECPR1 and were stained for indicated 
cellular marker proteins by immunofluorescence. Cells stained for EEA1, Rab7, LAMP2, Rab11A, 
and p62 were starved for 2 hours. Arrows indicate colocalizing structures. Scale bars, 10 µm.  
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3.3 Interaction of TECPR1 with hATG8 proteins 
Colocalization of TECPR1 with hATG8 proteins 
The specific accumulation of LC3C and GABARAPL2 in TECPR1-\- cells as well as the 
selective lipidation of LC3C and the GABARAPs in presence of TECPR1 in vitro raised the 
question whether TECPR1 interacts with specific hATG8 proteins. Assuming that a 
selective interaction correlates with a defined colocalization pattern of TECPR1 with 
hATG8s, the colocalization of RFP-TECPR1 with GFP-tagged hATG8s was analyzed. 
Interestingly, all hATG8 homologs partly colocalized with RFP-TECPR1, while GFP-LC3C 
exhibited the strongest colocalization with RFP-TECPR1 (Figure 10).  
 
 
Figure 10: Colocalization of TECPR1 with hATG8 proteins. HeLa cells were cotransfected with 
RFP-TECPR1 and GFP-tagged hATG8s and analyzed by live cell confocal microscopy. Arrows 
indicate structures that are colocalizing or in close vicinity. Scale bars, 10 µm. 
 
Since TECPR1 interacts with ATG12−ATG5 through an AIR motif (Kim et al., 2015), this 
interaction could be important for targeting of TECPR1 to hATG8-positive organelles and 
lysosomes. For this reason, it was tested if the correct subcellular localization as well as 
its colocalization with LC3C depend on the interaction with ATG12−ATG5. Therefore, the 
AIR motif in TECPR1 was deleted to abolish its interaction with ATG5 and the corre-
sponding construct TECPR1ΔAIR was expressed in TECPR1-\- cells. Surprisingly, GFP-tagged 
TECPR1ΔAIR still colocalized with both LAMP2 and RFP-LC3C, indicating that targeting of 
TECPR1 to lysosomes and LC3C-positive structures does not depend on its interaction 
with ATG12−ATG5 (Figure 11). 
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Figure 11: Colocalization of TECPR1ΔAIR with LAMP2 and LC3C. HeLa TECPR1-/- cells transiently 
expressing GFP-TECPR1ΔAIR were stained for LAMP2 and confocal images were acquired. HeLa 
TECPR1-/- cells cotransfected with GFP-TECPR1ΔAIR and RFP-LC3C were analyzed using live cell 
confocal microscopy. Scale bars, 10 µm.  
 
It was demonstrated in this thesis that TECPR1 strongly colocalizes with LC3C. To 
characterize this colocalization further, cells expressing GFP-LC3C or GFP-TECPR1 were 
stained for the lysosomal marker LAMP2 and the autophagosomal SNARE protein STX17 
(Figure 12A). STX17 is a late autophagosomal marker since it is recruited to the outer 
membrane of completed autophagosomes (Itakura et al., 2012). While GFP-LC3C 
colocalized strongly with STX17, only few GFP-LC3C puncta were positive for LAMP2. In 
contrast, GFP-TECPR1 strongly colocalized with LAMP2 and to a lesser extent with 
STX17. Only occasionally colocalization of TECPR1 or LC3C with both, LAMP2 and STX17, 
has been observed. The distinct localization of LC3C and TECPR1 to LAMP2- and STX17-
positive structures suggests that they are present on different membrane compartments 
that are often in close proximity. Superresolution structured-illumination microscopy 
(SIM) showed that indeed TECPR1 localizes to LAMP2-positive structures and LC3C to 
STX17-positive small puncta that are in juxtaposition to TECPR1 structures (Figure 12B). 
In addition, staining of GFP-TECPR1 expressing cells for endogenous LC3 (antibody 
recognizes LC3A, LC3B, and LC3C) and visualizing them using SIM confirmed that many 
small LC3 puncta are in close proximity to larger GFP-TECPR1 structures (Figure 12C).    
 
  Results 
  49 
 
Figure 12: Characterization of TECPR1 and LC3C colocalization. (A) Confocal images of HeLa cells 
transiently expressing GFP-LC3C or GFP-TECPR1 that were starved for 2 hours and stained for 
LAMP2 and STX17. Arrows indicate colocalization with both LAMP2 and STX17. Colocalization 
was quantified using the Pearson coefficient (n > 20 cells). (B) Structured-illumination microsco-
py of HeLa cells transiently expressing GFP-TECPR1 or coexpressing RFP-TECPR1 and GFP-LC3C 
that were starved for 2 hours and stained for LAMP2 or STX17. (C) Structured-illumination 
microscopy of HeLa cells transiently expressing GFP-TECPR1 that were starved for 2 hours and 
stained with anti-LC3 antibody (M152-3). Selected regions are cropped and enlarged. Scale bars, 
10 µm. 
 
To visualize the ultrastructure of LC3C puncta, CLEM was performed with HeLa cells 
transiently expressing RFP-LC3C. Interestingly, LC3C localized to structures with different 
morphologies (Figure 13). However, all of these structures shared their dark staining, 
corresponding to compact electron-dense cytoplasmic material, which is an indication 
for aggregated proteins. Furthermore, many of the darkly stained LC3C-positive 
structures resembled either autophagosomes that were surrounded by a double 
membrane or autolysosomes that contained intraluminal heterogeneous material. 
Therefore, the observed LC3C-positive structures could be classified into the following 
four categories: (1) autophagosome-like, (2) autolysosome-like, (3) MVB-like, and (4) 
others.  
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Figure 13: CLEM of HeLa cells transiently expressing RFP-LC3C. Fluorescent signals of 70 nm 
sections were correlated with EM images. RFP-LC3C localized to predominantly darkly stained 
structures with different morphologies of the following categories: autophagosome-like (A), 
autolysosome-like (B), and MVB-like (C). Scale bars, 200 nm. 
 
Video microscopy of LC3C- and TECPR1-positive structures 
This study has shown that TECPR1 and LC3C reside on two different membrane com-
partments, corresponding to lysosomes and mature autophagosomes, respectively. To 
analyze dynamics of these structures, time-lapse video microscopy was performed. 
While a number of LC3C puncta was stably associated with TECPR1 structures, another 
population moved independently of TECPR1 but transiently interacted with TECPR1 
structures (Figure 14A). Video microscopy of HeLa cells expressing GFP-LC3C or GFP-
TECPR1 that were treated with lysotracker revealed that TECPR1 is stably associated 
with lysosomes, sometimes forming ring-like structures around lysotracker staining 
(Figure 14B). Furthermore, there were again two populations of GFP-LC3C puncta, one 
that was stably in close proximity to lysotracker-positive structures and one that 
transiently contacted them (Figure 14C). Taken together, these results confirm that 
TECPR1 resides on lysosomes, while LC3C is present on different compartments that can 
transiently and stably interact with TECPR1-positive lysosomes. 
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Figure 14: Time-lapse video microscopy of LC3C and TECPR1 structures.  (A) Time-lapse 
experiment of HeLa TECPR1-\- cells cotransfected with GFP-LC3C and RFP-TECPR1. Confocal 
images were captured every 10 sec and every other frame is shown. Arrows indicate moving 
structures that transiently interact.  (B) and (C) Time-lapse experiment of HeLa wt cells that were 
transfected with GFP-TECPR1 or GFP-LC3C and treated with lysotracker. Arrows indicate moving 
ring-like TECPR1 structures that are stably associated with lysotracker or moving LC3C puncta 
that transiently contact lysotracker structures. Images were acquired 30 min after addition of 
lysotracker deep red. Enlarged sections of confocal frames are displayed at indicated time 
points. Scale bars, 10 µm.  
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Interaction of TECPR1 with LC3C and other hATG8 proteins 
The colocalization of TECPR1 with LC3C as well as the specific in vitro lipidation of LC3C 
and the GABARAPs in presence of TECPR1 suggests that TECPR1 can directly interact 
with LC3C. To test this hypothesis, co-immunoprecipitation (Co-IP) and in vitro pull-down 
assays were performed (Figure 39 in the appendix). However, GFP-TECPR1 did not co-
immunoprecipitate with HA-tagged hATG8s and recombinant LC3C did not specifically 
bind to His6-MBP-TECPR1 that was immobilized on Ni-NTA beads. In addition, TECPR1 
bound to PtdIns(4)P-containing GUVs was not able to recruit soluble LC3C to the 
membrane (Figure 15A). To the contrary, lipidated LC3C that was conjugated to small 
unilamellar vesicles (SUVs) was recruited to TECPR1-positive GUV membranes and not to 
membranes that were lacking TECPR1, suggesting that TECPR1 can selectively interact 
with lipidated LC3C (Figure 15B).  
 
 
Figure 15: Binding of LC3C to TECPR1 on GUVs. Confocal images of GUVs containing PtdIns(4)P 
that were incubated with TECPR1 and soluble LC3C (A) or LC3C that was conjugated to SUVs in 
presence of the ATG12−ATG5-ATG16NT complex (B). TECPR1 and LC3C were fluorescently 
labeled with CF405M and Alexa Fluor 488, respectively. Scale bars, 20 µm (A) or 3 µm (B).  
 
TECPR1 is a multidomain protein and comprises two β-propeller repeat containing 
domains (TR1 and TR2), which are known protein-protein interaction platforms. To 
reveal whether a specific TECPR1 domain is responsible for LC3C recognition or the 
subcellular localization of TECPR1, the domains TR1, TR2, and DR were expressed in 
TECPR1 deficient HeLa cells (Figure 4). Strikingly, GFP-tagged TR1, the N-terminal 
domain of TECPR1, showed a very similar subcellular localization like full-length TECPR1 
(Figure 16). TR1 strongly colocalized with Rab7, LAMP2, and LC3C in contrast to DR and 
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TR2 that were mostly distributed in the cytosol and nucleus and did not colocalize with 
LAMP2 or LC3C. The subcellular localization of the TR1 domain indicates that it is 
sufficient for targeting TECPR1 to lysosomal membranes and to interact with LC3C. 
 
 
Figure 16: Subcellular localization of TECPR1 domains. Confocal images of HeLa TECPR1-\- cells 
that were transfected with GFP-TR1, GFP-DR, or GFP-TR2, or cotransfected with HA-LC3C, 
starved for 2 hours and stained for Rab7, LAMP2, or HA by immunofluorescence. Scale bars, 
10 µm. 
 
Many hATG8-binding proteins interact with hATG8 family members through a conserved 
LC3-interacting region (LIR), which is a short WxxL/I motif. The strong colocalization of 
the TR1 domain with LC3C suggests that this domain contains a LIR motif and was 
therefore screened for potential LIRs. Most of the predicted LIRs are located in the β-
propeller repeats of TECPR1 und thus not accessible. The motif W175xxI178, however, is 
present in a loop region and can therefore potentially bind to hATG8s. To test if the 
isolated LIR motif is able to bind lipidated hATG8 proteins, floatation assays were 
performed with hATG8s that were conjugated to SUVs. Indeed, a TECPR1 peptide 
containing the W175xxI178 motif was found associated with lipidated hATG8s in the 
liposome fraction without discriminating between the different homologs (Figure 17). 
Mutating the motif to A175xxA178 significantly reduced the amount of peptide binding to 
hATG8-conjugated SUVs. This suggests that the W175xxI178 LIR motif binds to hATG8 
proteins in vitro. 
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Figure 17: Floatation assay with lipidated hATG8 proteins and a TECPR1 peptide containing the 
W175xxI178 LIR motif. hATG8s (6 µM) were conjugated to SUVs in presence of 1 µM ATG7, 1.5 µM 
ATG3, 0.5 µM ATG12−ATG5, and 0.1 µM ATG16L1. An MBP-fused TECPR1 peptide 
(V158RRRKWIRYRRYKSRDIWAKIPSKDDPKEL187; 6 µM) containing the W175xxI178 motif or the 
corresponding A175xxA178 LIR mutant (LIR mut) was added together with PreScission protease. 
Floatation assays were performed and protein fractions (P) or liposome fractions (L) were 
collected and analyzed by coomassie staining of SDS-PAGE gels. Black arrows indicate bands 
corresponding to the TECPR1 peptide present in liposome fractions and red arrows indicate the 
corresponding LIR mut. 
 
Since the W175xxI178 motif in TECPR1 is able to bind to hATG8 proteins in vitro, mutation 
of the LIR motif in TECPR1 should reduce its colocalization with LC3C in cells. Thus, the 
LIR motif was mutated to A175xxA178 in GFP-tagged TECPR1 (GFP-TECPR1W175A/I178A) and 
cotransfected with RFP-LC3C into TECPR1-/- cells (Figure 18). Surprisingly, the introduc-
tion of these point mutations completely altered the subcellular localization of TECPR1. 
GFP-TECPR1W175A/I178A was mainly distributed in the cytoplasm and only few small puncta 
were occasionally observed that sometimes colocalized with LC3C. Compared to TECPR1 
wt, LC3C colocalized considerably less with the TECPR1 LIR mutant, indicating that the 
W175xxI178 LIR motif in TECPR1 is indeed mediating the interaction with LC3C.  
Although a direct interaction between TECPR1 and the hATG8 proteins could not be 
confirmed by Co-IP or pull-down experiments, there is strong evidence that TECPR1 
selectively interacts with lipidated LC3C. LC3C strongly colocalized with TECPR1 and LC3C 
puncta accumulated in TECPR1 depleted cells. Moreover, LC3C lipidation was facilitated 
by TECPR1 and lipidated LC3C was recruited to TECPR1-positive GUV membranes. 
Finally, a LIR motif in TECPR1 could be identified that is able to bind to hATG8 proteins in 
vitro and mutation of the LIR motif reduced colocalization between TECPR1 and LC3C in 
vivo. Collectively, these data strongly suggest that TECPR1 specifically interacts with 
lipidated LC3C through a canonical LIR motif.  
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Figure 18: Colocalization of TECPR1 LIR mutant with LC3C. HeLa TECPR1-/- cells were 
cotransfected with RFP-LC3C and GFP-TECPR1 or GFP-TECPR1W175A/I178A, respectively. Cells were 
analyzed using live cell confocal microscopy. Arrows indicate colocalizing structures. Scale bars, 
10 µm. 
Tandem RFP-GFP-hATG8 reporter 
This study provided evidence that small LC3C-positive structures are recruited by 
TECPR1 to lysosomes, which implies that LC3C has to be present at the outer membrane 
of autophagosomes to interact with TECPR1. To confirm this hypothesis, the transport of 
LC3C and other hATG8s into the lysosomal lumen was analyzed using a pH-sensitive 
tandem RFP-GFP-hATG8 reporter system.  
Wt cells which have been transfected with the commonly used RFP-GFP-LC3 (rat LC3b 
in ptfLC3) reporter displayed RFP and GFP (yellow) fluorescent puncta as well as puncta 
that were only RFP-positive (red) due to quenching of GFP fluorescence by the low 
lysosomal pH (Kimura et al., 2014, Figure 19A). Thus, red puncta correspond to 
autophagosomes that have been fused with lysosomes (autolysosomes). Hence, rat LC3 
gets transported to the lysosomal lumen, which is only possible if it is present at the 
inner autophagosome membrane. Chen et al., 2012 reported that depletion of TECPR1 
blocks fusion of autophagosomes with lysosomes, resulting in a reduction of red RFP-
GFP-LC3 puncta. Here, however, TECPR1-\- cells exhibited a similar amount of yellow and 
red puncta compared to wt cells, suggesting that TECPR1 is not essential for fusion of 
canonical autophagosomes with lysosomes.  
Many hATG8 proteins are implicated in selective autophagy since they are binding to 
autophagy receptors at the inner autophagosome membrane. LC3C, for example, was 
shown to selectively bind to the receptor NDP52, thereby promoting clearance of 
intracellular Salmonella (von Muhlinen et al., 2012). Thus, the translocation of selected 
hATG8 proteins to the lysosomal lumen was tested using the pH-sensitive tandem 
reporter system. In contrast to rat LC3, the other tested human homologs LC3C, 
GABARAP, and GABARAPL2 almost exclusively displayed GFP- and RFP-positive yellow 
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puncta (Figure 19B). This indicates that the majority of these hATG8 proteins is not 
transported to the lysosomal lumen and therefore present at the outer autophagosome 
membrane. This further suggests that TECPR1 could potentially recruit autophagosomes 
through its interaction with LC3C or other hATG8 proteins that are located at the outer 
membrane of autophagosomes. 
 
 
Figure 19: Tandem RFP-GFP-hATG8 reporter. (A) HeLa wt or TECPR1-\- cells were transfected 
with RFP-GFP-LC3 (rat LC3b, ptfLC3), starved for 2 hours, and analyzed using live cell confocal 
microscopy. (B) HeLa cells were transfected with RFP-GFP-LC3C, RFP-GFP-GABARAP, or RFP-GFP-
GABARAPL2, starved for 2 hours, and analyzed using live cell confocal microscopy. Scale bars, 
10 µm.  
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3.4 Lipid-binding specificity of TECPR1 
Binding of TECPR1 to phosphoinositides in vitro 
TECPR1 possesses a PH domain, which is a known phosphoinositide-binding domain and 
has been reported to interact with PtdIns(3)P in a protein-lipid overlay assay (Chen et al., 
2012). However, lipids in protein-lipid overlay assays are immobilized on a solid support 
and binding to these lipids is therefore tested under highly non-physiological conditions. 
Thus, the interaction of TECPR1 with several phosphoinositides (PtdInsPs) important for 
autophagosome biogenesis was analyzed using fluorescently labeled recombinant 
TECPR1 and PtdInsP-positive GUV membranes (Figure 20). Besides PtdIns(3)P, which is 
essential for the formation of the isolation membrane, binding of TECPR1 to 
PtdIns(3,5)P2 and PtdIns(4)P was tested. PtdIns(3,5)P2 has been implicated in maturation 
and turnover of autophagosomes (Dall'Armi et al., 2013) and substantial amounts of 
PtdIns(4)P are present on lysosomes and important for autophagosome-lysosome fusion 
(Wang et al., 2015; Jeschke et al., 2015). As expected, TECPR1 showed low affinity for 
the GUV membrane without PtdInsPs. Surprisingly, TECPR1 was not found associated 
with GUVs containing PtdIns(3)P or PtdIns(3,5)P2. However, TECPR1 was strongly 
recruited to GUV membranes with PtdIns(4)P, suggesting that it specifically interacts 
with PtdIns(4)P in vitro. 
 
 
Figure 20: Binding of TECPR1 to GUV membranes containing phosphoinositides. Confocal images 
of GUVs containing indicated PtdInsPs that were incubated with Alexa Fluor 488-labeled TECPR1. 
Scale bars, 20 µm. 
 
  
Lipid-binding specificity of TECPR1  
58   
Colocalization of TECPR1 with phosphoinositides in vivo  
To test whether TECPR1 localizes to PtdInsP-positive membranes in vivo, the colocaliza-
tion of GFP-tagged TECPR1 with the PtdIns(3)P-sensor RFP-2xFYVE and with PtdIns(4)P 
was analyzed (Figure 21). Importantly, TECPR1 did not colocalize with RFP-2xFYVE, but 
strongly colocalized with PtdIns(4)P. This finding supports the in vitro data, which have 
demonstrated that TECPR1 selectively binds to PtdIns(4)P.  
To identify the influence of the PH domain on the localization of TECPR1 to PtdInsP-
rich membranes, two TECPR1 mutants were cloned that modify its lipid-binding 
specificity: First, the PH domain was deleted (TECPR1ΔPH) and second, the PH domain 
was replaced by a PtdIns(3)P-binding tandem FYVE zinc finger domain (TECPR1ΔPH-2xFYVE). 
The used tandem FYVE domain of HGS has been demonstrated to selectively recognize 
PtdIns(3)P on early endosomes as well as on internal vesicles of MVBs (David J.Gillooly, 
2000; Gillooly et al., 2003; Vicinanza et al., 2015). Similar to TECPR1wt, TECPR1ΔPH did not 
colocalize with the PtdIns(3)P-sensor RFP-2xFYVE, but showed reduced colocalization 
with PtdIns(4)P. This indicates that the PH domain contributes to targeting TECPR1 to 
PtdIns(4)P-positive membranes. Notably, TECPR1wt and TECPR1ΔPH colocalized with 
PtdIns(4)P-positive structures in juxtanuclear regions that could correspond to the Golgi 
apparatus, which comprises a major pool of PtdIns(4)P (Hammond et al., 2009). 
TECPR1ΔPH-2xFYVE on the other hand did not colocalize with large juxtanuclear PtdIns(4)P 
structures but often colocalized with smaller PtdIns(4)P-positive puncta, resulting in a 
Pearson correlation coefficient that was comparable to TECPR1wt. Importantly, the 
colocalization of TECPR1ΔPH-2xFYVE with RFP-2xFYVE was significantly increased, suggesting 
that TECPR1ΔPH-2xFYVE is mistargeted to PtdIns(3)P-positive membranes.   
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Figure 21: Colocalization of TECPR1 constructs with PtdInsP-positive membranes in vivo. HeLa 
TECPR1-\- cells were cotransfected with GFP-tagged TECPR1 constructs and RFP-2xFYVE (left side) 
or transfected with GFP-TECPR1 constructs and stained for PtdIns(4)P by immunofluorescence 
(right side). Samples were analyzed by confocal microscopy and colocalization was quantified 
using the Pearson coefficient (n > 25 cells). Scale bars, 10 µm.   
Mistargeting of TECPR1 to PtdIns(3)P-rich membranes 
The distinct localization of TECPR1 constructs to PtdInsP-rich membranes suggests that 
TECPR1 is present on lysosomes, while TECPR1ΔPH-2xFYVE is targeted to PtdIns(3)P-positive 
compartments. To test this hypothesis, the colocalization of TECPR1 constructs with the 
lysosomal marker LAMP2 and with the early endosomal marker EEA1 was investigated. 
As anticipated, a stronger colocalization of TECPR1wt with LAMP2 than with EEA1 was 
observed (Figure 22). Deletion of the PH domain resulted in similar colocalization with 
EEA1 and reduced colocalization with LAMP2 compared to TECPR1wt, supporting the 
finding that the PH domain contributes to targeting TECPR1 to PtdIns(4)P-positive 
membranes.  
Colocalization between the mistargeting mutant TECPR1ΔPH-2xFYVE and LAMP2 was 
similar to TECPR1wt. Consistent with the observation that TECPR1ΔPH-2xFYVE is recruited to 
PtdIns(3)P-positive membranes, it colocalized significantly stronger with the early 
endosomal marker EEA1 compared to TECPR1wt or TECPR1ΔPH. This strongly suggests 
that replacement of the PH domain by the PtdIns(3)P-binding tandem FYVE domain 
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results in mistargeting of TECPR1 to EEA1-positive compartments that could represent 
early endosomal compartments. Notably, the distribution of EEA1 structures was 
dramatically changed in TECPR1ΔPH-2xFYVE-expressing cells compared to TECPR1wt- or 
TECPR1ΔPH-expressing cells. Normally, small EEA1 puncta were distributed evenly in the 
cytoplasm, whereas cells expressing TECPR1ΔPH-2xFYVE displayed large EEA1 structures. 
These large structures colocalized with the lysosomal marker LAMP2, which is unusual 
for early endosomes. This indicates that TECPR1ΔPH-2xFYVE expression induces the 
formation of aberrant endosomal structures.  
  
 
Figure 22: Colocalization of TECPR1 constructs with LAMP2 and EEA1. Confocal images of HeLa 
TECPR1-\- cells that were transfected with GFP-TECPR1 constructs and stained for LAMP2 and 
EEA1 by immunofluorescence. Colocalization was quantified using the Pearson coefficient 
(n > 20 cells). Scale bars, 10 µm.   
 
To characterize these aberrant EEA1- and LAMP2-positive TECPR1ΔPH-2xFYVE structures 
further, their colocalization with endosomal markers and lysotracker was analyzed. 
Strikingly, GFP-TECPR1ΔPH-2xFYVE colocalized strongly with the early endosomal marker 
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Rab5 and the late endosomal marker Rab7 (Figure 23A). Conclusively, TECPR1ΔPH-2xFYVE 
structures are positive for markers from early endosomes to late endosomes and 
lysosomes, indicating that they cannot be classified into a specific organelle of the 
endocytic pathway. To test whether TECPR1ΔPH-2xFYVE structures are acidified and thus 
corresponding to late endosomes/MVBs or lysosomes, a lysotracker probe was used that 
labels compartments with low internal pH. Large TECPR1wt structures colocalized with 
lysotracker as expected. Frequently, ring-like TECPR1 structures were observed that 
surrounded lysotracker fluorescence, confirming that TECPR1 localizes to the membrane 
of late endosomes or lysosomes (Figure 23B). Strikingly, large TECPR1ΔPH-2xFYVE structures 
also colocalized with lysotracker, indicating that these structures correspond to acidified 
compartments, such as late endosomes or lysosomes. Smaller TECPR1ΔPH-2xFYVE struc-
tures, however, did not colocalize with lysotracker, suggesting that these structures 
correspond to non-acidified endosomes. 
 
 
Figure 23: Colocalization of TECPR1ΔPH-2xFYVE with Rab5, Rab7, and lysotracker. (A) Confocal 
images of HeLa TECPR1-/- cells that were transfected with GFP-TECPR1ΔPH-2xFYVE and stained for 
Rab5 or Rab7 by immunofluorescence. (B) Lysotracker deep red was added to HeLa TECPR1-\- 
cells transiently expressing GFP-TECPR1 and cells were analyzed by live cell confocal imaging. 
The arrow marks a GFP-TECPR1 ring-like structure that is surrounding lysotracker staining. Scale 
bars, 10 µm.  
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PtdInsP-binding domains are not only important regulators of autophagy but also of the 
endocytic pathway, for example in MVB biogenesis. Therefore, mistargeting of TECPR1 
to EEA1-positive structures could impair autophagy or endocytosis by interfering with 
the autophagic or endocytic machinery. To test the influence of TECPR1 constructs on 
autophagic flux, LC3B-II levels were analyzed in TECPR1-\- cells complemented with GFP-
TECPR1wt, GFP-TECPR1ΔPH, or GFP-TECPR1ΔPH-2xFYVE. Expression of all TECPR1 constructs 
resulted in comparable LC3B-II levels, both in absence and presence of BafA (Figure 
24A), which suggests that they do not affect canonical autophagy.  
To test the influence of TECPR1 on the endocytic pathway, epidermal growth factor 
receptor (EGFR) degradation assays in wt and TECPR1-\- cells were performed. Lysosomal 
degradation of EGFR can be induced with the epidermal growth factor (EGF) that leads 
to EGFR internalization and targeting of EGFR to lysosomes via endocytosis. Importantly, 
TECPR1 depleted cells showed similar EGFR levels over time compared to wt cells, 
indicating that TECPR1 is dispensable for the degradation of EGFR (Figure 24B). In 
addition, TECPR1-\- cells that expressed TECPR1ΔPH or TECPR1ΔPH-2xFYVE exhibited similar 
EGFR degradation kinetics compared to TECPR1-\- cells that expressed TECPR1wt. 
Although expression of TECPR1ΔPH-2xFYVE induced the formation of aberrant endosomal 
structures, this finding suggests that degradation of EGFR and thus MVB biogenesis is 
not impaired by expression of TECPR1ΔPH-2xFYVE. 
Taken together, these results suggest that the PH domain of TECPR1 is important for 
its targeting to lysosomes by interacting with PtdIns(4)P. Furthermore, replacement of 
the PH domain by a tandem FYVE domain mistargets TECPR1 to PtdIns(3)P-rich com-
partments that are positive for early endosomal, late endosomal, and lysosomal 
markers. The data further suggest that TECPR1ΔPH-2xFYVE localizes to both acidified and 
non-acidified compartments. Despite colocalizing with endosomal markers, the 
described TECPR1 constructs do not influence LC3B-II flux or lysosomal EGFR degrada-
tion, indicating that TECPR1 is not essential for canonical autophagy or endocytosis.  
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Figure 24: Effect of TECPR1 constructs on LC3B-II levels and EGFR degradation. (A) TECPR1-\- cells 
were transfected with GFP-TECPR1 constructs and incubated for 2 hours in either EBSS or EBSS 
including BafA. Cell lysates were run on a 4-20% Mini-PROTEAN TGX gel and immunoblotted 
using antibodies against GFP, β-actin, and LC3B. LC3B-II levels were quantified from 3 independ-
ent experiments and normalized to β-actin. (B) EGFR degradation assay with HeLa wt, TECPR1-/-, 
or TECPR1-/- cells transiently expressing TECPR1wt, TECPR1ΔPH, or TECPR1ΔPH-2xFYVE. The time of EGF 
stimulation is indicated and EGFR levels were normalized to β-actin as indicated below.  
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3.5 Recruitment of LC3C to TECPR1ΔPH-2xFYVE structures 
To reveal whether TECPR1 is the dominant factor for the subcellular localization of 
hATG8s, the recruitment of hATG8 homologs was investigated using the mistargeting 
mutant TECPR1ΔPH-2xFYVE that localizes to aberrant EEA1-positive structures. Therefore, 
RFP-TECPR1ΔPH-2xFYVE was coexpressed with GFP-tagged hATG8s in TECPR1-\- cells and the 
colocalization was quantified (Figure 25). A significant colocalization was only observed 
between RFP-TECPR1ΔPH-2xFYVE and GFP-LC3C and not with other hATG8 family members, 
indicating that TECPR1ΔPH-2xFYVE selectively recruits LC3C. Note that here again, bright 
GFP-LC3C puncta are juxtapositioned to large RFP-TECPR1ΔPH-2xFYVE structures. 
 
 
Figure 25: Colocalization of hATG8s with TECPR1ΔPH-2xFYVE. HeLa TECPR1-\- cells transiently 
expressing RFP-TECPR1ΔPH-2xFYVE and GFP-tagged hATG8s were analyzed by live cell confocal 
microscopy. Colocalization was quantified using the Pearson coefficient (n > 40 cells). Scale bars, 
10 µm. 
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To confirm that LC3C is indeed recruited to aberrant early endosomal structures by 
TECPR1ΔPH-2xFYVE, immunofluorescent staining for the early endosomal marker EEA1 was 
performed in TECPR1-\- cells that were coexpressing GFP-LC3C and RFP-TECPR1 con-
structs (Figure 26). While GFP-LC3C did not colocalize with EEA1 in RFP-TECPR1wt- or 
RFP-TECPR1ΔPH-expressing cells, colocalization with EEA1 was strongly increased when 
RFP-TECPR1ΔPH-2xFYVE was expressed. This result confirms that LC3C is recruited to EEA1-
positive structures by TECPR1ΔPH-2xFYVE. Note that again the distribution of EEA1 was 
drastically changed in RFP-TECPR1ΔPH-2xFYVE-expressing cells and only large EEA1 struc-
tures colocalized significantly with both RFP-TECPR1ΔPH-2xFYVE and GFP-LC3C. Similar 
results were obtained in HEK293 cells, which excludes that the recruitment of LC3C by 
TECPR1ΔPH-2xFYVE is a cell type-specific effect (Figure 40 in the appendix). 
 
 
Figure 26: Recruitment of LC3C to EEA1-positive structures by TECPR1ΔPH-2xFYVE. Confocal images 
of HeLa TECPR1-\- cells that were cotransfected with GFP-LC3C and RFP-TECPR1, RFP-TECPR1ΔPH, 
or RFP-TECPR1ΔPH-2xFYVE, starved for 2 hours and stained for EEA1 by immunofluorescence. Blue 
arrows indicate TECPR1 and LC3C structures that are not colocalizing with EEA1 and white 
arrows indicate colocalizing structures. Scale bars, 10 µm. 
 
  
Recruitment of LC3C to TECPR1ΔPH-2xFYVE structures  
66   
To reveal the nature of TECPR1ΔPH-2xFYVE-positive atypical endosomal compartments, 
which are positive for early and late endosomal markers, CLEM was performed to 
correlate GFP-TECPR1ΔPH-2xFYVE fluorescence with organelles at an ultrastructural level 
(Figure 27). Strikingly, GFP-TECPR1ΔPH-2xFYVE localized to the outer membrane of 
organelles that resemble MVBs. This strongly suggests that accumulated EEA1- and 
LAMP2-positive structures that were observed in immunofluorescent staining of 
TECPR1ΔPH-2xFYVE-expressing cells correspond to MVB-like compartments. Moreover, RFP-
LC3C-positive electron-dense vesicles were observed in vicinity of TECPR1ΔPH-2xFYVE-
positive MVBs. These LC3C-positive structures were often surrounded by either double 
membranes, typical for autophagosomes, or single membranes, which could correspond 
to amphisomes since they contain intraluminal vesicles.  
 
 
Figure 27: CLEM of HeLa TECPR1-/- cells transiently expressing GFP-TECPR1ΔPH-2xFYVE and RFP-LC3C. 
Tomograms of 300 nm sections were acquired and one representative slice of the tomogram 
and the correlated fluorescent images are depicted here. 
 
In this thesis, a LIR motif was identified and characterized in TECPR1 that is able to bind 
lipidated hATG8 proteins in vitro and is important for the recruitment of LC3C. To 
investigate whether mistargeting of LC3C by TECPR1ΔPH-2xFYVE is influenced upon muta-
tion of the LIR motif, the LIR mutants W175A, I178A, and W175A/I178A were analyzed 
for their ability to recruit LC3C to EEA1-positive structures. To exclude an effect of 
overexpression of fluorescently tagged LC3C, a non-selective LC3 antibody that recog-
nizes all three LC3 subfamily members was used due to lack of a specific LC3C antibody. 
In TECPR1-\- cells complemented with GFP-TECPR1ΔPH-2xFYVE, LC3 strongly colocalized with 
TECPR1ΔPH-2xFYVE and EEA1, demonstrating that LC3-positive structures are recruited by 
TECPR1ΔPH-2xFYVE to MVB-like compartments (Figure 28). Strikingly, the colocalization of 
LC3 with GFP-TECPR1ΔPH-2xFYVE LIR mutants was significantly reduced, although these 
constructs still localized to EEA1-positive endosomes. This indicates that the W175xxI178 
LIR motif in TECPR1 is important for the recruitment of LC3 proteins. A similar observa-
tion was made with HA-tagged hATG8s that were coexpressed with a LIR mutant of GFP-
TECPR1ΔPH-2xFYVE in TECPR1-/- cells. None of the hATG8 homologs colocalized with the 
W175A/I178A LIR mutant (Figure 41 in the appendix). Notably, cells expressing 
TECPR1ΔPH-2xFYVE LIR mutants exhibited smaller EEA1 structures compared to cells 
expressing TECPR1ΔPH-2xFYVE.  
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Figure 28: Recruitment of LC3 to TECPR1ΔPH-2xFYVE LIR mutants. Confocal images of HeLa TECPR1-/- 
cells transiently expressing GFP-TECPR1ΔPH-2xFYVE or the respective LIR mutants that were stained 
with anti-LC3 (M152-3) and anti-EEA1 by immunofluorescence. Selected regions of merged 
channels are cropped and enlarged. Colocalization between GFP-TECPR1ΔPH-2xFYVE LIR mutants 
and endogenous LC3 was quantified using the Pearson coefficient (n > 30 cells). Scale bars, 
10 µm. 
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Interestingly, GABARAPs were not observed to colocalize with or be in the vicinity of 
TECPR1ΔPH-2xFYVE compartments. However, both TECPR1 and the GABARAPs are imple-
mented in autophagosome-lysosome fusion. To investigate whether the GABARAPs are 
involved in the recruitment of LC3 to TECPR1ΔPH-2xFYVE-positive structures, an siRNA-
mediated knockdown of the GABARAP subfamily (validation of siRNAs see Figure 42 in 
the appendix) was performed and colocalization of LC3 with GFP-TECPR1ΔPH-2xFYVE was 
quantified (Figure 29). Notably, depletion of the GABARAPs resulted in increased 
colocalization, indicating that the GABARAPs are important in the turnover of LC3, likely 
by promoting autophagosome-lysosome fusion. 
In summary, mistargeting of TECPR1 to EEA1- and LAMP2-positive MVBs selectively 
recruits LC3C-positive electron-dense autophagosome-, autolysosome-, and amphisome-
like organelles to these structures. Furthermore, mutating the LIR motif W175xxI178 in 
TECPR1ΔPH-2xFYVE significantly reduces the recruitment of LC3, while depletion of the 
GABARAP subfamily increases colocalization between LC3 and TECPR1ΔPH-2xFYVE. These 
results strongly support the hypothesis that TECPR1 selectively recruits LC3C-positive 
autophagosomes to lysosomes.  
 
 
Figure 29: Involvement of GABARAPs in recruiting LC3 to EEA1-positive structures by 
TECPR1ΔPH-2xFYVE. HeLa TECPR1-\- cells were transfected with indicated siRNAs and with GFP-
TECPR1ΔPH-2xFYVE and stained with anti-LC3 (M152-3) and anti-EEA1. Colocalization between GFP-
TECPR1ΔPH-2xFYVE and LC3 was quantified using the Pearson coefficient (n > 25 cells). Scale bars, 
10 µm. 
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3.6 TECPR1 and hATG8 proteins in selective autophagy 
TECPR1 has been implicated in selective types of autophagy, such as xenophagy, 
mitophagy, and aggrephagy (Ogawa et al., 2011). Additionally, the findings of this thesis 
suggest that TECPR1 functions in selective rather than non-selective autophagy since it 
was shown that TECPR1 selectively recruits LC3C-positive autophagosomes to lyso-
somes. To test whether the LC3C-positive compartments at TECPR1ΔPH-2xFYVE structures 
contain specific autophagic cargo, such as mitochondria or peroxisomes, TECPR1-\- cells 
coexpressing RFP-TECPR1ΔPH-2xFYVE and GFP-LC3C were stained for the mitochondrial 
chaperonin Hsp60 or the peroxisomal membrane protein PMP70, respectively (Figure 
30A). Both markers neither colocalized with GFP-LC3C nor with RFP-TECPR1ΔPH-2xFYVE, 
indicating that LC3C-positive autophagosomes do not enclose mitochondria or peroxi-
somes. The involvement of LC3C in PINK1/Parkin-mediated mitophagy was further 
excluded by monitoring the degradation of damaged mitochondria. Therefore, HEK293 
cells were treated with CCCP, a reagent that depolarizes the inner mitochondrial 
membrane and thereby induces the degradation of damaged mitochondria via 
autophagy. Depletion of neither TECPR1 nor LC3C caused a significant accumulation of 
mitochondrial Hsp60, which is in agreement with the observation that LC3C-positive 
autophagosomes do not contain mitochondria (Figure 30B). 
However, most LC3C puncta colocalized with ubiquitin (Ub) and the Ub-binding 
receptor p62. Although ubiquitin and p62 are markers for different kinds of autophagic 
cargo, the absence of mitochondrial or peroxisomal markers suggests that LC3C-positive 
structures contain ubiquitinated protein aggregates. This interpretation is further 
supported by CLEM experiments, which have shown that LC3C structures do not enclose 
mitochondria or peroxisomes, but electron-dense amorphous material, which likely 
corresponds to aggregated proteins (Figure 13). The same observation that GFP-LC3C 
puncta colocalize with p62 and ubiquitin was made in HEK293 cells (Figure 40 in the 
appendix) and confirms that LC3C-positive autophagosomes contain ubiquitinated 
cargo, which is independent of the used cell line. 
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Figure 30: Colocalization of markers with LC3C at TECPR1ΔPH-2xFYVE structures. (A) HeLa TECPR1-\- 
cells were cotransfected with RFP-TECPR1ΔPH-2xFYVE and GFP-LC3C and stained for Hsp60, PMP70, 
p62, and ubiquitin (Ub). Selected regions are cropped and enlarged. Arrows indicate GFP-LC3C 
puncta that colocalize with p62 or Ub at TECPR1ΔPH-2xFYVE structures. Scale bars, 10 µm. (B) 
HEK293 cells were transfected with indicated siRNAs and treated with CCCP for 4 hours. Cell 
lysates were immunoblotted with anti-Hsp60 and anti-β-actin. 
 
Recruitment of TECPR1 and hATG8s to protein aggregates 
The ubiquitin-binding autophagy receptor p62 has been implicated in mitophagy, 
pexophagy, xenophagy, and aggrephagy (Rogov et al., 2014). The fact that LC3C-positive 
autophagosomes did not contain mitochondria or peroxisomes and the cells were not 
infected with pathogens suggests that LC3C-positive autophagosomes enclose protein 
aggregates. To test if TECPR1 and LC3C are involved in the formation or clearance of 
protein aggregates, TECPR1-\- cells were cotransfected with RFP-TECPR1 and GFP-LC3C 
and protein aggregate formation was induced with puromycin, a translational inhibitor 
that leads to an accumulation of misfolded proteins. The immunofluorescent staining of 
these cells with anti-Ub and anti-p62 antibodies revealed that both TECPR1 and LC3C 
strongly colocalized with Ub- and p62-positive protein aggregates (Figure 31). While 
TECPR1 only localized to large Ub-positive aggregates, LC3C localized to almost all Ub-
positive structures, suggesting that LC3C plays an important role in the autophagic 
clearance of aggregates. Interestingly, not only LC3C but all hATG8 homologs localized to 
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protein aggregates and colocalized with TECPR1 at these structures (Figure 43 in the 
appendix). Hence, TECPR1, LC3C, and other hATG8 family members are recruited to 
protein aggregates. 
 
 
Figure 31: Recruitment of TECPR1 and LC3C to protein aggregates. HeLa TECPR1-\- cells were 
cotransfected with RFP-TECPR1 and GFP-LC3C and aggregate formation was induced with 
puromycin for 2 hours. Cells were stained with anti-ubiquitin (Ub) and anti-p62 antibodies. Scale 
bars, 10 µm.  
 
To test whether the recruitment of hATG8s and TECPR1 to protein aggregates depend 
on each other, either hATG8 proteins or TECPR1 were depleted and colocalization with 
protein aggregates was analyzed. When cells were treated with siRNAs against all hATG8 
homologs simultaneously, GFP-tagged TECPR1 still localized to protein aggregates, 
indicating that TECPR1 recruitment to protein aggregates is independent of hATG8 
proteins (Figure 32A). To examine whether the recruitment of LC3C and other hATG8 
proteins depends on TECPR1, colocalization of GFP-tagged hATG8s with protein aggre-
gates was analyzed in TECPR1 deficient cells (Figure 32B). Here again, the recruitment of 
hATG8s to cellular aggregates did not depend on TECPR1, since GFP-LC3B and GFP-LC3C 
colocalized strongly with ubiquitinated protein aggregates in TECPR1-\- cells. 
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Figure 32: Recruitment of TECPR1 and hATG8 homologs to protein aggregates. (A) Confocal 
images of HeLa TECPR1-\- cells that were transfected with indicated siRNAs and with GFP-
TECPR1. Aggregate formation was induced with puromycin for 2 hours and cells were stained for 
ubiquitin (Ub) by immunofluorescence. (B) Confocal images of HeLa TECPR1-\- cells that were 
transfected with GFP-LC3B or GFP-LC3C. Aggregate formation was induced with puromycin for 
2 hours and cells were stained for ubiquitin (Ub) by immunofluorescence. Scale bars, 10 µm. 
 
Autophagic clearance of protein aggregates involves targeting of misfolded proteins to 
lysosomes for their degradation. To analyze whether TECPR1-positive protein aggregates 
are targeted to lysosomes, TECPR1-\- cells complemented with GFP-TECPR1 and induced 
with puromycin were stained for the lysosomal marker LAMP1. Strikingly, LAMP1 
colocalized more with TECPR1-positive protein aggregates than with aggregates that 
were negative for GFP-TECPR1 (Figure 33). This suggests that TECPR1 is important for 
targeting of protein aggregates to lysosomes, thereby promoting autophagic removal of 
cellular aggregates. 
 
  Results 
  73 
 
Figure 33: Colocalization of TECPR1 with protein aggregates and LAMP1. HeLa TECPR1-\- cells 
were transfected with GFP-TECPR1. Formation of protein aggregates was induced with 
puromycin for 2 hours and cells were stained by immunofluorescence using anti-ubiquitin (Ub, 
Lys48 specific) and anti-LAMP1 antibodies. White arrows indicate Ub-aggregates that are 
positive for GFP-TECPR1 and LAMP1, while blue arrows indicate Ub-aggregates that are negative 
for GFP-TECPR1 and LAMP1. Scale bar, 10 µm. 
 
Impact of TECPR1 and hATG8s on the clearance of protein aggregates 
The recruitment of TECPR1 and hATG8 family members to protein aggregates suggests 
that they are involved in eliminating misfolded proteins. Thus, the impact of TECPR1, 
LC3C, and other hATG8 homologs on the clearance of protein aggregates was investigat-
ed. Protein aggregate formation was induced with puromycin and the clearance of 
protein aggregates was examined after removal of puromycin. In control wt cells, the 
number of protein aggregates was strongly reduced already four hours after puromycin 
withdrawal (Figure 34A). Knockdown of LC3A, LC3B, and LC3C simultaneously resulted in 
similar numbers of protein aggregates compared to control cells, indicating that LC3 
subfamily members including LC3C are dispensable for the effective removal of protein 
aggregates (validation of siRNAs see Figure 42 in the appendix). Knockdown of the 
GABARAP subfamily, on the other hand, significantly increased the percent of cells 
containing large aggregates, immediately as well as four hours after removal of puromy-
cin. This result indicates that the GABARAPs are essential for the elimination of protein 
aggregates and is consistent with observations of this thesis and of previous studies that 
suggested that GABARAP and not LC3 subfamily members are pivotal for autophagy, 
particularly for the fusion of autophagosomes with lysosomes (Szalai et al., 2015; 
Nguyen et al., 2016). Knockout of TECPR1 in HeLa cells, however, only slightly but not 
significantly increased the number of protein aggregates (Figure 34B). Moreover, there 
was no synergistic effect of hATG8 depletion and TECPR1 knockout, indicating that 
TECPR1 is not important for the clearance of protein aggregates under these conditions.  
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Figure 34: Effect of depletion of LC3 or GABARAP subfamilies on the clearance of protein 
aggregates in wt and TECPR1-\- cells. HeLa wt (A) or TECPR1-\- (B) cells were transfected with 
indicated siRNA pools and formation of protein aggregates was induced with puromycin for 
4 hours. The time after removal of puromycin is indicated (0h and 4h). Cells were stained with 
anti-ubiquitin antibody by immunofluorescence, analyzed by confocal microscopy, and cells 
containing large aggregates were counted (n > 300 cells from 3 independent experiments). Scale 
bar, 20 µm.  
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The weak effect of TECPR1 knockout on the removal of aggregates suggests that either 
TECPR1 is not involved in aggregate clearance or there are mechanisms that compensate 
for its loss. To exclude that cells bypass TECPR1-mediated autophagic degradation of 
protein aggregates by enhanced proteasome activity, wt and TECPR1-\- cells were 
incubated with the proteasome inhibitor MG132, which also leads to an accumulation of 
protein aggregates. Importantly, after eight hours of MG132 treatment, TECPR1-\- cells 
contained more protein aggregates than wt cells, suggesting that TECPR1 plays a role in 
the clearance of protein aggregates via autophagy (Figure 35).  
Collectively, these data show that TECPR1 and hATG8 proteins are recruited to pro-
tein aggregates and TECPR1 promotes targeting of these aggregates to lysosomes. 
Furthermore, aggregate clearance assays demonstrate that the GABARAPs are essential 
for eliminating protein aggregates in HeLa cells, whereas the LC3s as well as TECPR1 are 
less important. However, inhibition of the proteasome increases the impact of TECPR1 
on the clearance of protein aggregates. 
 
 
Figure 35: Aggregate formation with MG132 in wt and TECPR1-\- cells. HeLa wt or TECPR1-\- cells 
were incubated with MG132 for 8 hours, stained for ubiquitin by immunofluorescence, analyzed 
by confocal microscopy, and cells containing aggregates were counted (n > 250 cells from 3 
independent experiments). Scale bar, 20 µm. 
 
Interaction of TECPR1 with WDR81 
The BEACH and WD40 repeat-containing protein WDR81 has recently been implicated in 
the removal of protein aggregates by interacting with p62 and LC3C (Liu et al., 2017). 
The study reported that loss of either WDR81 or LC3C causes an accumulation of 
ubiquitinated protein aggregates. Since it was shown here that TECPR1 recruits LC3C- 
and p62-positive structures, the question arose whether TECPR1 can interact and 
cooperate with WDR81 to eliminate misfolded proteins via autophagy. To answer this 
question, co-immunoprecipitation experiments were performed using TECPR1-\- cells 
transiently expressing HA-tagged WDR81 and GFP-tagged TECPR1. HA-WDR81 indeed 
co-immunoprecipitated with GFP-TECPR1, suggesting that the two proteins interact 
(Figure 36A). In addition, GFP-tagged WDR81 colocalized strongly with RFP-tagged 
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TECPR1 and LC3C at ubiquitinated aggregates that were induced with puromycin (Figure 
36B). This supports the finding that WDR81 interacts with TECPR1 and LC3C at protein 
aggregates and implies that WDR81, LC3C, and TECPR1 could cooperate to promote 
autophagic clearance of misfolded proteins. 
 
 
Figure 36: Interaction of TECPR1 with WDR81. (A) Co-immunoprecipitation of HeLa TECPR1-\- 
cells transiently expressing HA-WDR81 and GFP-TECPR1 or GFP, respectively, using a GFP-Trap. 
(B) Confocal images of HeLa cells that were transfected with GFP-WDR81 and RFP-TECPR1 or 
RFP-LC3C. Protein aggregates were induced with puromycin for 2 hours and cells were stained 
for ubiquitin (Ub) by immunofluorescence. Arrows indicate colocalizing structures. Scale bars, 
10 µm. 
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4 DISCUSSION 
Autophagy is a central recycling system of cells and thus essential to maintain cellular 
homeostasis and to respond to stress conditions. It prevents cells from accumulating 
damaged or dispensable material and protects organisms from diseases like cancer, 
infections, and neurodegeneration. Macroautophagy involves the formation of the 
autophagosome, a unique double-membraned compartment that encloses cytoplasmic 
material to deliver it to the lysosome (or the vacuole in yeast). During autophagosome 
formation, the ubiquitin-like conjugation of hATG8 proteins (Atg8 in yeast) to autopha-
gosomal membranes plays an important role. The UBL conjugation cascade results in a 
covalent bond between hATG8 proteins and the lipid PE and its last step is catalyzed by 
the E3-like ATG12−ATG5 conjugate that can form complexes with either ATG16L1 or 
TECPR1. Although the mechanism of autophagosome biogenesis is well understood in 
yeast, the system in higher eukaryotes is more complex. Mammals often express 
multiple orthologs of yeast ATG proteins; for example there are six different hATG8 
homologs that can be divided into LC3 and GABARAP subfamilies. Moreover, 
mammalian ATG proteins also exert autophagy-unrelated functions, like the GABARAPs, 
which are involved in intracellular trafficking. In addition, there is crosstalk between 
autophagy and other cellular pathways, which makes the mammalian system even more 
complex compared to yeast.  
TECPR1 is a multidomain protein that lacks a yeast ortholog but has been implicated 
in mammalian autophagy. However, the function of TECPR1 in canonical autophagy is 
still unclear, since conflicting data have been published previously. One study reported 
that autophagosomes accumulate in absence of TECPR1, suggesting that TECPR1 is 
important for autophagosome maturation and fusion with lysosomes (Chen et al., 2012). 
On the contrary, another study observed the opposite effect of TECPR1 depletion on 
canonical autophagy, but found TECPR1 to be involved in selective types of autophagy 
(Ogawa et al., 2011). TECPR1 interacts with ATG12−ATG5 through a conserved AIR motif 
and the complex has been shown to be mutually exclusive from the ATG12−ATG5-
ATG16L1 complex (Kim et al., 2015). However, the role of the ATG12−ATG5-TECPR1 
complex remains largely unknown. One study suggested that the complex functions as 
tethering factor that joins autophagosomes with lysosomes (Chen et al., 2012), whereas 
another study speculated that it serves as adaptor for bacterial pathogens (Ogawa et al., 
2011). Yet, the fact that ATG16L1 and TECPR1 bind to the same site in ATG5 through a 
conserved motif implies that TECPR1 plays a role in the hATG8 conjugation system, 
which has not been investigated in previous studies. Furthermore, the molecular 
mechanism of how TECPR1 promotes autophagosome-lysosome fusion, as well as 
autophagic degradation of selective cargo remains elusive.  
To characterize the function of TECPR1 in autophagy, the following four questions 
were addressed in this thesis: (1) What is the impact of TECPR1 on the conjugation of 
the different hATG8 homologs compared to ATG16L1? (2) Does TECPR1 interact with 
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specific hATG8 proteins? (3) What is the subcellular localization of TECPR1 and interact-
ing hATG8 proteins and how are they targeted to the respective compartments? (4) 
What are the roles of TECPR1 and hATG8 proteins in selective types of autophagy, such 
as aggrephagy and mitophagy? To answer the first question, to what extent TECPR1 
regulates the conjugation of the different hATG8 proteins to membranes, a combinato-
rial approach using in vitro reconstitution experiments and complementary in vivo 
studies was used. In vitro experiments required the production of recombinant ATG 
proteins and the lipidation reaction to be reconstituted on artificial membranes, while in 
vivo studies required CRISPR/Cas9-mediated knockout HeLa cell lines that are deficient 
for ATG16L1 or TECPR1. Based on these results, the second question, whether TECPR1 
interacts with specific hATG8 homologs, was addressed. Potential interaction sites in 
TECPR1 were identified in in vivo colocalization experiments and in vitro binding assays 
using hATG8 proteins conjugated to artificial membranes. To answer the third question, 
what the subcellular localization of TECPR1 and interacting hATG8 proteins is, a combi-
nation of electron microscopy and immunofluorescence methods was used. In addition, 
mutagenesis of single TECPR1 domains was performed to reveal how TECPR1 is targeted 
to specific cellular membranes and compartments. Finally, the role of TECPR1 and 
hATG8 proteins in selective types of autophagy was defined by analyzing the colocaliza-
tion of TECPR1 and hATG8s with selective cargo markers. Moreover, the influence of 
depletion of TECPR1 and hATG8 proteins on the clearance of aggregated proteins and 
damaged mitochondria was investigated. 
4.1 The role of TECPR1 in the hATG8 conjugation system 
Knockout of TECPR1 leads to an accumulation of LC3C and GABARAPL2 puncta 
The interaction of TECPR1 with ATG5 has been confirmed by independent labs and has 
been further demonstrated to be mutually exclusive from the interaction of ATG16L1 
with ATG5 (Ogawa et al., 2011; Chen et al., 2012; Kim et al., 2015). This implies that in 
addition to ATG16L1, TECPR1 is also involved in the UBL conjugation of hATG8 proteins. 
To test whether TECPR1 promotes lipidation of hATG8 proteins, hATG8 puncta for-
mation was systematically analyzed in HeLa cells that are deficient for either TECPR1 
(TECPR1-/-) or ATG16L1 (ATG16L1-/-). As expected, the number of GFP-tagged LC3A, 
LC3B, and LC3C puncta is drastically reduced in ATG16L1-/- cells. Moreover, the number 
of GFP-tagged GABARAP and GABARAPL1 puncta is also decreased, suggesting that 
ATG16L1 is essential for the recruitment of hATG8s to isolation membranes. Consistent 
with the reduction in hATG8 puncta, lipidation of LC3 family members is blocked in 
ATG16L1-/- cells, indicating that ATG16L1 is also essential for the lipidation of hATG8 
proteins. In contrast to ATG16L1, knockout of TECPR1 does not influence the lipidation 
of hATG8 proteins. However, the number of GFP-LC3C and GFP-GABARAPL2 puncta are 
significantly increased in TECPR1-/- cells, while the number of other hATG8 proteins stays 
unchanged compared to wt cells. This indicates that either expression of LC3C and 
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GABARAPL2 is increased, or that the turnover of LC3C- and GABARAPL2-positive 
membranes is impaired upon knockout of TECPR1. Since TECPR1 has been implicated in 
later steps in autophagosome formation, particularly in fusion of autophagosomes with 
lysosomes (Chen et al., 2012; Kim et al., 2015), it appears likely that LC3C and 
GABARAPL2 puncta correspond to late autophagosomes that accumulate upon a block 
of fusion by knockout of TECPR1.  
TECPR1 promotes conjugation of LC3C and GABARAP family members to 
artificial membranes 
The selective accumulation of LC3C- and GABARAPL2-positive structures upon depletion 
of TECPR1 indicates that TECPR1 can interact with specific hATG8 proteins. To test 
whether TECPR1 indeed interacts with specific hATG8 proteins and to further investigate 
its function in the UBL conjugation system, the entire UBL conjugation cascade was 
reconstituted in vitro using recombinant proteins and artificial membranes. Previously, it 
has been shown that the E3-like ATG12−ATG5 conjugate needs to be activated by 
ATG16L1 to efficiently catalyze conjugation of hATG8s to PE on GUV membranes 
(Kaufmann, 2015). Here, it was further demonstrated that TECPR1 is also able to activate 
ATG12−ATG5 and, in contrast to ATG16L1, selectively promotes the lipidation of LC3C 
and the GABARAPs. This indicates that TECPR1 selectively recruits these hATG8 proteins 
to the membrane, thereby facilitating their conjugation to the membrane. However, 
depletion of TECPR1 in HeLa cells does not affect the lipidation of hATG8s but leads to a 
selective accumulation of LC3C and GABARAPL2 puncta. This discrepancy between in 
vitro and in vivo data implies that although TECPR1 does not promote hATG8 conjuga-
tion, TECPR1 can specifically interact with these hATG8 homologs.  
Deletion of the ATG5 interaction site in TECPR1 does not alter its subcellular 
distribution 
The fact that TECPR1 is dispensable for hATG8 lipidation raises the question: What is the 
function of the ATG12−ATG5-TECPR1 complex? The complex has been suggested to 
tether autophagosomes to lysosomes to regulate their fusion (Kim et al., 2015; Chen et 
al., 2012). Strikingly, it was shown in this thesis that deletion of the ATG5 interaction site 
in TECPR1 (TECPR1ΔAIR) does not change its subcellular localization. Instead, TECPR1ΔAIR 
still localizes to lysosomes and colocalizes with LC3C, which excludes the possibility that 
the ability of TECPR1 to bind to lysosomal as well as LC3C-positive membranes depends 
on the interaction with ATG12−ATG5. Therefore, the physiological role of this interaction 
needs to be clarified in future experiments.  
Taken together, the function of the interaction of TECPR1 with ATG12−ATG5 is s ll 
not completely understood. It was demonstrated in this thesis that TECPR1 can activate 
the E3-like ATG12−ATG5 conjugate, similarly to ATG16L1, and therefore promote the 
lipidation of LC3C and GABARAP proteins in vitro. The specificity of TECPR1 towards 
LC3C and GABARAP proteins strongly suggests that TECPR1 interacts with these hATG8 
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homologs and is consistent with the finding that TECPR1 is important for the turnover of 
LC3C- and GABARAPL2-positive membranes in vivo. 
4.2 Interaction of TECPR1 with hATG8 proteins 
TECPR1 interacts with lipidated LC3C and dynamically interacts with LC3C-
positive compartments 
The selective in vitro lipidation of LC3C by TECPR1 as well as the accumulation of LC3C 
puncta in TECPR1 depleted cells suggests that TECPR1 interacts with LC3C-positive 
compartments. However, an interaction between LC3C and TECPR1 could not be 
observed in pull-down or other in vitro assays, which raises the possibility that TECPR1 is 
recognizing only lipidated, and not soluble, LC3C. Indeed, PE-conjugated LC3C is 
recruited to TECPR1-positive artificial membranes, indicating that TECPR1 specifically 
recognizes LC3C in its lipidated form. Based on differential binding of antibodies to the 
lipidated versus unlipidated form, it has been suggested that Atg8 changes its confor-
mation upon PE-conjugation (Nakatogawa et al., 2007). As a consequence, Atg8/hATG8 
interaction partners are believed to have a preference for either the lipidated or 
unlipidated form and this hypothesis is supported by the data shown here. However, the 
mechanism of how exactly the lipidation state is recognized is still unclear and needs to 
be investigated in future studies.  
Further evidence for the interaction of TECPR1 with LC3C is provided by the fact that 
LC3C puncta are often found in close proximity to TECPR1 structures. However, TECPR1 
was not observed to co-immunoprecipitate with LC3C, indicating that this interaction 
may be transient. Moreover, some LC3C puncta dynamically contact TECPR1 structures 
or lysotracker-stained compartments, suggesting that there might be docking events 
between LC3C- and TECPR1-positive compartments that do not result in complete 
fusions of these vesicles. Alternatively, there might be kiss-and-run fusions of LC3C-
positive autophagosomes with TECPR1-positive lysosomes, which result in a transfer of 
autophagosomal content to the lysosome while maintaining two separate vesicles. This 
kiss-and-run mechanism has been previously suggested to play a role in autophago-
some-lysosome fusion (Jahreiss et al., 2008). Therefore, the data presented here 
propose that TECPR1-positive lysosomes and LC3C-positive compartments dynamically 
interact with each other. 
TECPR1 possesses a LIR motif 
TECPR1 possesses multiple domains, including two WD-repeat domains composed of β-
propeller repeats (TR1 and TR2), two dysferlin motifs, a disordered DR domain, and a PH 
domain. In contrast to the DR domain and the C-terminal TR2 domain, the N-terminal 
TR1 domain, which contains four β-propeller repeats, colocalizes with lysosomal markers 
as well as with LC3C. Therefore, it appears likely that the TR1 domain can interact with 
LC3C and indeed a LIR motif was found in the N-terminal domain that binds to lipidated 
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hATG8 homologs in floatation assays. Although in vivo TECPR1 is mainly found 
associated with LC3C and not with other hATG8 homologs, the isolated TECPR1 peptide 
containing the W175xxI178 LIR motif interacts with all hATG8 homologs to a similar extent. 
This suggests that TECPR1 recognizes additional regions in LC3C that provide specificity, 
a possibility that should be addressed in future experiments. Moreover, mutations in the 
LIR motif affect not only the colocalization with hATG8 proteins but also the cellular 
distribution of TECPR1, which implies that either the LIR mutant of TECPR1 is not 
functional or that TECPR1 needs to interact with LC3C or other hATG8 proteins to be 
targeted to the correct compartments. 
In conclusion, this work shows that TECPR1 can interact with lipidated LC3C through a 
canonical LIR motif in the N-terminal domain of TECPR1. Furthermore, LC3C-positive 
compartments dynamically interact with TECPR1-positive structures, indicating that the 
interaction between TECPR1 and LC3C is transient. 
4.3 Subcellular localization of TECPR1 and LC3C 
TECPR1 localizes to (auto-)lysosomes 
A previous study reported that TECPR1 localizes to early autophagosomal structures to 
target bacteria to autophagosomal membranes (Ogawa et al., 2011), while another 
study suggested that TECPR1 localizes to autolysosomes (Chen et al., 2012). To clarify 
the subcellular localization of TECPR1, CLEM was performed and revealed that large 
GFP-TECPR1 structures correspond to lysosomes or autolysosomes. Consistent with that 
finding, large GFP-TECPR1 structures colocalize with late endosomal and lysosomal 
markers in IF experiments. However, smaller TECPR1 puncta, which are negative for 
endosomal markers, are occasionally observed. In immuno-EM experiments, TECPR1 
was found to localize to clusters of small vesicles, which could correspond to the small 
TECPR1 puncta observed in IF. TECPR1 has been reported to interact with the human 
TRAPPIII tethering complex (Behrends et al., 2010), which was recently shown to be 
important in ATG9 trafficking and in promoting autophagy (Lamb et al., 2016; Imai et al., 
2016). Moreover, it was shown here that TECPR1 colocalizes with ATG9 and partially 
with the TGN marker TGN46 and the recycling endosomal marker Rab11A, which both 
have been associated with ATG9 vesicles (Young et al., 2006; Orsi et al., 2012). Hence, 
small TECPR1 puncta that are negative for endosomal markers could be involved in 
trafficking of ATG9 vesicles.   
The PH domain binds to PtdIns(4)P and targets TECPR1 to lysosomal 
membranes 
The interaction with ATG12−ATG5 has been suggested to allow TECPR1 to bind to the 
lipid PtdIns(3)P (Chen et al., 2012). Here, however, TECPR1 was not found associated 
with PtdIns(3)P, neither at PtdIns(3)P-positive artificial membranes, nor at PtdIns(3)P-
rich membranes in HeLa cells. Instead, TECPR1 exhibits a strong affinity for PtdIns(4)P-
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positive membranes both, in vitro and in vivo. This observation is in agreement with the 
localization of TECPR1 to lysosomes, which have been reported to be rich in PtdIns(4)P 
but not PtdIns(3)P (Jeschke et al., 2015). PtdIns(4)P is essential to preserve lysosomal 
identity, since the absence of the PtdIns(4)P-generating PI4KIIIβ results in abnormal 
formation of lysosomal tubules and unwanted lysosomal efflux (Sridhar et al., 2013). 
Moreover, the conversion of PtdIns(4)P to PtdIns(4,5)P2 regulates autophagic lysosome 
reformation and is therefore important to maintain lysosome homeostasis (Rong et al., 
2012). In addition, the generation of PtdIns(4)P on autophagosomes has been suggested 
to be important for the fusion of autophagosomes with lysosomes (Wang et al., 2015). 
Therefore, the localization of TECPR1 to PtdIns(4)P on lysosomal membranes might play 
a role in fusion and fission events that involve lysosomal membranes. Furthermore, it 
was shown in this thesis that, to a certain extent, the phosphoinositide-binding PH 
domain targets TECPR1 to PtdIns(4)P-positive and lysosomal membranes. However, 
TECPR1ΔPH is still partly colocalizing with PtdIns(4)P and lysosomal markers. Moreover, 
the N-terminal TR1 domain that lacks the PH domain is, like full-length TECPR1, strongly 
colocalizing with lysosomal and late endosomal markers. Thus, the interaction of the PH 
domain with PtdIns(4)P cannot be the only mechanism through which TECPR1 is 
targeted to lysosomes. The involvement of the TR1 domain in targeting TECPR1 to 
lysosomal membranes should therefore be investigated further. 
Replacing the PH domain of TECPR1 by a tandem FYVE domain mistargets 
TECPR1 to MVBs 
To investigate the impact of the PtdIns(4)P-binding PH domain on the localization of 
TECPR1 further, the PH domain was replaced by two repeats of the PtdIns(3)P-binding 
FYVE domain to generate TECPR1ΔPH-2xFYVE. The replacement of these phosphoinositide-
binding domains results in mistargeting of TECPR1 to the outer membrane of MVB-like 
organelles. Surprisingly, these compartments are positive for all tested endosomal 
markers, from early endosomal markers EEA1 and Rab5 to late endosomal and lysoso-
mal markers Rab7 and LAMP2, respectively. Moreover, TECPR1ΔPH-2xFYVE colocalizes with 
PtdIns(3)P and PtdIns(4)P as well as with lysotracker, which labels acidified compart-
ments. Thus, the conventional transition from Rab5- to Rab7-positive endosomes is not 
observed in TECPR1ΔPH-2xFYVE-expressing cells, suggesting that maturation and sorting of 
MVBs is impaired. This would in turn imply that TECPR1ΔPH-2xFYVE dramatically interferes 
with the endocytic pathway. Therefore, the effect of TECPR1ΔPH-2xFYVE expression in 
TECPR1-/- cells on the degradation of EGFR was investigated. Strikingly, EGFR degrada-
tion is not affected in TECPR1ΔPH-2xFYVE-expressing cells, which indicates that the endo-
cytic system is still functional. Thus, it appears likely that functional endosomes coexist 
with TECPR1ΔPH-2xFYVE-induced aberrant MVBs. Importantly, it was demonstrated in this 
work that expression of TECPR1ΔPH-2xFYVE also recruits LC3C-positive compartments to 
these aberrant EEA1-positive endosomes. The selectivity of this recruitment demon-
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strates that TECPR1 dictates the subcellular localization of LC3C and strongly suggests 
that TECPR1 directly interacts with LC3C. 
LC3C localizes to a large number of electron-dense structures and colocalizes 
with STX17 and ubiquitin 
Since LC3C-positive compartments are selectively recruited by TECPR1ΔPH-2xFYVE, it was of 
eminent importance to reveal the nature of these LC3C-positive structures. Interestingly, 
the number of GFP-LC3C puncta in HeLa cells exceeds the number of GFP-LC3B or GFP-
LC3A puncta by more than two fold. Since LC3C has been mainly implicated in selective 
types of autophagy, such as xenophagy, mitophagy, and aggrephagy (von Muhlinen et 
al., 2012; Liu et al., 2017; Le Guerroué et al., 2017) as well as in maintaining functional 
ER exit sites (Stadel et al., 2015), many LC3C puncta do not correspond to canonical 
autophagosomes. Surprisingly, although LC3C has been reported to play a role in basal 
PINK1/Parkin-independent mitophagy, the majority of LC3C puncta does not colocalize 
with mitochondrial markers in HeLa cells. Instead, most LC3C structures are positive for 
ubiquitin and the ubiquitin-binding autophagy receptor p62 as well as for the late 
autophagosomal marker STX17, the SNARE that localizes to the outer membrane of 
completed autophagosomes and promotes fusion with lysosomes (Itakura et al., 2012). 
The colocalization of LC3C with these marker proteins suggests that LC3C-positive 
structures correspond to late autophagosomes that contain ubiquitinated cargo. 
Importantly, CLEM experiments revealed that LC3C almost exclusively localizes to 
electron-dense structures, many of which resemble autophagosomes, amphisomes, and 
autolysosomes. This indicates that LC3C-positive compartments contain aggregated 
proteins and therefore strongly supports the hypothesis that LC3C plays a role in 
aggrephagy.  
The specific localization of LC3C to protein aggregates would further suggest that 
LC3C is mediating the selective engulfment of protein aggregates by autophagosomal 
membranes. Similar to this theory, LC3C has been reported to be involved in the 
selective targeting of intracellular bacteria into autophagosomes by binding to the 
autophagy receptor NDP52 (von Muhlinen et al., 2012). If LC3C was mediating the 
selective engulfment of protein aggregates, LC3C would have to be conjugated to the 
inner membrane of the autophagosome to bind to selective receptors. However, it was 
shown here that, using an RFP-GFP-hATG8 reporter in absence of intracellular patho-
gens, the majority of LC3C, GABARAP and GABARAPL2 is not transported into lysosomes, 
suggesting that these proteins are mainly attached to the outer membrane of autopha-
gosomes. Since only a small fraction of LC3C puncta colocalizes with lysosomal markers, 
the majority of LC3C does not remain on the membrane of autolysosomes after fusion. 
This implies that LC3C could be recycled by ATG4 proteins before LC3C-positive 
autophagosomes fuse with lysosomes, a possibility that should be analyzed in future 
studies. Importantly, LC3C and other hATG8 homologs that are present at the outer 
membrane of autophagosomes can potentially interact with proteins on other mem-
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brane compartments, which could be important for the recruitment of autophagosomes 
to lysosomes. Thus, the precise mechanism of how aggregated proteins are selectively 
targeted into the lumen of LC3C-positive autophagosomes remains elusive and needs to 
be investigated in future studies. 
4.4 The role of TECPR1 and LC3C in selective autophagy 
TECPR1 is involved in the clearance of protein aggregates 
The role of TECPR1 in canonical autophagy, which involves the lipidation and turnover of 
LC3B, is still a matter of debate. On the one hand, it was reported that autophagosomes 
accumulate in TECPR1 depleted cells (Chen et al., 2012), while on the other hand, it was 
published that LC3B-II levels are slightly decreased when TECPR1 is depleted (Ogawa et 
al., 2011). Consistent with the latter study, it was shown here that the level of LC3B-II is 
slightly but not significantly reduced in HeLa TECPR1-\- cells in absence and presence of 
Bafilomycin A1, suggesting that TECPR1 is dispensable for canonical autophagy.  
Both TECPR1 and LC3C have been implicated in various types of selective autophagy. 
It was shown that the removal of intracellular bacteria, damaged mitochondria, and 
protein aggregates was reduced in TECPR1-/- mouse embryonic fibroblasts (Ogawa et al., 
2011). Furthermore, LC3C has been shown to be important for the clearance of intracel-
lular bacteria (von Muhlinen et al., 2012), mitochondria (Le Guerroué et al., 2017), as 
well as protein aggregates (Liu et al., 2017). However, in this thesis it was demonstrated 
that depletion of LC3C or TECPR1 has at most a minor effect on the degradation of 
damaged mitochondria and protein aggregates. Consistent with a previous study that 
suggested that the GABARAPs and not the LC3s are important for autophagosome 
maturation and fusion with lysosomes (Nguyen et al., 2016), it was observed in this 
thesis that knockdown of the GABARAP subfamily but not of the LC3 subfamily results in 
impaired clearance of protein aggregates. This suggests that the GABARAPs can com-
pensate for the loss of LC3 subfamily members. Moreover, depletion of the GABARAP 
subfamily increases the colocalization between LC3 and TECPR1ΔPH-2xFYVE, which indicates 
that the turnover of LC3 proteins is impaired and is consistent with the assumption that 
GABARAP proteins are essential for autophagosome-lysosome fusion. 
Only when TECPR1-/- HeLa cells are treated with the proteasome inhibitor MG132 do 
protein aggregates significantly accumulate compared to wt cells, indicating that the 
cells can compensate for the loss of TECPR1-mediated autophagic clearance of aggre-
gates by proteasomal activity. Generally, fusion of autophagosomes with lysosomes 
requires the Rab7 effector and tethering complex HOPS, as well as SNARE proteins. 
Therefore, knockout of TECPR1 might be compensated by other tethering factors like 
the HOPS complex. However, LC3C and TECPR1 both localize to puromycin-induced 
protein aggregates, which strongly implies that they function in the removal of these 
aggregates. Moreover, LC3C-positive autophagosomes that contain electron-dense 
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material are recruited by TECPR1 variants, supporting the hypothesis that TECPR1 and 
LC3C are involved in the clearance of protein aggregates through autophagy. 
A recent study has reported that the BEACH and WD40 repeat-containing protein 
WDR81 is involved in the elimination of aggregated proteins by interacting with p62 and 
LC3C (Liu et al., 2017). Since TECPR1 is also found associated with LC3C- and p62-positive 
autophagosomes, its interaction and colocalization with WDR81 was investigated. 
Strikingly, TECPR1 and LC3C colocalize with WDR81 at protein aggregates and TECPR1 
interacts with WDR81 in co-immunoprecipitations. WDR81 could therefore mediate the 
recruitment of TECPR1 to p62-positive protein aggregates. This further suggests that 
TECPR1 could cooperate with WDR81 in an LC3C-dependent manner to promote 
clearance of protein aggregates, which should be further analyzed. 
Collectively, the results obtained in this thesis suggest a new model for the role of 
TECPR1 in autophagic clearance of protein aggregates (Figure 37). TECPR1 resides on 
lysosomal membranes, where it binds to PtdIns(4)P via its PH domain and selectively 
recruits LC3C-positive autophagosomes via a canonical LIR motif. LC3C-positive 
autophagosomes contain ubiquitin- and p62-positive protein aggregates that are 
delivered to the lysosome after being recruited by TECPR1. Therefore, TECPR1 and LC3C 
cooperate to promote clearance of protein aggregates through autophagy. 
 
 
Figure 37: Proposed model for the role of TECPR1 in autophagic clearance of protein aggregates. 
TECPR1 binds to PtdIns(4)P at the lysosomal membrane and specifically recruits LC3C-positive 
autophagosomes to lysosomes via a LIR motif in TECPR1. The recruitment of these LC3C-positive 
autophagosomes that contain ubiquitin (Ub)- and p62-positive protein aggregates by TECPR1 
thus promotes clearance of protein aggregates. 
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5 OUTLOOK 
This thesis provided evidence of a novel role of TECPR1 in the clearance of protein 
aggregates through autophagy. TECPR1 closely cooperates with LC3C to recruit selective 
autophagosomes that enclose aggregated proteins to lysosomes and therefore pro-
motes their degradation. Despite the provided details about the molecular mechanism 
of TECPR1- and LC3C-mediated aggrephagy, there are open questions that need to be 
addressed in the future.  
The nature of large and bright structures of fluorescently tagged TECPR1 has been 
well described in this thesis. However, smaller TECPR1 puncta are occasionally observed 
that do not colocalize with endosomal markers and could not be detected in CLEM, 
probably due to their limited fluorescent intensity. Thus, these small TECPR1 structures 
should be characterized in further studies. To identify more interaction partners of 
TECPR1 and its domains, MS analysis could be performed and for example reveal how 
the N-terminal TR1 domain targets TECPR1 to lysosomal membranes. In addition, 
interactions between TECPR1 and previously reported TECPR1-binding proteins, like the 
human TRAPPIII tethering complex (Behrends et al., 2010), need to be validated and 
characterized. 
It was demonstrated in this thesis that TECPR1 selectively recruits LC3C, which 
depends on the LIR motif in TECPR1. However, a direct interaction was not observed, 
likely due to a transient interaction between the two proteins as well as the membrane 
anchoring of LC3C, which makes interactions difficult to study. Therefore, alternative 
methods should be used that can detect transient interactions and be applied to 
insoluble proteins. One of these methods is BioID, which is based on biotinylation of 
neighboring proteins by a biotin ligase fused to the protein of interest. Moreover, the 
interaction between TECPR1 and LC3C should be further characterized by mapping the 
binding site in LC3C, for example by mutational analysis. This could also reveal the 
molecular details of how TECPR1 selectively recognizes LC3C. 
To investigate the function of TECPR1 and the hATG8 proteins in vivo, they were 
cloned together with fluorescent or affinity tags into mammalian expression vectors 
harboring a CMV promoter and transfected into HeLa or HEK293 cells. However, fusion 
of proteins with large tags as well as overexpression of the proteins can dramatically 
change their biochemical properties. Therefore, specific antibodies should be used to 
analyze the subcellular localization as well as the levels of endogenous proteins. Yet, 
there are no antibodies available that reliably distinguish between the homologs of the 
LC3 subfamily or specifically recognize TECPR1. A solution to this issue would be to 
genetically tag the proteins of interest by using CRISPR/Cas9 gene editing, which allows 
for the expression of proteins at their physiological levels. 
It is still unclear how exactly protein aggregates are recognized by the autophagic 
machinery. Although autophagy receptors, including p62 and OPTN, are involved in 
aggrephagy, they are also known to recognize other ubiquitinated autophagic sub-
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strates, like outer mitochondrial membrane proteins (Rogov et al., 2014). Thus, the 
selective engulfment of aggregated proteins by autophagosomal membranes cannot be 
explained by the presence of currently identified autophagy receptors. Moreover, 
although LC3C almost exclusively localizes to electron-dense structures, the majority of 
LC3C is not transported into the lysosome, suggesting that it does not mediate tethering 
of protein aggregates to autophagosomal membranes. Therefore, it is important to 
identify the factors that recognize and target protein aggregates into the autophagoso-
mal lumen, for example by MS analysis, which allows for detection of the interactome of 
aggregated proteins. 
The model system used in this thesis is adequate for investigating principle mecha-
nisms in autophagy. However, cell lines that are more relevant for diseases should be 
used in the future to analyze how toxic protein aggregates are recognized and cleared 
through autophagy. Since aggrephagy is mainly related to neurodegenerative diseases, 
such as amyotrophic lateral sclerosis (ALS) or Huntington’s disease, neuronal cell lines, 
patient cells, or mouse models should be used to investigate the removal of 
physiological relevant protein aggregates. Moreover, different aggregate-prone proteins 
cause different neurodegenerative diseases, for example amyloid beta is involved in 
Altzheimer’s disease and alpha-synuclein in Parkinson’s disease. It would be of peculiar 
interest whether the here identified TECPR1- and LC3C-mediated mechanism also plays 
a role in the clearance of disease-related protein aggregates. Therefore, the recruitment 
of TECPR1 and LC3C to specific protein aggregates of cells derived from patients and the 
effect on the elimination of these aggregates should be investigated. Furthermore, the 
identification of additional factors that recognize and target specific protein aggregates 
to autophagosomes could provide new therapeutic targets. 
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6 APPENDIX 
 
Figure 38: Recombinant proteins used for in vitro experiments.  
 
 
 
Figure 39: Co-immunoprecipitation and in vitro pull-down assay with TECPR1 and hATG8 
proteins. (A) HeLa TECPR1-/- cells were cotransfected with GFP-TECPR1 and HA-tagged hATG8s or 
the empty pLPCX vector, respectively. Co-immunoprecipitation was performed using anti-HA 
affinity matrix and samples were immunoblotted with anti-HA and anti-GFP antibodies. (B) His6-
MBP-tagged TECPR1 (MBP-TEC) or His6-MBP (MBP) was incubated together with LC3C and Ni-
NTA agarose beads. Input (I) and pull-down (PD) samples were subjected to SDS-PAGE and 
stained with coomassie staining solution. 
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Figure 40: Colocalization of markers with LC3C at TECPR1ΔPH-2xFYVE structures in HEK293 cells. 
Confocal images of HEK293 cells that were cotransfected with RFP-TECPR1ΔPH-2xFYVE and GFP-LC3C 
and stained for EEA1, p62, and ubiquitin (Ub) by immunofluorescence. Scale bars, 10 µm.  
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Figure 41: Colocalization of hATG8s with TECPR1ΔPH-2xFYVE W175A/I178A LIR mutant and EEA1. 
Confocal images of HeLa TECPR1-/- cells that were cotransfected with HA-tagged hATG8s and 
TECPR1ΔPH-2xFYVE W175A/I178A and stained for EEA1 by immunofluorescence. Scale bars, 10 µm.  
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Figure 42: Validation of used siRNAs. (A-D) HeLa cells were transfected with indicated siRNAs 
(10 nM each), incubated for 72 hours, and immunoblotted with indicated antibodies. HeLa cells 
stably expressing GFP-tagged LC3A (E), LC3C (F), or GABARAPL1 (G) were transfected with 
indicated siRNAs (10 nM each), incubated for 72 hours, and immunoblotted with anti-GFP and 
anti-β-actin antibodies. hATG8 levels were normalized to β-actin as indicated below.  
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Figure 43: Colocalization of TECPR1 and hATG8s at protein aggregates. Confocal images of HeLa 
TECPR1-/- cells that were cotransfected with RFP-TECPR1 and GFP-tagged hATG8s. Aggregate 
formation was induced with puromycin for 2 hours and cells were stained for ubiquitin (Ub) by 
immunofluorescence. Arrows indicate colocalization of both RFP-TECPR1 and GFP-hATG8s with 
ubiquitin. Scale bars, 10 µm.  
 
94   
  
  References 
  95 
7 REFERENCES 
Axe, E. L., Walker, S. A., Manifava, M., Chandra, P., Roderick, H. L., Habermann, A., Griffiths, G. & 
Ktistakis, N. T. (2008). Autophagosome formation from membrane compartments 
enriched in phosphatidylinositol 3-phosphate and dynamically connected to the 
endoplasmic reticulum. The Journal of Cell Biology, 182, 685-701. 
Balderhaar, H. J. & Ungermann, C. (2013). CORVET and HOPS tethering complexes - coordinators 
of endosome and lysosome fusion. J Cell Sci, 126, 1307-16. 
Bandyopadhyay, U., Kaushik, S., Varticovski, L. & Cuervo, A. M. (2008). The chaperone-mediated 
autophagy receptor organizes in dynamic protein complexes at the lysosomal 
membrane. Mol Cell Biol, 28, 5747-63. 
Behrends, C., Sowa, M. E., Gygi, S. P. & Harper, J. W. (2010). Network organization of the human 
autophagy system. Nature, 466, 68-76. 
Bjørkøy, G., Lamark, T., Brech, A., Outzen, H., Perander, M., Øvervatn, A., Stenmark, H. & 
Johansen, T. (2005). p62/SQSTM1 forms protein aggregates degraded by autophagy and 
has a protective effect on huntingtin-induced cell death. The Journal of Cell Biology, 171, 
603-614. 
Chen, D., Fan, W., Lu, Y., Ding, X., Chen, S. & Zhong, Q. (2012). A mammalian autophagosome 
maturation mechanism mediated by TECPR1 and the Atg12-Atg5 conjugate. Mol Cell, 45, 
629-41. 
Chen, Y. A. & Scheller, R. H. (2001). SNARE-mediated membrane fusion. Nat Rev Mol Cell Biol, 2, 
98-106. 
Cherra, S. J., Kulich, S. M., Uechi, G., Balasubramani, M., Mountzouris, J., Day, B. W. & Chu, C. T. 
(2010). Regulation of the autophagy protein LC3 by phosphorylation. The Journal of Cell 
Biology, 190, 533-539. 
Coyle, J. E., Qamar, S., Rajashankar, K. R. & Nikolov, D. B. (2002). Structure of GABARAP in two 
conformations: implications for GABA(A) receptor localization and tubulin binding. 
Neuron, 33, 63-74. 
Dall'armi, C., Devereaux, K. A. & Di Paolo, G. (2013). The role of lipids in the control of 
autophagy. Curr Biol, 23, R33-45. 
David J.Gillooly, I. C. M., Margaret Lindsay, Robert Gould, Nia J.Bryant, Jean-Michel Gaullier, 
Robert G.Parton and Harald Stenmark (2000). Localization of phosphatidylinositol 3-
phosphate in yeast and mammalian cells. The EMBO Journal, 19, 4577±4588. 
Dempfle, L. (2014). Analyzing the Function of TECPR1 in Autophagy by In Vitro Reconstitution. 
Diao, J., Liu, R., Rong, Y., Zhao, M., Zhang, J., Lai, Y., Zhou, Q., Wilz, L. M., Li, J., Vivona, S., 
Pfuetzner, R. A., Brunger, A. T. & Zhong, Q. (2015). ATG14 promotes membrane 
tethering and fusion of autophagosomes to endolysosomes. Nature, 520, 563-6. 
Dice, J. F. (1990). Peptide sequences that target cytosolic proteins for lysosomal proteolysis. 
Trends Biochem Sci, 15, 305-9. 
Dooley, H. C., Razi, M., Polson, H. E., Girardin, S. E., Wilson, M. I. & Tooze, S. A. (2014). WIPI2 
links LC3 conjugation with PI3P, autophagosome formation, and pathogen clearance by 
recruiting Atg12-5-16L1. Mol Cell, 55, 238-52. 
Elkin, S. R., Lakoduk, A. M. & Schmid, S. L. (2016). Endocytic pathways and endosomal trafficking: 
a primer. Wien Med Wochenschr, 166, 196-204. 
Farre, J. C. & Subramani, S. (2004). Peroxisome turnover by micropexophagy: an autophagy-
related process. Trends Cell Biol, 14, 515-23. 
Fujita, N., Itoh, T., Omori, H., Fukuda, M., Noda, T. & Yoshimori, T. (2008). The Atg16L complex 
specifies the site of LC3 lipidation for membrane biogenesis in autophagy. Mol Biol Cell, 
19, 2092-100. 
 
96   
Ganley, I. G., Wong, P. M., Gammoh, N. & Jiang, X. (2011). Distinct autophagosomal-lysosomal 
fusion mechanism revealed by thapsigargin-induced autophagy arrest. Mol Cell, 42, 731-
43. 
Ge, L., Melville, D., Zhang, M. & Schekman, R. (2013). The ER-Golgi intermediate compartment is 
a key membrane source for the LC3 lipidation step of autophagosome biogenesis. Elife, 
2, e00947. 
Gillooly, D. J., Raiborg, C. & Stenmark, H. (2003). Phosphatidylinositol 3-phosphate is found in 
microdomains of early endosomes. Histochem Cell Biol, 120, 445-53. 
Hammond, G. R., Machner, M. P. & Balla, T. (2014). A novel probe for phosphatidylinositol 4-
phosphate reveals multiple pools beyond the Golgi. J Cell Biol, 205, 113-26. 
Hammond, G. R., Schiavo, G. & Irvine, R. F. (2009). Immunocytochemical techniques reveal 
multiple, distinct cellular pools of PtdIns4P and PtdIns(4,5)P(2). Biochem J, 422, 23-35. 
Hanada, T., Noda, N. N., Satomi, Y., Ichimura, Y., Fujioka, Y., Takao, T., Inagaki, F. & Ohsumi, Y. 
(2007). The Atg12-Atg5 conjugate has a novel E3-like activity for protein lipidation in 
autophagy. J Biol Chem, 282, 37298-302. 
Harding, T. M., Morano, K. A., Scott, S. V. & Klionsky, D. J. (1995). Isolation and characterization 
of yeast mutants in the cytoplasm to vacuole protein targeting pathway. The Journal of 
Cell Biology, 131, 591-602. 
He, H., Dang, Y., Dai, F., Guo, Z., Wu, J., She, X., Pei, Y., Chen, Y., Ling, W., Wu, C., Zhao, S., Liu, J. 
O. & Yu, L. (2003). Post-translational modifications of three members of the human 
MAP1LC3 family and detection of a novel type of modification for MAP1LC3B. J Biol 
Chem, 278, 29278-87. 
Hosokawa, N., Hara, T., Kaizuka, T., Kishi, C., Takamura, A., Miura, Y., Iemura, S., Natsume, T., 
Takehana, K., Yamada, N., Guan, J. L., Oshiro, N. & Mizushima, N. (2009). Nutrient-
dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for 
autophagy. Mol Biol Cell, 20, 1981-91. 
Ichimura, Y., Imamura, Y., Emoto, K., Umeda, M., Noda, T. & Ohsumi, Y. (2004). In vivo and in 
vitro reconstitution of Atg8 conjugation essential for autophagy. J Biol Chem, 279, 
40584-92. 
Ichimura, Y., Kirisako, T., Takao, T., Satomi, Y., Shimonishi, Y., Ishihara, N., Mizushima, N., Tanida, 
I., Kominami, E., Ohsumi, M., Noda, T. & Ohsumi, Y. (2000). A ubiquitin-like system 
mediates protein lipidation. Nature, 408, 488-92. 
Imai, K., Hao, F., Fujita, N., Tsuji, Y., Oe, Y., Araki, Y., Hamasaki, M., Noda, T. & Yoshimori, T. 
(2016). Atg9A trafficking through the recycling endosomes is required for 
autophagosome formation. J Cell Sci, 129, 3781-3791. 
Itakura, E., Kishi-Itakura, C. & Mizushima, N. (2012). The hairpin-type tail-anchored SNARE 
syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes. Cell, 151, 
1256-69. 
Itakura, E., Kishi, C., Inoue, K. & Mizushima, N. (2008). Beclin 1 forms two distinct 
phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Mol Biol 
Cell, 19, 5360-72. 
Itakura, E. & Mizushima, N. (2010). Characterization of autophagosome formation site by a 
hierarchical analysis of mammalian Atg proteins. Autophagy, 6, 764-76. 
Jager, S., Bucci, C., Tanida, I., Ueno, T., Kominami, E., Saftig, P. & Eskelinen, E. L. (2004). Role for 
Rab7 in maturation of late autophagic vacuoles. J Cell Sci, 117, 4837-48. 
Jahreiss, L., Menzies, F. M. & Rubinsztein, D. C. (2008). The itinerary of autophagosomes: from 
peripheral formation to kiss-and-run fusion with lysosomes. Traffic, 9, 574-87. 
Jeschke, A., Zehethofer, N., Lindner, B., Krupp, J., Schwudke, D., Haneburger, I., Jovic, M., Backer, 
J. M., Balla, T., Hilbi, H. & Haas, A. (2015). Phosphatidylinositol 4-phosphate and 
phosphatidylinositol 3-phosphate regulate phagolysosome biogenesis. Proc Natl Acad Sci 
U S A, 112, 4636-41. 
  References 
  97 
Jiang, P., Nishimura, T., Sakamaki, Y., Itakura, E., Hatta, T., Natsume, T. & Mizushima, N. (2014). 
The HOPS complex mediates autophagosome–lysosome fusion through interaction with 
syntaxin 17. Molecular Biology of the Cell, 25, 1327-1337. 
Joachim, J., Jefferies, H. B., Razi, M., Frith, D., Snijders, A. P., Chakravarty, P., Judith, D. & Tooze, 
S. A. (2015). Activation of ULK Kinase and Autophagy by GABARAP Trafficking from the 
Centrosome Is Regulated by WAC and GM130. Mol Cell, 60, 899-913. 
Joachim, J., Razi, M., Judith, D., Wirth, M., Calamita, E., Encheva, V., Dynlacht, B. D., Snijders, A. 
P., O'reilly, N., Jefferies, H. B. J. & Tooze, S. A. (2017). Centriolar Satellites Control 
GABARAP Ubiquitination and GABARAP-Mediated Autophagy. Curr Biol, 27, 2123-2136 
e7. 
Juhasz, G. & Neufeld, T. P. (2006). Autophagy: A Forty-Year Search for a Missing Membrane 
Source. PLOS Biology, 4, e36. 
Jung, C. H., Jun, C. B., Ro, S. H., Kim, Y. M., Otto, N. M., Cao, J., Kundu, M. & Kim, D. H. (2009). 
ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol 
Biol Cell, 20, 1992-2003. 
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, 
Y. & Yoshimori, T. (2000). LC3, a mammalian homologue of yeast Apg8p, is localized in 
autophagosome membranes after processing. The EMBO Journal, 19, 5720-5728. 
Kabeya, Y., Mizushima, N., Yamamoto, A., Oshitani-Okamoto, S., Ohsumi, Y. & Yoshimori, T. 
(2004). LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on 
form-II formation. J Cell Sci, 117, 2805-12. 
Kaufmann, A. (2015). In vitro reconstitution of the autophagic membrane scaffold. 
Kaufmann, A., Beier, V., Franquelim, H. G. & Wollert, T. (2014). Molecular mechanism of 
autophagic membrane-scaffold assembly and disassembly. Cell, 156, 469-81. 
Kihara, A., Kabeya, Y., Ohsumi, Y. & Yoshimori, T. (2001). Beclin-phosphatidylinositol 3-kinase 
complex functions at the trans-Golgi network. EMBO Rep, 2, 330-5. 
Kim, J., Kundu, M., Viollet, B. & Guan, K. L. (2011). AMPK and mTOR regulate autophagy through 
direct phosphorylation of Ulk1. Nat Cell Biol, 13, 132-41. 
Kim, J. H., Hong, S. B., Lee, J. K., Han, S., Roh, K. H., Lee, K. E., Kim, Y. K., Choi, E. J. & Song, H. K. 
(2015). Insights into autophagosome maturation revealed by the structures of ATG5 
with its interacting partners. Autophagy, 11, 75-87. 
Kimura, S., Noda, T. & Yoshimori, T. (2014). Dissection of the Autophagosome Maturation 
Process by a Novel Reporter Protein, Tandem Fluorescent-Tagged LC3. Autophagy, 3, 
452-460. 
Kirisako, T., Ichimura, Y., Okada, H., Kabeya, Y., Mizushima, N., Yoshimori, T., Ohsumi, M., Takao, 
T., Noda, T. & Ohsumi, Y. (2000). The reversible modification regulates the membrane-
binding state of Apg8/Aut7 essential for autophagy and the cytoplasm to vacuole 
targeting pathway. J Cell Biol, 151, 263-76. 
Klionsky, D. J. (2008). Autophagy revisited: A conversation with Christian de Duve. Autophagy, 4, 
740-743. 
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., 
Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., Adhihetty, P. J., Adler, S. G., Agam, G., 
Agarwal, R., Aghi, M. K., Agnello, M., Agostinis, P., Aguilar, P. V., Aguirre-Ghiso, J., Airoldi, 
E. M., Ait-Si-Ali, S., Akematsu, T., Akporiaye, E. T., Al-Rubeai, M., Albaiceta, G. M., 
Albanese, C., Albani, D., Albert, M. L., Aldudo, J., Algul, H., Alirezaei, M., Alloza, I., 
Almasan, A., Almonte-Beceril, M., Alnemri, E. S., Alonso, C., Altan-Bonnet, N., Altieri, D. 
C., Alvarez, S., Alvarez-Erviti, L., Alves, S., Amadoro, G., Amano, A., Amantini, C., 
Ambrosio, S., Amelio, I., Amer, A. O., Amessou, M., Amon, A., An, Z., Anania, F. A., 
Andersen, S. U., Andley, U. P., Andreadi, C. K., Andrieu-Abadie, N., Anel, A., Ann, D. K., 
Anoopkumar-Dukie, S., Antonioli, M., Aoki, H., Apostolova, N., Aquila, S., Aquilano, K., 
Araki, K., Arama, E., Aranda, A., Araya, J., Arcaro, A., Arias, E., Arimoto, H., Ariosa, A. R., 
 
98   
Armstrong, J. L., Arnould, T., Arsov, I., Asanuma, K., Askanas, V., Asselin, E., Atarashi, R., 
Atherton, S. S., Atkin, J. D., Attardi, L. D., Auberger, P., Auburger, G., Aurelian, L., Autelli, 
R., Avagliano, L., Avantaggiati, M. L., Avrahami, L., Awale, S., Azad, N., Bachetti, T., 
Backer, J. M., Bae, D. H., Bae, J. S., Bae, O. N., Bae, S. H., Baehrecke, E. H., Baek, S. H., 
Baghdiguian, S., Bagniewska-Zadworna, A., et al. (2016). Guidelines for the use and 
interpretation of assays for monitoring autophagy (3rd edition). Autophagy, 12, 1-222. 
Komatsu, M., Waguri, S., Ueno, T., Iwata, J., Murata, S., Tanida, I., Ezaki, J., Mizushima, N., 
Ohsumi, Y., Uchiyama, Y., Kominami, E., Tanaka, K. & Chiba, T. (2005). Impairment of 
starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol, 169, 
425-34. 
Kremer, J. R., Mastronarde, D. N. & Mcintosh, J. R. (1996). Computer visualization of three-
dimensional image data using IMOD. J Struct Biol, 116, 71-6. 
Kukulski, W., Schorb, M., Welsch, S., Picco, A., Kaksonen, M. & Briggs, J. A. (2012). Precise, 
correlated fluorescence microscopy and electron tomography of lowicryl sections using 
fluorescent fiducial markers. Methods Cell Biol, 111, 235-57. 
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., 
Tokuhisa, T. & Mizushima, N. (2004). The role of autophagy during the early neonatal 
starvation period. Nature, 432, 1032-6. 
Kuznetsov, S. A. & Gelfand, V. I. (1987). 18 kDa microtubule-associated protein: identification as 
a new light chain (LC-3) of microtubule-associated protein 1 (MAP-1). FEBS Lett, 212, 
145-8. 
Lamb, C. A., Nuhlen, S., Judith, D., Frith, D., Snijders, A. P., Behrends, C. & Tooze, S. A. (2016). 
TBC1D14 regulates autophagy via the TRAPP complex and ATG9 traffic. EMBO J, 35, 281-
301. 
Landajuela, A., Hervas, J. H., Anton, Z., Montes, L. R., Gil, D., Valle, M., Rodriguez, J. F., Goni, F. 
M. & Alonso, A. (2016). Lipid Geometry and Bilayer Curvature Modulate LC3/GABARAP-
Mediated Model Autophagosomal Elongation. Biophys J, 110, 411-22. 
Le Guerroué, F., Eck, F., Jung, J., Starzetz, T., Mittelbronn, M., Kaulich, M. & Behrends, C. (2017). 
Autophagosomal Content Profiling Reveals an LC3C-Dependent Piecemeal Mitophagy 
Pathway. Molecular Cell, 68, 786-796.e6. 
Legesse-Miller, A., Sagiv, Y., Porat, A. & Elazar, Z. (1998). Isolation and characterization of a novel 
low molecular weight protein involved in intra-Golgi traffic. J Biol Chem, 273, 3105-9. 
Li, M., Hou, Y., Wang, J., Chen, X., Shao, Z. M. & Yin, X. M. (2011). Kinetics comparisons of 
mammalian Atg4 homologues indicate selective preferences toward diverse Atg8 
substrates. J Biol Chem, 286, 7327-38. 
Liu, X., Li, Y., Wang, X., Xing, R., Liu, K., Gan, Q., Tang, C., Gao, Z., Jian, Y., Luo, S., Guo, W. & Yang, 
C. (2017). The BEACH-containing protein WDR81 coordinates p62 and LC3C to promote 
aggrephagy. J Cell Biol. 
Longatti, A., Lamb, C. A., Razi, M., Yoshimura, S., Barr, F. A. & Tooze, S. A. (2012). TBC1D14 
regulates autophagosome formation via Rab11- and ULK1-positive recycling endosomes. 
J Cell Biol, 197, 659-75. 
Madjo, U., Leymarie, O., Fremont, S., Kuster, A., Nehlich, M., Gallois-Montbrun, S., Janvier, K. & 
Berlioz-Torrent, C. (2016). LC3C Contributes to Vpu-Mediated Antagonism of 
BST2/Tetherin Restriction on HIV-1 Release through a Non-canonical Autophagy 
Pathway. Cell Rep, 17, 2221-2233. 
Mancias, J. D. & Kimmelman, A. C. (2016). Mechanisms of Selective Autophagy in Normal 
Physiology and Cancer. J Mol Biol, 428, 1659-80. 
Mann, S. S. & Hammarback, J. A. (1994). Molecular characterization of light chain 3. A 
microtubule binding subunit of MAP1A and MAP1B. J Biol Chem, 269, 11492-7. 
Mcewan, D. G., Popovic, D., Gubas, A., Terawaki, S., Suzuki, H., Stadel, D., Coxon, F. P., Miranda 
De Stegmann, D., Bhogaraju, S., Maddi, K., Kirchof, A., Gatti, E., Helfrich, M. H., 
  References 
  99 
Wakatsuki, S., Behrends, C., Pierre, P. & Dikic, I. (2015). PLEKHM1 regulates 
autophagosome-lysosome fusion through HOPS complex and LC3/GABARAP proteins. 
Mol Cell, 57, 39-54. 
Mizushima, N., Kuma, A., Kobayashi, Y., Yamamoto, A., Matsubae, M., Takao, T., Natsume, T., 
Ohsumi, Y. & Yoshimori, T. (2003). Mouse Apg16L, a novel WD-repeat protein, targets to 
the autophagic isolation membrane with the Apg12-Apg5 conjugate. J Cell Sci, 116, 
1679-88. 
Mizushima, N., Levine, B., Cuervo, A. M. & Klionsky, D. J. (2008). Autophagy fights disease 
through cellular self-digestion. Nature, 451, 1069-75. 
Mizushima, N., Noda, T., Yoshimori, T., Tanaka, Y., Ishii, T., George, M. D., Klionsky, D. J., Ohsumi, 
M. & Ohsumi, Y. (1998). A protein conjugation system essential for autophagy. Nature, 
395, 395-8. 
Mizushima, N., Yamamoto, A., Matsui, M., Yoshimori, T. & Ohsumi, Y. (2004). In vivo analysis of 
autophagy in response to nutrient starvation using transgenic mice expressing a 
fluorescent autophagosome marker. Mol Biol Cell, 15, 1101-11. 
Moreau, K., Ravikumar, B., Renna, M., Puri, C. & Rubinsztein, D. C. (2011). Autophagosome 
precursor maturation requires homotypic fusion. Cell, 146, 303-17. 
Nair, U., Yen, W. L., Mari, M., Cao, Y., Xie, Z., Baba, M., Reggiori, F. & Klionsky, D. J. (2012). A role 
for Atg8-PE deconjugation in autophagosome biogenesis. Autophagy, 8, 780-93. 
Nakatogawa, H., Ichimura, Y. & Ohsumi, Y. (2007). Atg8, a ubiquitin-like protein required for 
autophagosome formation, mediates membrane tethering and hemifusion. Cell, 130, 
165-78. 
Nakatogawa, H. & Ohsumi, Y. (2012). SDS-PAGE techniques to study ubiquitin-like conjugation 
systems in yeast autophagy. Methods Mol Biol, 832, 519-29. 
Nemos, C., Mansuy, V., Vernier-Magnin, S., Fraichard, A., Jouvenot, M. & Delage-Mourroux, R. 
(2003). Expression of gec1/GABARAPL1 versus GABARAP mRNAs in human: 
predominance of gec1/GABARAPL1 in the central nervous system. Brain Res Mol Brain 
Res, 119, 216-9. 
Nguyen, T. N., Padman, B. S., Usher, J., Oorschot, V., Ramm, G. & Lazarou, M. (2016). Atg8 family 
LC3/GABARAP proteins are crucial for autophagosome-lysosome fusion but not 
autophagosome formation during PINK1/Parkin mitophagy and starvation. J Cell Biol. 
Nishimura, T., Tamura, N., Kono, N., Shimanaka, Y., Arai, H., Yamamoto, H. & Mizushima, N. 
(2017). Autophagosome formation is initiated at phosphatidylinositol synthase-enriched 
ER subdomains. EMBO J. 
Noda, N. N., Kumeta, H., Nakatogawa, H., Satoo, K., Adachi, W., Ishii, J., Fujioka, Y., Ohsumi, Y. & 
Inagaki, F. (2008). Structural basis of target recognition by Atg8/LC3 during selective 
autophagy. Genes Cells, 13, 1211-8. 
Ogawa, M., Yoshikawa, Y., Kobayashi, T., Mimuro, H., Fukumatsu, M., Kiga, K., Piao, Z., Ashida, 
H., Yoshida, M., Kakuta, S., Koyama, T., Goto, Y., Nagatake, T., Nagai, S., Kiyono, H., 
Kawalec, M., Reichhart, J. M. & Sasakawa, C. (2011). A Tecpr1-dependent selective 
autophagy pathway targets bacterial pathogens. Cell Host Microbe, 9, 376-89. 
Orsi, A., Razi, M., Dooley, H. C., Robinson, D., Weston, A. E., Collinson, L. M. & Tooze, S. A. 
(2012). Dynamic and transient interactions of Atg9 with autophagosomes, but not 
membrane integration, are required for autophagy. Mol Biol Cell, 23, 1860-73. 
Otomo, C., Metlagel, Z., Takaesu, G. & Otomo, T. (2013). Structure of the human ATG12~ATG5 
conjugate required for LC3 lipidation in autophagy. Nat Struct Mol Biol, 20, 59-66. 
Pankiv, S., Clausen, T. H., Lamark, T., Brech, A., Bruun, J. A., Outzen, H., Overvatn, A., Bjorkoy, G. 
& Johansen, T. (2007). p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation 
of ubiquitinated protein aggregates by autophagy. J Biol Chem, 282, 24131-45. 
 
100   
Paul-Gilloteaux, P., Heiligenstein, X., Belle, M., Domart, M.-C., Larijani, B., Collinson, L., Raposo, 
G. & Salamero, J. (2017). eC-CLEM: flexible multidimensional registration software for 
correlative microscopies. Nat Meth, 14, 102-103. 
Pengo, N., Agrotis, A., Prak, K., Jones, J. & Ketteler, R. (2017). A reversible phospho-switch 
mediated by ULK1 regulates the activity of autophagy protease ATG4B. Nat Commun, 8, 
294. 
Pfisterer, S. G., Bakula, D., Frickey, T., Cezanne, A., Brigger, D., Tschan, M. P., Robenek, H. & 
Proikas-Cezanne, T. (2014). Lipid droplet and early autophagosomal membrane targeting 
of Atg2A and Atg14L in human tumor cells. Journal of Lipid Research, 55, 1267-1278. 
Pickart, C. M. (2001). Mechanisms underlying ubiquitination. Annu Rev Biochem, 70, 503-33. 
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A. & Zhang, F. (2013). Genome 
engineering using the CRISPR-Cas9 system. Nat Protoc, 8, 2281-308. 
Ravikumar, B., Moreau, K., Jahreiss, L., Puri, C. & Rubinsztein, D. C. (2010). Plasma membrane 
contributes to the formation of pre-autophagosomal structures. Nat Cell Biol, 12, 747-
57. 
Rogov, V., Dotsch, V., Johansen, T. & Kirkin, V. (2014). Interactions between autophagy receptors 
and ubiquitin-like proteins form the molecular basis for selective autophagy. Mol Cell, 
53, 167-78. 
Rong, Y., Liu, M., Ma, L., Du, W., Zhang, H., Tian, Y., Cao, Z., Li, Y., Ren, H., Zhang, C., Li, L., Chen, 
S., Xi, J. & Yu, L. (2012). Clathrin and phosphatidylinositol-4,5-bisphosphate regulate 
autophagic lysosome reformation. Nat Cell Biol, 14, 924-34. 
Russell, R. C., Tian, Y., Yuan, H., Park, H. W., Chang, Y.-Y., Kim, J., Kim, H., Neufeld, T. P., Dillin, A. 
& Guan, K.-L. (2013). ULK1 induces autophagy by phosphorylating Beclin-1 and activating 
VPS34 lipid kinase. Nat Cell Biol, 15, 741-750. 
Saftig, P. & Klumperman, J. (2009). Lysosome biogenesis and lysosomal membrane proteins: 
trafficking meets function. Nat Rev Mol Cell Biol, 10, 623-35. 
Sanchez-Wandelmer, J., Kriegenburg, F., Rohringer, S., Schuschnig, M., Gomez-Sanchez, R., Zens, 
B., Abreu, S., Hardenberg, R., Hollenstein, D., Gao, J., Ungermann, C., Martens, S., Kraft, 
C. & Reggiori, F. (2017). Atg4 proteolytic activity can be inhibited by Atg1 
phosphorylation. Nat Commun, 8, 295. 
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., 
Rueden, C., Saalfeld, S., Schmid, B., Tinevez, J. Y., White, D. J., Hartenstein, V., Eliceiri, K., 
Tomancak, P. & Cardona, A. (2012). Fiji: an open-source platform for biological-image 
analysis. Nat Methods, 9, 676-82. 
Scholz, J., Besir, H., Strasser, C. & Suppmann, S. (2013). A new method to customize protein 
expression vectors for fast, efficient and background free parallel cloning. BMC 
Biotechnol, 13, 12. 
Sengupta, S., Peterson, T. R. & Sabatini, D. M. (2010). Regulation of the mTOR complex 1 
pathway by nutrients, growth factors, and stress. Molecular cell, 40, 310-322. 
Shpilka, T. W., H.; Pietrokovski, S.; Elazar, Z. (2011). Atg8: an autophagy-related ubiquitin-like 
protein family. Genome Biology. 
Shvets, E., Abada, A., Weidberg, H. & Elazar, Z. (2011). Dissecting the involvement of LC3B and 
GATE-16 in p62 recruitment into autophagosomes. Autophagy, 7, 683-688. 
Sou, Y. S., Waguri, S., Iwata, J., Ueno, T., Fujimura, T., Hara, T., Sawada, N., Yamada, A., 
Mizushima, N., Uchiyama, Y., Kominami, E., Tanaka, K. & Komatsu, M. (2008). The Atg8 
conjugation system is indispensable for proper development of autophagic isolation 
membranes in mice. Mol Biol Cell, 19, 4762-75. 
Sridhar, S., Patel, B., Aphkhazava, D., Macian, F., Santambrogio, L., Shields, D. & Cuervo, A. M. 
(2013). The lipid kinase PI4KIIIbeta preserves lysosomal identity. EMBO J, 32, 324-39. 
Stadel, D., Millarte, V., Tillmann, K. D., Huber, J., Tamin-Yecheskel, B. C., Akutsu, M., Demishtein, 
A., Ben-Zeev, B., Anikster, Y., Perez, F., Dotsch, V., Elazar, Z., Rogov, V., Farhan, H. & 
  References 
  101 
Behrends, C. (2015). TECPR2 Cooperates with LC3C to Regulate COPII-Dependent ER 
Export. Mol Cell, 60, 89-104. 
Suzuki, K., Kubota, Y., Sekito, T. & Ohsumi, Y. (2007). Hierarchy of Atg proteins in pre-
autophagosomal structure organization. Genes Cells, 12, 209-18. 
Szalai, P., Hagen, L. K., Saetre, F., Luhr, M., Sponheim, M., Overbye, A., Mills, I. G., Seglen, P. O. & 
Engedal, N. (2015). Autophagic bulk sequestration of cytosolic cargo is independent of 
LC3, but requires GABARAPs. Exp Cell Res, 333, 21-38. 
Thumm, M., Egner, R., Koch, B., Schlumpberger, M., Straub, M., Veenhuis, M. & Wolf, D. H. 
(1994). Isolation of autophagocytosis mutants of Saccharomyces cerevisiae. FEBS Letters, 
349, 275-280. 
Tokuyasu, K. T. (1973). A TECHNIQUE FOR ULTRACRYOTOMY OF CELL SUSPENSIONS AND 
TISSUES. The Journal of Cell Biology, 57, 551-565. 
Tsukada, M. & Ohsumi, Y. (1993). Isolation and characterization of autophagy-defective mutants 
of Saccharomyces cerevisiae. FEBS Letters, 333, 169-174. 
Verlhac, P., Gregoire, I. P., Azocar, O., Petkova, D. S., Baguet, J., Viret, C. & Faure, M. (2015). 
Autophagy receptor NDP52 regulates pathogen-containing autophagosome maturation. 
Cell Host Microbe, 17, 515-25. 
Vicinanza, M., Korolchuk, V. I., Ashkenazi, A., Puri, C., Menzies, F. M., Clarke, J. H. & Rubinsztein, 
D. C. (2015). PI(5)P regulates autophagosome biogenesis. Mol Cell, 57, 219-34. 
Von Muhlinen, N., Akutsu, M., Ravenhill, B. J., Foeglein, A., Bloor, S., Rutherford, T. J., Freund, S. 
M., Komander, D. & Randow, F. (2012). LC3C, bound selectively by a noncanonical LIR 
motif in NDP52, is required for antibacterial autophagy. Mol Cell, 48, 329-42. 
Wang, H., Bedford, F. K., Brandon, N. J., Moss, S. J. & Olsen, R. W. (1999). GABA(A)-receptor-
associated protein links GABA(A) receptors and the cytoskeleton. Nature, 397, 69-72. 
Wang, H., Sun, H. Q., Zhu, X., Zhang, L., Albanesi, J., Levine, B. & Yin, H. (2015). GABARAPs 
regulate PI4P-dependent autophagosome:lysosome fusion. Proc Natl Acad Sci U S A, 
112, 7015-20. 
Weidberg, H., Shpilka, T., Shvets, E., Abada, A., Shimron, F. & Elazar, Z. (2011). LC3 and GATE-16 
N termini mediate membrane fusion processes required for autophagosome biogenesis. 
Dev Cell, 20, 444-54. 
Weidberg, H., Shvets, E., Shpilka, T., Shimron, F., Shinder, V. & Elazar, Z. (2010). LC3 and GATE-
16/GABARAP subfamilies are both essential yet act differently in autophagosome 
biogenesis. The EMBO Journal, 29, 1792-1802. 
Wild, P., Farhan, H., Mcewan, D. G., Wagner, S., Rogov, V. V., Brady, N. R., Richter, B., Korac, J., 
Waidmann, O., Choudhary, C., Dötsch, V., Bumann, D. & Dikic, I. (2011). Phosphorylation 
of the Autophagy Receptor Optineurin Restricts <em>Salmonella</em> Growth. Science, 
333, 228-233. 
Wild, P., Mcewan, D. G. & Dikic, I. (2014). The LC3 interactome at a glance. J Cell Sci, 127, 3-9. 
Wilkinson, D. S., Jariwala, J. S., Anderson, E., Mitra, K., Meisenhelder, J., Chang, J. T., Ideker, T., 
Hunter, T., Nizet, V., Dillin, A. & Hansen, M. (2015). Phosphorylation of LC3 by the Hippo 
kinases STK3/STK4 is essential for autophagy. Mol Cell, 57, 55-68. 
Yamamoto, H., Kakuta, S., Watanabe, T. M., Kitamura, A., Sekito, T., Kondo-Kakuta, C., Ichikawa, 
R., Kinjo, M. & Ohsumi, Y. (2012). Atg9 vesicles are an important membrane source 
during early steps of autophagosome formation. J Cell Biol, 198, 219-33. 
Young, A. R., Chan, E. Y., Hu, X. W., Kochl, R., Crawshaw, S. G., High, S., Hailey, D. W., Lippincott-
Schwartz, J. & Tooze, S. A. (2006). Starvation and ULK1-dependent cycling of mammalian 
Atg9 between the TGN and endosomes. J Cell Sci, 119, 3888-900. 
Yu, L., Mcphee, C. K., Zheng, L., Mardones, G. A., Rong, Y., Peng, J., Mi, N., Zhao, Y., Liu, Z., Wan, 
F., Hailey, D. W., Oorschot, V., Klumperman, J., Baehrecke, E. H. & Lenardo, M. J. (2010). 
Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature, 
465, 942-6. 
 
102   
 
  
  Acknowledgements 
  103 
8 ACKNOWLEDGEMENTS 
I would like to thank everyone who made this thesis possible and successful. 
First of all, I want to thank my supervisor Dr. Thomas Wollert for his exceptional 
support during my PhD. Particularly, I want to thank him for providing me challenges I 
would have probably not taken of my own accord, like presenting my work at a sympo-
sium already in my first year or undergo a 3-month training at the EMBL, Heidelberg. 
Moreover, I enjoyed the scientific discussions with him, which usually ended in construc-
tive ideas.  
I also want to thank Prof. Stefan Jentsch, who at the beginning of my PhD kindly 
agreed to be my official supervisor before he sadly passed away too soon. In addition, I 
want to thank Prof. Ulrich Hartl for being second reviewer of this thesis. Thanks also to 
my TAC members, especially Julia von Blume and Christian Behrends, who showed great 
interest in my project, gave useful advice, and were always willing to collaborate with 
our lab. 
Furthermore, I would like to thank my (former) lab members for the scientific ex-
change as well as for their company during lunch breaks and other work-(un)related 
activities. Particularly, I want to thank Viola Beier, who lightened my workload, so that I 
had more time to analyze data and plan experiments. Moreover, I want to thank Anna 
Kaufmann for her excellent supervision during my master thesis, which made a smooth 
transition into my PhD possible. 
I would also like to thank the Biochemistry Core and Imaging Facility of the Max 
Planck Institute of Biochemistry in Martinsried as well as the Electron Microscopy Core 
Facility of the EMBL in Heidelberg for providing their equipment and scientific services. 
Finally, I am grateful to my family and friends who always supported me, with special 
thanks to Andi, who always encouraged me with his positive attitude.  
